Utilising data for a better understanding of disease by Agostino, Jason
Utilising data for a better 
understanding of disease 
Dr Jason William Agostino 
January 2016 
 
Master of Philosophy in Applied Epidemiology bound volume 
National Center for Epidemiology and Population Health 
 
 
A thesis submitted for the degree of Masters of Philosophy in Applied 
Epidemiology of the Australian National University 
Field Supervisors:  
Dr Alan Ruben, Dr Katie Panaretto and Dr Ana Herceg 
Academic Supervisors:  
Dr Mahomed Patel, Dr Martyn Kirk and Dr Stephanie Davis 
 
 i 
Originality Statement 
‘I hereby declare that this submission is my own work and to the best of my knowledge it 
contains no materials previously published or written by another person, or substantial 
proportions of material which have been accepted for the award of any other degree or 
diploma at the Australian National University or any other educational institution, except 
where due acknowledgement is made in the thesis.  Any contribution made to the research by 
others, with whom I have worked with is explicitly acknowledged in the thesis.  I also declare 
that the intellectual content of this thesis is the product of my own work, except to the extent 
that assistance from others in the project’s design and conception or in style, presentation or 
linguistic expression is acknowledged’. 
 
 
Signed…………………………………………………………………… 
 
Date……………………………………………………………………… 
 ii 
Acknowledgements 
To my wife, you are the main reason I finished this thesis. Without your support I would never 
have persevered. Thanks for sharing my vision on what it means to be a doctor. 
To Dr Mahomed Patel, thank you for pushing me to the edge of my capabilities. Like the best 
coaches I’ve had, you challenged and frustrated me and I am better for it. 
To Dr Martyn Kirk, thanks for your understanding throughout what have been a tumultuous 
four years. Thank you for always inspiring confidence in my own abilities. 
To Dr David McGill, thanks for pushing me and supporting me in my studies for the past 25 
years.  The Yogabell study sessions were invaluable. 
To Dr Alan Ruben, thanks for convincing me to do this course. I suspect your prediction will 
come true and this course will change my life. 
To Dr Katie Panaretto, thanks for showing me how to be a tenacious and fearless advocate for 
Aboriginal and Torres Strait Islander people.   
To Dr Ana Herceg and Dr Stephanie Davis, thank you for reviewing my work towards the end of 
the course. It was a big ask and your insights proved invaluable. 
To all the MAE’ers, I have had the privilege of being part of three separate year groups and 
have learnt so much from so many.  Thanks in particular to Tove Fitzgerald who put things in 
perspective when I thought I was busy, Dr Phillipa Chidgzey and Dina Saulo for being my 
education buddies, Kerryn Lodo for being the person to talk to when it all seemed too hard 
and Leone Malamoo working with me on the outbreak investigation  
To mum and dad, thanks for giving me a life where anything is possible. 
To Jayne and Emma, thanks for your support through the tough times over the four years and 
for giving me two brothers, two nieces and one nephew in that time. 
 iii 
Contents 
Abstract..........................................................................................................................iv 
Chapter 1 : Overview of placements and summary of course requirements for the 
Master of Philosophy in Applied Epidemiology ............................................................ 1 
Chapter 2 : Conduct and interpret an epidemiological study.   Birth weight and early 
childhood growth in Cape York: Findings from 10 birth cohorts .................................. 9 
Chapter 3 : Evaluation of a health information system.  Evaluation of the National Key 
Performance Indicators for Aboriginal and Torres Strait Islander Primary Health Care 
Services........................................................................................................................ 31 
Chapter 4 : Analysis of a public health dataset.  The changing epidemiology of 
methicillin resistant Staphylococcus aureus infection in north-eastern New South 
Wales and implications for management ................................................................. 155 
Chapter 5 : Investigation of an acute public health problem.  Investigation of increased 
notifications of Salmonella Saintpaul in Queensland ............................................... 205 
Appendixes ................................................................................................................ 247 
 
 iv 
Abstract 
The Australian health system is awash with data. Across our primary and public healthcare 
systems we are collecting data through administrative systems, medical records, and 
pathology laboratories, to name just a few. These data have been used by researchers and 
policy makers, but there remains much to be gained from harnessing new technologies and 
linking datasets to better inform our understanding of disease.  
In this thesis, I present four pieces of work on topics that are united through their use of data 
linkage or new technology.  Throughout my four years as a Master of Philosophy in Applied 
Epidemiology (MAE) scholar I undertook a variety of work in conjunction with four field 
placement organisations: Apunipima Cape York Health Council, the National Aboriginal 
Community Controlled Health Organisation, the Hunter New England local hospitals district, 
and Queensland Health.  This thesis presents the results of the applied research from these 
organisations. 
My first project is an epidemiological study on early childhood growth in Cape York 
communities from 1999-2010.  By combining routinely collected data on child weights with 
birth data from the National Perinatal Epidemiology and Statistics Unit we demonstrated a 
relationship between birth weight and early childhood growth.  We also highlighted that while 
significant improvements have been made in early childhood growth, there remained high 
rates of low birth weight and prematurity. 
My second project is an evaluation of the National Key Performance Indicators for Aboriginal 
and Torres Strait Islander Primary Health Care Services (nKPIs).  This collection is the first 
attempt by the Australian Government to use data extracted from clinical records to monitor 
the effectiveness of the health system.  Our evaluation assessed the quality and usability of 
the 24 indicators that comprise the nKPIs. While these data have great potential, our 
evaluation highlighted that they also have important limitations, such as the biases introduced 
when using these data for population health indicators like smoking status. 
My third project is a data analysis of Staphylococcus aureus isolates in the Hunter New England 
region from 2008-2014.  This region has established a dataset of patient demographics and 
hospitalisations that we combined with laboratory data on S. aureus isolates. By combining 
these data we demonstrated a high proportion of methicillin resistant S. aureus (MRSA) that 
primarily occurred within young people with no recent exposure to the public healthcare 
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system. This study highlights that control measures for MRSA must move from the hospital 
into the community setting. 
My final project is a report on an outbreak investigation of Salmonella Saintpaul that I 
conducted on behalf of Queensland Health in March 2015.  We conducted hypothesis-
generating interviews with 23 cases and while our investigation did not reveal a source of the 
outbreak, analysis with further typing raised the possibility that the increase in reported cases 
was not in fact an outbreak.  This raises the importance of characterisation of Salmonella with 
genetic tests to identify common strains. 
My thesis demonstrates the possibilities available through data linkage and molecular 
characterisation as we move into a new era of public health. 
Chapter 1 : Overview of placements 
and summary of course requirements 
for the Master of Philosophy in Applied 
Epidemiology 
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1. Overview 
My time as a Masters of Philosophy in Applied Epidemiology (MAE) scholar differed from the 
conventional MAE structure. Throughout my four years of study I was self-funded and worked 
part time in jobs relevant to epidemiology while continuing my work as a general practitioner 
in Aboriginal community controlled health organisations.  I began my studies in Cairns where I 
conducted an epidemiological study on birth weight and early childhood growth amongst the 
Aboriginal and Torres Strait Islander communities of Cape York Peninsula.  I then moved to 
Canberra and worked for the National Aboriginal Community Controlled Health Organisation 
(NACCHO).  At the NACCHO I helped develop the organisations capacity to collect and analyse 
data from 136 Aboriginal community controlled health organisations across Australia.  As part 
of this work I completed an evaluation of the national Key Performance Indicators that these 
organisations report on to the Australian Government.  In addition to these jobs in Cairns and 
Canberra, I worked in my own time to meet the final requirements of the MAE. For my data 
analysis project I collaborated with staff from Hunter New England Local Health District to 
analyse a dataset on Staphylococcus aureus infections. For my outbreak investigation, I worked 
under the direction of staff from Queensland Health and OzFoodNet to investigate an 
outbreak of Salmonella Saintpaul.  
This chapter briefly describes my work placement, my MAE core activities and the public 
health importance of my projects. 
2. Work placements 
My first work placement was at James Cook University where I was employed as an academic 
general practitioner as part of my general practice training.  At the university, I conducted a 
study on birth weight and early childhood growth in the Aboriginal and Torres Strait Islander 
communities of Cape York Peninsula.  This study arose from a research question I developed 
while working in these communities and my first field placement supervisor was a 
paediatrician and MAE alumnus Dr Alan Ruben. In addition to this epidemiological study I 
began developing a surveillance system for skin infection in remote Aboriginal and Torres 
Strait communities with the Tropical Public Health Unit.  This work was stopped after family 
concerns meant I needed to move to Canberra. 
In Canberra, I was employed at the NACCHO, the national peak body representing Aboriginal 
community controlled health organisations across Australia. At the NACCHO my supervisor 
was Dr Katie Panaretto—a public health physician and general practitioner—and our work 
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focused on data extracted from general practice electronic medical records (otherwise known 
as Patient Information and Recall Systems, PIRS). The organisations that the NACCHO 
represent began reporting to the Australian Government on a set of national key performance 
indicators extracted from PIRS in 2012 and I helped develop a system for the NACCHO to 
collect and analyse these data. In addition, I sat on several Australian Government advisory 
groups relating to Aboriginal and Torres Strait Islander data and I also helped develop new 
indicators that could be extracted from PIRS in areas such as maternal health, sexual health 
and ear disease.   
3. Summary of core activities 
During my time as an MAE scholar I undertook four projects that enabled me to develop 
expertise in the use of primary health care data.  All but one project used data that was 
extracted from primary health care systems and two projects focused on non-communicable 
diseases. This focus was driven by my experiences as a clinician and a desire to apply the 
principles of field epidemiology to the new datasets being generated from primary health care. 
Through understanding how concepts such as selection and measurement bias apply to these 
new datasets I could then use these data to better understand conditions such as early 
childhood growth.  I was also able to highlight where improvements are needed in areas such 
as data entry for primary health care data to provide more valid results. 
Through completing these four projects my ability to work independently as an epidemiologist 
has evolved. When undertaking my first project I was very much a clinical expert and worked 
closely with my supervisor and co-authors to shape the study design and data analysis. By the 
time I did my final project on S. aureus infections, my role had reversed and I was able to come 
in to a team of clinical experts and use my knowledge of biases, data linkage and data analysis 
to bring meaning to their data. 
The projects and activities I conducted to meet the requirements of the MAE were as follows. 
3.1 Conduct and interpret an epidemiological study 
This study was on birth weights and early childhood growth of children in the remote 
Aboriginal and Torres Strait Islander communities of Cape York Peninsula from 1999 - 2010. 
We assessed time trends in the proportion of underweight children in these communities and 
explored the association between birth outcomes and underweight.  This study was done in 
collaboration with Apunipima Cape York Health Council and is presented in chapter 2. 
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3.2 Evaluation of a health information system 
This project was an evaluation of the national Key Performance Indicators for Aboriginal and 
Torres Strait Islander Primary Health Care Services. These are a set of 24 indicators that are 
extracted from PIRS and reported to the Australian Government. Our evaluation assessed the 
validity and usability of the indicators using criteria set by the United Kingdom National Health 
Service in ‘The Good Indicators Guide’.  The evaluation was done with consultation with the 
Aboriginal community controlled health sector and is presented in chapter 3. 
3.3 Analysis of a public health dataset 
This project was an analysis of individuals with S. aureus isolated from pathology specimens in 
the Hunter New England region from 2008-2014. I compared the demographics of individuals 
with methicillin sensitive S. aureus to those methicillin resistant S. aureus (MRSA) and assessed 
changes over time to antibiotic resistance and exposure to the public hospital system for 
individuals with MRSA. To do this analysis, I combined a dataset of patient demographics and 
hospitalisations with laboratory data on S. aureus isolates. This work was done with staff from 
the Hunter New England Local Health District and is presented in chapter 4. 
3.4 Investigation of an acute public health problem 
This was an investigation of increased notifications of S. Saintpaul in Queensland in January 
2015. I analysed data on S. Saintpaul notifications for the past five years and conducted 
hypothesis-generating interviews with new notifications under the direction of staff from 
Queensland Health and OzFoodNet. This work is presented in chapter 5. 
3.5 Critical review of the scientific literature 
While every project required a review of the scientific literature to inform it’s context and 
scope, a focused literature review on the prevalence of underweight and the timing of growth 
faltering amongst Aboriginal and Torres Strait Islander infants is presented as an appendix  
3.6 Preparation of an advanced draft of a paper for publication 
The body of chapter 2 is an advanced draft of a paper prepared for publication and this paper 
has been submitted to an Australian journal for review. 
3.7 An oral presentation at a national scientific conference 
I presented at three national conferences during my time as an MAE scholar. My first 
presentation related to my epidemiological study:  
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 Agostino J, Ruben A, Larkins S. ‘Early Childhood Growth in Cape York Communities 
1999-2010.’ Primary Health Care Research Conference. Canberra, 18-20 July 2011. 
The slides from this presentation are attached as an appendix. 
Additionally I presented at two other national conferences on work that was informed by my 
evaluation of the national Key Performance Indicators: 
 Agostino J, Panaretto K, Williams R, Briggs L, Brown N. ‘Aboriginal data in Aboriginal 
hands: The NACCHO data repository’ Lowitja Institute’s 2nd Annual Conference on 
Continuous Quality Improvement in Aboriginal and Torres Strait Islander Primary 
Health Care. Melbourne, 17-18 March 2014. 
 Agostino J, Panaretto K. ‘Aboriginal primary healthcare data in Aboriginal hands – 
improving health service delivery and outcomes in the Aboriginal community control 
sector nationally. Royal Australian College of General Practitioners national 
conference.  Adelaide, 9-11 October 2014. 
3.8 A report on the project to a non-scientific audience 
While conducting my epidemiological study I presented to the board of Apunipima Cape York 
Health Council on my preliminary findings. The board of Apunipima Cape York Health Council 
are all local Aboriginal and Torres Strait Islander people and while they have expertise in the 
needs of their communities, some have not received formal training in a health field. The slides 
from this presentation are presented as an appendix. 
3.9 Teaching requirements 
As part of my employment at James Cook University I conducted weekly tutorials with fourth 
year medical students and also lectured the year group as a whole. I also held three education 
sessions for the Far North Queensland Division of General Practice on the management of 
underweight children that included the findings from my study. 
In addition to this work, I conducted a teaching session for the 2014 MAE cohort on analysing 
time series data and held a lesson from the field on successful communication.  The slides and 
handouts for these education sessions are presented as an appendix. 
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4. Public health implications 
The public health implications of each project are detailed within the prologue and discussion 
of each chapter. However, uniting all four projects is the use of new technologies to provide 
insights into persistent health problems. Through data extraction and data linkage my 
epidemiological study demonstrated an association between intrauterine and early childhood 
growth in the Aboriginal and Torres Strait Islander communities of Cape York Peninsula.  Using 
the same technologies, my data analysis project highlighted the changing epidemiology of 
methicillin resistant S. aureus infections in the Hunter New England region. In both instances, 
these data were sitting within information systems uncollated and unanalysed.  Likewise, my 
evaluation has highlighted how data extraction of primary health care clinical records can help 
clinicians and policy makers to collate and analyse these data to improve our monitoring of 
chronic disease. Finally my disease outbreak investigation showed how cluster identification 
could be improved through the use of new genetic typing.  Together these chapters 
demonstrate the possibilities available through data extraction, data linkage and molecular 
characterisation as we move into a new era of public health. 
Chapter 2 : Conduct and interpret an 
epidemiological study.  
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1. Prologue 
1.1 My role 
I was the lead researcher in this study, from the design phase to write up. The concept for this 
study was developed during my time as a registrar in the Cape York paediatric outreach clinic. 
My clinical supervisor was a general practitioner who had worked in the communities of Cape 
York Peninsula for twenty years and believed children’s weights had improved.  I was 
interested to see if there was truth to his observation and audited the clinic’s records. This 
audit confirmed a decrease in the proportion of underweight children presenting to the clinic 
over time. I then designed a more formal study and applied for a research grant through 
General Practice Education and Training. This grant provided me with a two year funded 
position as a lecturer at James Cook University and additional funds for travel, software and 
support with statistical analysis.  
The study design was refined with my field supervisor, Dr Alan Ruben, who is credited with 
adding birth characteristics as a component of the study. In order to collect the data for this 
project, I travelled to all nine study communities to audit children’s medical records and linked 
these result with data received from the Queensland Perinatal Data Collection and Queensland 
Health’s Ferret database.  
Statistical analysis was performed with support from Dr Reinhold Mueller, a statistician 
affiliated with James Cook University. While I cleaned the data and performed descriptive and 
time series analyses, Dr Mueller confirmed my initial analyses, explored the data for 
confounders and performed logistic regression. Dr Mueller was paid for the time he 
contributed from my research grant. This approach was taken as data analyses were 
completed prior to taking the relevant course block within the MAE. 
I was the lead author for the paper and Dr Mahomed Patel provided significant guidance in the 
structure of the paper and language used. 
1.2 Lessons learned 
This was my first foray into research and consequently I learned many lessons in how to 
conduct a study.  The first lesson learnt was the difficulty in obtaining ethics approval. While I 
had the support of the local Aboriginal and Torres Strait Islander communities from early in the 
study’s development, it was still difficult to obtain approval from the relevant data custodians. 
The second lesson learnt was in the importance of communicating my findings to the right 
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audience.  While the goal was to publish in a scientific journal, this would not reach many 
people who would benefit from the findings of this study. By presenting to the board of 
Apunipima Cape York Health Council and to local doctors and nurses, I was able to ensure the 
findings were used to shape health care locally. Finally, the study taught me a great deal about 
the collaborative nature of scientific writing. It took many edits, and a great deal of support 
from my academic supervisor, to have the paper at a level that is fit to submit to an academic 
journal. 
1.3 Public Health Implications 
This study highlighted that most growth faltering first occurs in utero for children in the 
Aboriginal and Torres Strait Islander communities of Cape York Peninsula. This means that 
interventions to improve antenatal care may be the safest and most effective way to prevent 
children from becoming underweight. This link between antenatal care and early childhood 
outcomes has shaped Apunipima Cape York Health Council’s approach to health care. 
Following the findings of this study, Apunipima has strengthened it’s focus on antenatal care 
and runs a program that focuses on the first 1000 days of life, from gestation to 2 years old, 
called ‘The Baby One Program’.  
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2. Abstract 
Objectives: To assess time trends in the proportion of underweight children among children in 
nine remote Cape York communities and explore the association between birth outcomes and 
underweight. 
Design, setting and participants: A historical birth cohort study of 1276 children from birth to 
two years of age, between January 1999 and December 2010. 
Main outcome measure: Birth weight, gestational age at birth and weight measurements 
taken at approximately 3, 6, 9, 12, 18 and 24 months of age. 
Results:  The proportion of underweight children decreased overall with a high of 16% in the 
1999 cohort and a low of 3.3% in the 2007 cohort (χ2 for trend 20.9, df =1, p <0.001).   Small 
for gestational age  (SGA) was a risk factor for being underweight (OR 5.1, 95% CI 3.3, 7.9, 
P<0.001) as was prematurity (OR 2.4, 95% CI 1.4, 4.0, P<0.01). The proportion of small for 
gestational age births decreased from 2002 onwards from a maximum of 35.5% with the 
minimum of 17.8% observed in 2006 (χ2 for trend 8.2, df =1, p <0.001) but other birth 
outcomes remained consistently poor.  Mean birth weight was more than 300gm below the 
national average and the proportion of premature births was double the national average.   
Conclusion: Early childhood growth has improved consistently since 1999 and was associated 
with both a reduction in SGA births and in weaning malnutrition.  However, there were 
consistently low mean birth weights and elevated rates of prematurity.  These poor birth 
outcomes were associated with a greater risk of being underweight in the first two years of life.
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3. Introduction 
Poor growth from conception to two years of age has lifelong implications for health.   Both 
low birth weight and underweight children have increased morbidity and mortality in 
childhood1 as well as an increased risk of chronic diseases.2 The risk of chronic disease appears 
highest amongst low birth weight children who undergo rapid early childhood growth with 
studies showing this is associated with a higher prevalence of obesity3 and insulin resistance.4 
The promotion of catch-up growth through the use of enriched formula is also associated with 
increased risk of obesity and diastolic blood pressure in childhood.5, 6 Thus growth faltering 
that occurs first in utero requires a different approach to growth faltering in early childhood. 
Although an increased prevalence of intrauterine growth restriction7-9, underweight children10 
and adult chronic disease11 have been recorded in remote Aboriginal and Torres Strait Islander 
communities, the association between poor intrauterine growth and underweight is not clearly 
defined.  No studies in Aboriginal and Torres Strait Islander communities have followed growth 
from birth through the first two years of life since the introduction of the internationally 
accepted World Health Organization (WHO) growth standards.  If a child’s weight gain in the 
first two years of life results from poor growth in utero, we may be causing later harm by 
directing interventions to increase weight after birth. 
We studied annual birth cohorts of children from nine Aboriginal and Torres Strait Islander 
communities of Cape York Peninsula born between 1999 and 2008 to assess time trends in 
birth weights, in the proportion who are underweight in the first two years of life and to assess 
the relationship between SGA, prematurity and underweight. We also explored whether 
changes in social policy and health service delivery may have been associated with the trends 
in birth weight and childhood growth  
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4. Methods 
This study was conducted through health services in nine remote Aboriginal and Torres Strait 
Islander communities of Cape York Peninsula with populations of between 285 and 1394 
people, and where over 80% of the population identifies as Aboriginal and/or Torres Strait 
Islander.12 All nine communities are classified as either ‘remote’ or ‘very remote’ by the 
Australian Standard Geographical Classification. 
The study population was defined as all children born between January 1999 and December 
2008 whose primary residence was in one or more of the nine study communities for most of 
their first two years of life. The children were identified from clinic medical records and had 
attended a clinic within a study community over at least 12 months of their first two years of 
life. Children with a congenital condition known to affect growth or with insufficient data to 
determine gestational age at birth were excluded.  
Data were obtained from three sources: records held in each community clinic, Queensland 
Health’s Ferret database which contains data on anthropometric measurements collected 
after 2003 and the Queensland Perinatal Data Collection (PDC) database.  The records were 
matched by date of birth, sex and birth weight. The outcome measures were birth weight, 
gestational age at birth and weight measurements taken at approximately 3, 6, 9, 12, 18 and 
24 months of age. 
SGA was defined as a birth weight in the lowest 10% of the corresponding gestational age in 
the most recent Australian birth weight charts.13 Gestational age at birth was taken from 
either the PDC or the clinic records.  In cases of discrepant results between these sources, the 
gestational age documented by the paediatric team at the hospital was taken to be the valid 
measure.  Because such discrepancies are most likely for neonates with a low birth weight, the 
PDC entries recorded as premature or less than 2700gm were compared with data in the 
referral hospital’s discharge summary.  
Underweight was defined as a weight for age two standard deviations scores (z-scores) or 
more below the median weight for age, based on the WHO growth standards. Overweight was 
defined as two z-scores above the median. Children’s age was adjusted for prematurity at time 
of measurement. To be classified as either underweight or overweight, two or more 
measurements had to be recorded above or below these thresholds at separate age 
milestones.  
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Data from records of each child were searched within 6 age milestones: 1-4 months, 5-7 
months, 8-10 months, 11-14 months, 15-20 months and 21-26 months to yield data for 
approximately 3, 6, 9, 12, 18 and 24 months of age.  Only one weight was taken from each 
milestone using a hierarchy to determine what weight entry was used in the study.  First, the 
most data rich entry was identified (i.e. the entry with weight, length and head circumference) 
and then the entry closest to the central date.  
The data were analysed using Statistical Product and Service Solutions version 20 with the 
WHO Anthro macro (version 3.2.2).  
Duplicate and implausible entries were removed from the database.  Implausible entries for 
birth weight were flagged for each gestational age as recommended in the Australian birth 
weight percentiles13 and medical charts reviewed. For weight for age, data were excluded 
according to the WHO criteria for implausible entries. 
Chi-squared tests were used to determine the significance of differences between groups and 
thus determine covariates for binomial logistic regression.  Chi-squared test for trend was 
performed to determine any significant change in the proportion of underweight, SGA and 
prematurity by year of birth.  One-way analysis of variance was performed on the change in 
mean weight for age z-score by year of birth. Binomial logistic regression was performed to 
estimate the effect of time on proportion of underweight taking into account the effect of 
covariates SGA, prematurity and sex. 
The study was developed in conjunction with Apunipima Cape York Health Council.  Ethical 
approval was obtained from Cairns and Hinterland Human Research Ethics Committee and the 
James Cook University Human Research Ethics Committee.  Datasets from the Queensland 
Health Ferret database and the Queensland PDC were obtained after approval from the 
relevant data custodians. 
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5. Results 
Of the 1301 records of children eligible for inclusion, 13 (1%) were removed because their 
gestational age at birth was not documented and a further 12 (1%) were removed because 
they had a congenital condition affecting growth, yielding a total of 1276 children.   
Table 2-1 shows birth characteristics of the population by year of birth; most children were 
Aboriginal and/or Torres Strait Islander and there was a spike in births in 2005.
Table 2–1: Population characteristics by year of birth. Aboriginal and Torres Strait Islander communities of Cape York Peninsula, 1999-2008 
Birth year 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 Total 
 
n % n % n % n % n % n % n % n % n % n % n % 
Total 100 
 
115 
 
99 
 
111 
 
109 
 
138 
 
174 
 
134 
 
150 
 
146 
 
1276 
 
                       Sex (male) 46 46.0 65 56.5 52 52.5 64 57.7 51 46.8 75 54.3 81 46.6 69 51.5 77 51.3 78 53.4 658 51.6 
                       Aboriginal 
and/or Torres 
Strait Islander 93 93.0 109 97.3 94 94.9 109 98.2 104 95.5 131 94.9 167 96.5 124 92.5 143 93.5 143 98.0 1217 95.6 
                       Non-
indigenous 4 4.0 1 0.9 1 1.0 0 0.0 1 0.9 4 2.9 4 2.3 5 3.7 3 2.0 2 1.4 25 2.0 
                       Not stated 3 3.0 2 1.8 4 4.0 2 1.8 4 3.7 3 2.2 2 1.2 5 3.7 4 2.7 1 0.7 30 2.4 
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Birth weights of 41 children (3.2%) were missing.  After birth, 818 children (64.1%) had a 
weight recorded at each of the six age milestones and 1268 children (99.4%) had weight 
entries for three or more milestones.   
The median gestational age was 39 weeks (inter-quartile range (IQR) 37 - 40) and was 
consistent across sex and Aboriginal and Torres Strait Islander status. 
The proportion of premature births was elevated consistently across the study period ranging 
from a low of 8.1% in 2001 to a high of 17.4% in 2004, with a mean of 13.7%.  The national rate 
for premature births is 5.9%.13  
Birth weights were distributed normally with a mean of 3100gm (SD 650gm) and 3034gm (SD 
620gm) for males and females respectively; both means are over 300gm lower than the 
Australian average (males 3463gm, females 3399gm).13   
The proportion of children diagnosed as SGA by birth year is shown in Figure 2-1. There is a 
statistically significant decrease from 2002 onwards (χ2for trend=8.2, df=1, p<0.01) with a 
maximum of 35.5% observed in 2002 with a low of 17.8% observed in 2006. 
 
 
Figure 2-1: Proportion of small for gestational age births by birth year. Aboriginal and 
Torres Strait Islander communities of Cape York Peninsula, 1999 - 2008. 
* Expected level is 10% based on definition of small for gestational age as below the 10th 
percentile in the Australian population. 
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The proportion of underweight children dropped significantly overall (χ2for trend = 20.9, df =1, 
p <0.001) with an observed high of 16% in 1999 and an observed low of 3.3% in 2007 (Figure 2-
2). 
There was no statistically significant change in the proportion of large for gestational age 
infants or overweight children across the study period. The prevalence of large for gestational 
age was 6.2% across the 10 birth cohorts while the prevalence of overweight was 3.8% 
Logistic regression analysis revealed a consistent downward trend in the proportion of children 
underweight (Table 2-2).  Whilst SGA, premature birth and male sex were all significantly 
associated with underweight, the time trend remained significant when these factors were 
taken into account.  SGA was most strongly associated with being underweight (odds ratio 5.1; 
95% CI 3.3, 7.9). 
Figure 2-2: Proportion of children under 2 diagnosed as underweight by birth year. 
Aboriginal and Torres Strait Islander communities of Cape York Peninsula, 1999 – 2010 
* Expected level is approximately 2.25% based on definition of underweight -2 z-scores 
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Table 2–2: Logistic regression on the effects on underweight. Aboriginal and Torres Strait 
Islander communities of Cape York Peninsula, 1999 - 2010 
Variable p-value Odds 
ratio 
95% confidence 
interval 
   Lower Upper 
1999(baseline)     
2000 0.478 0.747 0.334 1.672 
2001 0.129 0.489 0.194 1.231 
2002 0.047 0.409 0.169 0.989 
2003 0.045 0.381 0.148 0.979 
2004 0.039 0.404 0.171 0.955 
2005 0.001 0.155 0.056 0.43 
2006 0.068 0.438 0.181 1.063 
2007 0.001 0.172 0.059 0.505 
2008 0.010 0.292 0.114 0.747 
Premature 0.002 2.369 1.381 4.065 
Female 0.006 0.532 0.339 0.835 
SGA 0.001 5.096 3.281 7.913 
Constant 0.000 0.129   
 
The community of usual residence of the child was also significantly associated with being 
underweight; however, the proportion of children contributed by a community to each birth 
cohort remained stable and did not confound the effect of time. 
The birth characteristics of children who were underweight are shown in Figure 2-3.  Children 
born either SGA or premature constituted 68% of underweight children. 
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Figure 2-4 shows the changing pattern of growth across the study period.  Birth weight z-
scores remained persistently low with a mean of -0.48 but mean weight at six months was 
above or close to the expected level from 2001 onward.  However mean weight after six 
months was consistently below the expected WFA at each of the subsequent age milestones. 
The mean WFA z-scores improved in each successive birth cohort, but only the improvement 
in z-scores at 18 and 24 months were statistically significant (p<0.001). 
Figure 2-3: Distribution of small for gestational age (SGA) and prematurity among underweight 
children less than two years of age. Aboriginal and Torres Strait Islander communities of Cape York 
Peninsula, 1999 -2010 
Figure 2-4: Mean weight for age z-scores by age and birth year. Aboriginal and Torres Strait 
Islander communities of Cape York Peninsula, 1999 - 2010 
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6. Discussion 
Our study of birth cohorts between 1999 and 2008 showed significant improvements in early 
childhood growth, some reduction in frequency of SGA neonates but consistently low mean 
birth weights and elevated rates of prematurity.  These poor birth outcomes were associated 
with a greater risk of being underweight in the first two years of life. 
The growth of children in the first two years of life improved across the study period with 
evidence of decreased weaning malnutrition.  Childhood growth improved at each age 
milestone in subsequent birth cohorts, however, the WFA z-score deteriorated after six 
months within each cohort.  This pattern of faltering weight gain after six months is termed 
weaning malnutrition and has been documented in other Aboriginal and Torres Strait Islander 
communities.10, 14 It is attributed to a combination of increased caloric needs beyond that 
provided in breast milk (or formula) alone and increased susceptibility to infection.  However, 
because the WFA after six months came closer to expected levels in subsequent cohorts, we 
conclude that weaning malnutrition has largely been addressed in the region.  The results 
represent a significant achievement for the carers and health staff within these communities. 
In contrast with improved weight gain, birth outcomes remained poor throughout the study. 
While there was some improvement in SGA births after 2002, the mean birth weight was 
considerably lower than the national average and the proportion of premature births over 
twice that seen in the rest of Australia.13 Neither of these outcomes improved over time.  
These persistent poor birth outcomes are to be expected given the high prevalence of well-
defined socioeconomic and environmental risk factors. Studies in the region have shown 
dramatically elevated prevalence of maternal smoking (70%), teenage pregnancy (29.3%)15 and 
underweight in young women (17.1%).16 The study communities all rank amongst Australia’s 
most disadvantaged with regards to education, housing and employment.17 Community level 
socioeconomic disadvantage is an independent determinant of SGA and prematurity.18, 19 Our 
results highlight the need to strengthen investments in antenatal care as well as addressing 
education and employment. 
Children with poor birth outcomes also had the highest risk of being underweight. Children 
born either premature or SGA constituted 68% of all underweight children with the risk of 
underweight highest among SGA infants.  It is possible that the poor growth of the SGA cohort 
reflects an intrinsic growth trajectory that protects against the development of chronic disease.  
Alternatively this poor growth could reflect a persistence of the adverse conditions that lead to 
their initial lower birth weight. In a cohort of Aboriginal and Torres Strait Islander newborns 
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followed through to early adulthood, results suggest that SGA infants who have remained 
small have a lower incidence of chronic disease risk factors.  At a mean of 18 years old, those 
born SGA were significantly shorter (165.2cm vs. 168.4cm, p<0.01) and had a lower prevalence 
of overweight and obesity (8.64 vs. 22.31, p<0.01).20  The SGA cohort also had significantly 
lower systolic blood pressure at 11 years of age.21 While it is unclear how the SGA cohort grew 
through early childhood, their shorter adult height suggests early catch up may not have 
occurred.  Whether to encourage weight gain in SGA infants is a subject of debate that has 
been termed the ‘catch-up dilemma’.22 More rapid weight gain is associated with decreased 
infant hospitalisations23; however, this may come at a price of later chronic disease.  Whilst the 
cause of poor weight gain in SGA infants remains unclear, our results highlight that most 
growth faltering first occurs in utero and that interventions to improve antenatal care may be 
the safest and most effective way to address underweight children. 
Our results differ from the findings of a study of growth in the Kimberley region where growth 
failure was found predominately among full term infants with appropriate birth weight.10 This 
study defined growth failure through a medical diagnosis of failure to thrive, whereas ours 
used the standard statistical definition of underweight.  The Kimberley study also used growth 
charts that have since been replaced by the WHO growth standards, which complicate 
comparisons with our study findings. 
The main limitation of our study is potential bias in measuring gestational age. Studies using 
either early ultrasound or clinical assessment to measure gestational age in Aboriginal and 
Torres Strait Islanders have shown rates of prematurity lower than that measured through 
routinely collected data.7, 8 We attempted to mitigate this potential bias among infants most 
likely to be incorrectly categorised as premature by searching for a clinical assessment of 
gestational age within the hospital discharge summary.  However, the proportion of low birth 
weight infants (birth weight < 2500gm) recorded as premature in our study was higher than for 
studies that used clinical assessment (55.5% vs. 47.1%).7 This suggests that there may be an 
overestimate of absolute proportions of prematurity but the relative comparisons over time 
remain valid. 
Whilst our study was not designed to assess cause-effect relationships, we can postulate some 
plausible explanations for the improvement in early childhood growth. These relate to 
improvements in access to care, childhood vaccination and alcohol restrictions.  From 1999 
there has been an increase in primary health care staff.  While in 1999 a doctor and child nurse 
would visit up to three communities in one week, by 2010 most communities had a dedicated 
Aboriginal child health worker, child health nurse and general practitioner on most weekdays. 
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Over the course of the study five vaccines were introduced to the immunisation schedule for 
Aboriginal and Torres Strait Islander children including Hepatitis A virus in 1999, Streptococcus 
pneumoniae in 2001, Neisseria meningitidis in 2003 and rotavirus in 2007.  These vaccines 
could have contributed to the improved childhood growth through decreasing the infectious 
burden.  In 2002 restrictions on the sale of alcohol were implemented through community 
alcohol management plans. These plans began as restrictions on sale and carriage and 
progressed to prohibition in most communities by 2008. Numerous studies in Aboriginal Torres 
Strait Islander people have identified alcohol use as a risk factor for lower birth weight8, 24, 25 
and it is plausible that the limiting of supply may have contributed to the decrease in SGA 
births seen after 2002. Alcohol management plans also have the potential to improve nutrition 
during weaning by increasing the amount of money available for food.  However caution 
should be used when interpreting our results in this manner, as associations may be prone to 
the ecological fallacy.  
We did not study the extent different maternal risk factors may have contributed to the 
persistent poor birth outcomes. Data on maternal variables that influence birth weight are 
now being routinely collected through the national perinatal data collection including maternal 
body mass index, smoking, alcohol use, hypertension, date of first antenatal visit and total 
antenatal visits.  Therefore trends in both risk factors and birth outcomes can be assessed as 
improvements are made to antenatal care. 
This is the first study in Aboriginal and Torres Strait Islander people to demonstrate a region 
wide improvement in early childhood growth.  This improvement can be attributed to multiple 
factors, which probably include improved access to primary health care services, increased 
childhood vaccinations, and the introduction of alcohol management plans to reduce 
consumption.  While it is disappointing that there were no changes to rates of prematurity and 
mean birth weight, these poor outcomes are to be expected given the high prevalence of well-
established risk factors and persistent socioeconomic disadvantage.  An increased focus on 
both antenatal care and economic development is required to enable the children of Cape 
York to thrive. 
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1. Prologue 
1.1 My role 
I was the lead evaluator and author for this project and was asked to lead this evaluation upon 
commencing work with the National Aboriginal Community Controlled Health Organisation 
(NACCHO). Working with my field supervisor, Dr Katie Panaretto, I started the evaluation by 
consulting with public health medical officers and other experts from Aboriginal community 
controlled health organisations about the focus of the evaluation. These consultations involved 
a number of one on one meetings as well as discussions at national and state meetings. 
Once the focus of the evaluation was decided I began working on the evaluations methodology. 
Through this process my academic supervisor Dr Mahomed Patel provided me with direction in 
the methods to apply and in particular he encouraged the use of a Theory of Change and the 
World Health Organization’s Monitoring and Evaluation Framework for Health System 
Strengthening. After becoming familiar with the literature on Theory of Change, I conducted a 
literature review on indicator criteria in order to find an appropriate evaluation instrument. 
The merits of each instrument were discussed with Dr Patel and together we agreed on the 
most appropriate criteria for the evaluation. 
After an instrument was selected, I began evaluating the indicators. This required generating a 
Theory of Change for each indicator and reviewing the literature with a particular focus on key 
policy documents and government commissioned reviews of the national Key Performance 
Indicators.  Once I had collated my finding they were reviewed by Dr Patel and Dr Panaretto. 
During my time at the NACCHO Dr Panaretto left and Dr Ana Herceg, a public health medical 
officer at the Canberra Aboriginal community controlled health organisation, took on the role 
of the field supervisor for this project. I also received a great deal of advice in regards to the 
language and structure of my arguments from all my supervisors and towards my final drafts 
Dr Stephanie Davis took over the role of academic supervisor for this project and provided 
additional comments. 
1.2 Lessons learned 
This evaluation was, by far, the biggest project I have undertaken. Through this process the 
main lessons learned have been on the importance of having a structured approach to 
evaluation and the difficulty in refining a message in order to communicate clearly. 
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Having to cover such a wide range of topics in this evaluation has required me to be 
methodical in my approach. This evaluation has required a consistent structure that has been 
applied throughout the entire project, not only to the over-arching methodology but also to 
the structure of the answers to each evaluation question and the structure of each paragraph. 
I have learned that with this consistent approach, the reader can focus on the message, 
instead of trying to decipher what exactly has been said. 
Another lesson has been on the use of evidence to construct an argument. My early drafts of 
the evaluation were based largely on opinion, not evidence. One of the challenges in 
completing this evaluation was that the evidence to shape my findings was not obtained 
through statistical analysis but instead through reviewing government documents and key 
articles. With the help of my supervisors I considered what evidence was available to answer 
each evaluation question and based my findings on this. 
1.3 Public health implications 
Our evaluation has highlighted that while individual indicators collected from primary health 
care services may be of merit, their value in improving health care requires high quality data 
and the measurement of indicators across the health care system. These findings have 
implications throughout the Australian health system as it adapts to deal with the increasing 
burden of complex chronic disease.  
Our evaluation has highlighted that indicators extracted from primary health care medical 
records can provide important data that cannot be collected from other sources. However, for 
these data to be used most effectively, a number of improvements are required in data entry 
and the reporting of results. Our evaluation identifies the strengths of these new data and 
recommends changes to enable their use to help improve health service delivery and inform 
policy and planning. 
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2. Abstract 
Primary health care is undergoing a major change in monitoring and evaluation.  A driver of 
this change is improvements in data collection from primary health care services.  While data 
collection on clinical care provided in these services previously required resource intensive 
chart audits, it is now possible to use data extraction software to rapidly collect information 
from electronic medical records. This enables data to be easily collected in areas such as the 
population characteristics of a service and facilitates analysis on whether care follows 
evidence-based guidelines 
The national Key Performance Indicators for Aboriginal and Torres Strait Islander Primary 
Health Care (nKPIs) are the first attempt by the Australian Government to use data extraction 
software to monitor primary health care on a large scale.  Since 2012, Aboriginal and Torres 
Strait Islander primary health care services have been collecting and submitting nKPIs that are 
populated by data extraction software.  The purpose of this data collection is to stimulate 
improvements in services’ quality of care and provide accountability to the government as 
funders. 
Our evaluation focused on the quality and usability of the 24 indicators that constitute the 
nKPIs to determine whether they can be used to meet the purposes articulated by the 
government.  To do this we assessed the nKPIs against criteria set by the United Kingdom’s 
National Health Service in ‘The Good Indicators Guide’.1 In evaluating the indicators against 
these criteria we used evidence from the published literature, key policy documents as well as 
two early evaluations of nKPI data quality.  Using these sources and the first three reports of 
nKPI results we assessed whether the indicators are fit for the purposes stated by the 
Australian Government. 
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2.1 Structure of the evaluation 
We based the approach to our evaluation on the US Centers for Disease Control and 
Prevention (CDC) ‘Framework for Program Evaluation in Public Health’.2 The term program is 
used by the CDC to describe any organised public health action and this definition is 
deliberately broad as the framework can be applied to almost any organised public health 
activity.  Within this context, the nKPIs can be classified as part of a program for monitoring 
Aboriginal and Torres Strait Islander primary health care services.   
The CDC’s framework has six questions that must be answered to assign value and make 
judgments regarding a program on the basis of evidence:  
1. What will be evaluated? 
2. What aspects of the program will be considered when judging program performance? 
3. What standards must be reached for the program to be considered successful? 
4. What evidence will be used to indicate how the program has performed? 
5. What conclusions regarding program performance are justified by comparing the 
available evidence to the selected standards? 
6. How will the lessons learned from the inquiry be used to improve public health 
effectiveness? 
Our evaluation answered these questions within a modified IMRAD format 
Introduction: What will be evaluated?  
We followed the CDC’s format for describing a program and outlined the context surrounding 
the introduction of the nKPIs as well as the activities, resources and stage of development of 
the nKPI monitoring system. 
Objectives: What aspects of the program will be considered when judging performance?  
The objectives of the evaluation were determined with the input from key stakeholders.  The 
CDC’s framework stresses the importance of stakeholder engagement and we described how 
their input focused the evaluation on the quality and usability of the nKPIs.  
Methods: What standards must be reached for the program to be considered successful? 
What evidence will be used to indicate how the program has performed? 
Our methods describe the standards set and the evidence used in evaluating the nKPI 
monitoring system. This section begins with a description of the literature review that led to 
the selection of our evaluation instrument. The methods then include an overview of the 
standards and evidence used in assessing the nKPIs against the evaluation instrument. 
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Results: What conclusions regarding program performance are justified by comparing the 
available evidence to the selected standards? 
Our results are divided into six sections due to the broad range of topics covered by the 
evaluation. The evaluation covered topics such as PHC systems, Aboriginal and Torres Strait 
Islander health priorities, type II diabetes mellitus, antenatal care and smoking cessation. The 
findings for these diverse topics are difficult to interpret when presented together and to 
assist the reader the results were divided into two sections relating to evaluation questions on 
the nKPI set as a whole and four sections on individual nKPIs.  This resulted in six sections with 
each containing results, conclusions and recommendations relevant to that component of the 
evaluation (Figure 3–1).   
These six sections contain additional information on the methods used to answer their 
respective evaluation question.  The sections on the indicator set as a whole contain detail on 
the standards set in assessing that component of the evaluation.  In a similar way, the sections 
on individual indicators contain a Theory of Change on the steps involved for primary health 
care to impact on health outcomes before presenting the results. 
Discussion: How will the lessons learned from the inquiry be used to improve public health 
effectiveness? 
The evaluation ends with a discussion that ties the conclusions from all six sections together.  
Due to the complexity and breadth of topics covered, this evaluation is targeted at people with 
experience in both Aboriginal and Torres Strait Islander health and primary health care.  
 42 
 
Figure 3–1: Structure of the evaluation of the national Key Performance Indicators
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3. Introduction:  
Describing the nKPI monitoring system 
The national Key Performance Indicators for Aboriginal and Torres Strait Islander Primary 
Health Care (nKPIs) are a set of 24 indicators on processes of care and health outcomes 
collected nationally by Aboriginal and Torres Strait Islander primary health care (PHC) services 
and reported to the Australian Government.   The data for these indicators are drawn from the 
electronic Patient Information and Recall Systems (PIRS) of services through data extraction 
software.  The indicators are outlined in Appendix 1.  They cover four broad topics: maternal 
health, preventative health activities, chronic disease care and chronic disease risk factors. 
The objectives and goals of the nKPIs indicator set have not been clearly articulated and vary in 
different sources.3,4 For the propose of our review the goals of the indicators set have been 
taken from the Australian Institute of Health and Welfare’s three national reports on the 
nKPIs.5-7 These documents state that the purposes of the nKPIs are: 
1. To improve PHC service delivery through promoting continuous quality improvement 
(CQI) activity among service providers. 
 
2. To support policy and planning at the national and state/territory level by 
monitoring progress and highlighting areas for improvement. 
3.1: Context 
The goals of the nKPI monitoring system reflect two priority areas within government: a need 
for accountability for funded programs and a desire to drive improvements in quality of PHC.   
This section describes the policy context surrounding the nKPIs: how the nKPI monitoring 
system was funded to assess, in part, progress in addressing the ‘Closing the Gap’ campaign of 
the Council of Australian Governments (COAG), and how it was developed as an extension of 
an existing Australian Government CQI program. 
In addition to placing the nKPIs in a policy context, this section describes the impact that 
quality of health care, the focus of the nKPIs, has on health outcomes and places the nKPIs 
within the many other measurements relating to Aboriginal and Torres Strait Islander health. 
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3.1a: Policy context 
Closing the Gap campaign  
The discrepancy in health outcomes between Aboriginal and Torres Strait Islander people and 
non-Indigenous Australians is well documented.  The most recent data show the life 
expectancy of Aboriginal and Torres Strait Islander men is 10.6 years lower than non-
Indigenous men, with a life expectancy gap of 9.5 years for women.8 Underlying these headline 
statistics are a number of other poor outcomes from birth onwards.  Aboriginal and Torres 
Strait Islander people have twice the rate of low birth weight than non-indigenous Australians9 
and throughout their life experience approximately 2.5 times the burden of disease.10   
The nKPI monitoring system was introduced to assess progress in the COAG’s response to 
these poor outcomes.  In 2006 Australia’s peak Aboriginal and Torres Strait Islander and non-
Indigenous health bodies, health professional bodies and human rights organisations came 
together and set the goal to raise the health and life expectancy of Aboriginal and Torres Strait 
Islander peoples to that of the non-Indigenous population within a generation: to close the gap 
by 2030.11 The Australian Government responded to this in 2007 when COAG agreed to 
strengthen partnership at all levels of government to close the gap in Aboriginal and Torres 
Strait Islander peoples disadvantage.12 Two targets of the ‘Closing the Gap’ initiative are to 
close the life expectancy gap between Aboriginal and Torres Strait Islander and non-Indigenous 
Australians within a generation and to halve the mortality gap for children under five within a 
decade. To achieve these targets the Australian, state and territory governments committed to 
a $1.6 billion National Partnership Agreement.13 The roll out of a national web-based system 
for collecting nKPI data was a component of the National Partnership Agreement’s 
implementation plan for the priority area: ‘Primary health care services that can deliver’.  The 
aim of the web based indicator system was ‘to improve monitoring and evaluation (M&E) of 
chronic disease initiatives’ and was part of a $39.5 million budget for M&E from 2009-2013.14 
Need for accountability 
The introduction of the nKPIs is part of a wider trend to enable greater accountability for 
government-funded services.  The monitoring of health system performance is a focus area in 
many health systems and international umbrella health organisations such as the World Health 
Organization (WHO) and the Organisation for Economic Co-operation and Development 
(OECD) have encouraged health system performance measurement.15,16  
Accountability and performance reporting were focus areas within the National Indigenous 
Reform Agreement that outlined the objectives, outcomes and outputs of the ‘Closing the Gap’ 
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initiative.17 Accountability is identified within the National Indigenous Reform Agreement’s 
‘Service delivery principles for programs and services for Indigenous Australians’.  It specifies 
that attention should be given to ‘choosing performance measures based on contribution to 
the COAG targets and report them publicly’.17 Consequently, the nKPIs adopted six of the nine 
health performance indicators listed for the Australian, state and territory governments within 
the National Indigenous Reform Agreement, in addition to a number of indicators that monitor 
quality of care. 
Improving the quality of health care 
Improving the quality of health care was another focus of the ‘Closing the Gap’ initiative. This 
focus on quality is articulated in the National Partnership Agreement priority area ‘Primary 
health care services that can deliver’.13 The expected outcomes of this priority are listed below, 
and capture three dimensions of quality of health care as defined by the World Health 
Organization (Box 1).18 
1. Implementation of national best practice standards and accreditation processes for 
Aboriginal and Torres Strait Islander health services delivering primary health care 
(WHO dimension: effective) 
2. Increased uptake of MBS-funded primary health care services by Aboriginal and Torres 
Strait Islander people (WHO dimension: accessible) 
3. Improved access to quality primary health care through improved coordination across 
the care continuum, particularly for people with chronic diseases and/or complex 
needs (WHO dimension: accessible) 
4. Provision of improved cultural security in services, and increased cultural competence 
of the primary health care workforce (WHO dimension: acceptable/patient-centered) 
Prior to the ‘Closing the Gap’ initiative the Australian Government was already funding 
improvements to quality of care through CQI programs.  Wide scale funding for CQI in 
Aboriginal and Torres Strait Islander PHC began in 2007 with the Healthy for Life program.19 
This program aimed to improve maternal and child health outcomes and chronic disease 
prevention and treatment. As part of the program participating services were required to 
submit data on a set of 11 key indicators.  The experience of the Healthy for Life program 
informed the development of the nKPIs and many of the Healthy for Life indicators are now 
part of the nKPIs monitoring system.19  
The Australian Government continues to provide funding for CQI. In the last financial year they 
funded the development of a national framework for CQI in Aboriginal and Torres Strait 
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Islander PHC and extended Healthy for Life funding to all Aboriginal community controlled 
health organisations (ACCHOs).20 
Box 1: World Health Organization definition of health care quality18 
While there are many definitions of quality of health care, a definition that has resonance in 
the Aboriginal community controlled health sector (the Sector) is the one put forward by the 
WHO.21 Their definition takes a whole-system perspective, and reflects a concern for the 
outcomes achieved for both individual service users and whole communities.  This has parallels 
with the Sector’s holistic view of Aboriginal health. 
‘Aboriginal health means not just the physical well-being of an individual but refers to the 
social, emotional and cultural well-being of the whole Community in which each individual is 
able to achieve their full potential as a human being thereby bringing about the total well-
being of their Community. It is a whole of life view and includes the cyclical concept of life-
death-life.’22  
The WHO definition of quality has six dimensions; it requires health care be: 
1. Effective, delivering health care that is adherent to an evidence base and results in 
improved health outcomes for individuals and communities, based on need; 
2. Efficient, delivering health care in a manner which maximizes resource use and 
avoids waste; 
3. Accessible, delivering health care that is timely, geographically reasonable, and 
provided in a setting where skills and resources are appropriate to medical need; 
4. Acceptable/patient-centered, delivering health care which takes into account the 
preferences and aspirations of individual service users and the cultures of their communities; 
5. Equitable, delivering health care which does not vary in quality because of personal 
characteristics such as gender, race, ethnicity, geographical location, or socioeconomic status; 
6. Safe, delivering health care which minimizes risks and harm to service users.18  
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3.1b: The impact of health care quality on health outcomes 
To improve health outcomes, a focus on improving quality of clinical care must be balanced 
with a focus on addressing the determinants that are not directly under the control of the 
healthcare sector. As outlined by the OECD’s conceptual framework for indicators of quality of 
health care23 (Figure 3–2), health is also influenced by non-healthcare determinants such as 
housing and employment.  Within the Australian system many non-health care determinants 
of health are labelled the ‘social determinants of health’. 
 
Figure 3–2: Organisation for Economic Co-operation and Development conceptual 
framework for health care quality indicators. Source: Kelley and Hurst, 2006 
The influence of social determinants on health has been highlighted by the Australian Institute 
of Health and Welfare (AIHW).  Using data from two national surveys conducted in 2004-2005, 
they found that social determinants such as education, employment status, overcrowding and 
household income together with behavioural risk factors explained up to 57% of the gap in 
health outcomes between Aboriginal and Torres Strait Islander and non-Indigenous Australians 
(Figure 3–3).24 
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Figure 3–3: Proportion of health gap attributed to social determinants and behavioural risk 
factors. Source: Australian Institute of Health and Welfare, 2014 
The influence of social determinants is further emphasised by analysis of risk factors for 
cardiovascular disease (CVD). Table 3-1 shows CVD risk factors25 and Table 3-2 the difference in 
the prevalence of these factors in Aboriginal and Torres Strait Islander and non-Indigenous 
Australians.  A focus on quality of clinical care would concentrate efforts on the treatment of 
biomedical risk factors such as hypertension and hypercholesterolemia. However, the 
prevalence ratio of these risk factors in Aboriginal and Torres Strait Islander and non-
Indigenous Australians is relatively small and focusing on this area alone would have a minimal 
impact on CVD outcomes.  Existing data also show that many Aboriginal PHC services already 
outperform other PHC services in quality prescribing.26 The largest prevalence ratios are seen 
in risk factors that are influenced by social determinants, such as smoking, obesity and low 
birth weight.  This stresses that the greatest improvements in health outcomes may be 
achieved by focusing on areas outside of quality of healthcare. 
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Table 3–1: Risk factors for cardiovascular disease. Source: Australian Institute of Health and 
Welfare, 2014 
Non-modifiable 
Modifiable 
May or may not be 
modifiable Biomedical Behavioural 
Age Excess body weight Tobacco smoking Socioeconomic 
Sex High blood pressure Physical inactivity Psychosocial 
Family history of 
coronary heart 
disease 
High blood 
cholesterol  Poor diet Early life factors 
Genetics Low birth weight Excessive alcohol  Environmental 
 Depression   
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Table 3–2: Relative prevalence of selected risk factors for cardiovascular disease. Source: 
Multiple data collections, 2008-2013 
Risk factor 
Prevalence in 
Aboriginal and 
Torres Strait 
Islander 
population (%) 
Prevalence ratio 
(Aboriginal and 
Torres Strait 
Islander people: 
non-Indigenous) 
Prevalence 
difference (between 
Aboriginal and Torres 
Strait Islander people 
and non-Indigenous) 
Behavioural risk factors    
Sedentary/low level of exercise(a) 62 1.1 7 
Current daily smoker(a) 44 2.6 25 
Inadequate daily fruit intake(a, b) 58 0.9(c) n.a. 
Inadequate daily vegetable intake(a, d) 95 0.9(c) n.a. 
Alcohol consumption exceeding 
lifetime risk guidelines(a, e) 
 
20 
 
1.0 
 
-1 
Biomedical risk factors     
High blood pressure (a, f) 20 1.2(c) 4 
High blood cholesterol (g, h) 25 0.8(c) -8 
Obesity(a, i) 41 1.5 14 
Low birth weight (j, k) 13 1.9 7 
May or may not be modifiable    
Unemployment (l) 52.2 2.1 27 
High psychological distress (a,m) 32 2.7 15 
Developmentally vulnerable (n) 26 2.6 16 
Overcrowding (l, o) 25 6.3 21 
Exposure to environmental tobacco 
(a) 65 2.0 33 
(a) Source: Australian Bureau of Statistics, National Aboriginal and Torres Strait Islander Health Survey, 
2012-2013 
(b) Defined as less than 2 serves of fruit per day 
(c) Age standardised 
(d) Defines as less than 5 serves of vegetables per day 
(e) Defined as more than 2 standard drinks per day on average 
(f) Defined as blood pressure of 140/90 mmHg or higher 
(g) Source: Australian Bureau of Statistics, National Aboriginal and Torres Strait Islander Health Survey: 
Biomedical results, 2012-2013 
(h) Defined as total cholesterol of 5.5 mmol/L or higher 
(i) Defined as Body Mass Index of 30 or higher 
(j) Source: Australian Health Ministers Advisory Council, Aboriginal and Torres Strait Islander Health 
Performance Framework 2014 report, 2015 
(k) Defined as birth weight of 2500gm or less 
(l) Source: Australian Bureau of Statistics, National Aboriginal and Torres Strait Islander Social Survey, 
2008-2009 
(m) Defined as Kessler-5 score of 12 or higher 
(n) Source: Australian Early Development Census, 2013 
(o) Defined by Canadian National Occupancy Standard for Housing Appropriateness. 
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3.1c: Indicators in Aboriginal and Torres Strait Islander Health. 
The nKPIs are one of many data collections that generate indicators in Aboriginal and Torres 
Strait Islander health   Indicators are succinct measures that aim to summarise details of a 
system in as few points as possible.1 The WHO classifies indicators for monitoring and 
evaluation of health system strengthening activities into four domains: inputs and processes, 
outputs, outcomes and impacts (Figure 3–4).15 Inputs, processes and outputs reflect health 
system capacity, while outcomes and impacts reflect health system performance. The WHO 
framework also classifies two key data sources: those that generate data relative to 
populations as a whole, and those that generate data related to health-related administrative 
and operational activities.  In this context, nKPI data are primarily indicators of health system 
performance generated through operational activities of the service, that is nKPI data are 
collected directly from PIRS.  Therefore, they do not include population level data or the inputs 
and processes that reflect health system capacity as defined in the WHO framework.  However, 
indicators in the remaining domains of the WHO framework are collected through other 
national data collections. 
 
Figure 3–4: The World Health Organization framework for monitoring and evaluation of 
health systems strengthening. Source World Health Organization, 2009 
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Other Aboriginal and Torres Strait Islander indicators 
Indicators on Aboriginal PHC service capacity are generated through the Online Services 
Report (OSR). The OSR is an annual report completed by Australian Government funded 
Aboriginal PHC services.  It collects data on health services and activities provided by these 
organisations, staffing levels and client numbers, as well as health service gaps and challenges 
faced by the communities they serve.27 Like the nKPIs, the OSR generates indicators through 
operational activities of the service and does not include population level data. 
Indicators on the Aboriginal and Torres Strait Islander population as a whole are generated 
from a number of national surveys and registries. Table 3–3 highlights a number of these data 
collections and aligns them with the WHO indicator domains.  In many cases the collections 
cross over with indicators covered by the nKPIs (e.g. Australian Childhood Immunisation 
Register) while others are indicators that cannot be derived from Aboriginal PHC service data 
(e.g. National Mortality Database). 
Table 3–3: Data collections on Aboriginal and Torres Strait Islander health aligned to the 
World Health Organization (WHO) Framework for Monitoring and Evaluating for Health 
System Strengthening 
Data Collection WHO Indicator 
Domain 
Description 
Australian 
Childhood 
Immunisation 
Register 
Coverage of 
interventions 
A national register that records details of vaccinations 
given to children younger than 7 years who live in 
Australia.  Contains details on Aboriginal and Torres 
Strati Islander status.28  
Australian 
Bureau of 
Statistics 
Australian 
Aboriginal and 
Torres Strait 
Islander Health 
Survey 
Prevalence of risk 
factors and 
behaviours 
A nationally representative sample of around 13,000 
Aboriginal and Torres Strait Islander people. Contains 
information on 
 Estimates of the prevalence of certain chronic 
diseases and conditions and selected behavioural 
risk factors- including physical activity participation 
and sedentary behaviour  
 Objective measures of selected chronic diseases, 
nutrition status and other risk factors which can be 
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combined with self-reported data about health 
status and conditions (e.g. diabetes)  
 Health risk factors and outcomes for different 
population groups of interest, such as different age 
groups and people living in remote and non-remote 
areas.29 
National 
Perinatal Data 
Collection 
 
 
 
Intervention 
access and 
service readiness 
 
Improved health 
outcomes and 
equity 
A national population-based cross sectional data 
collection of pregnancy and childbirth.  The minimum 
dataset for the collection includes Aboriginal and Torres 
Strait Islander status of the child.30 
 
Admitted Patient 
Care National 
Minimum Data 
Set 
Improved health 
outcomes and 
equity 
The purpose of this National Minimum Data Set is to 
collect information about care provided to admitted 
patients in Australian hospitals.  The scope is episodes 
of care for admitted patients in all public and private 
acute and psychiatric hospitals, free standing day 
hospital facilities and alcohol and drug treatment 
centres in Australia.  A mandatory component of the 
dataset is Aboriginal and Torres Strait Islander status.31  
National 
Mortality 
Database  
Improved health 
outcomes and 
equity 
The database holds records for deaths in Australia from 
1964 to 2012.  It comprises information about causes of 
death and other characteristics of the person, such as 
sex, age at death, area of usual residence and Aboriginal 
and Torres Strait Islander status. The cause of death 
data are sourced from the Registrars of Births, Deaths 
and Marriages in each state and territory, the National 
Coronial Information System and compiled and coded 
by the Australian Bureau of Statistics.32 
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Indicators on Aboriginal and Torres Strait Islander health are collated into a biannual report: 
The Aboriginal and Torres Strait Islander Health Performance Framework.9 The Health 
Performance Framework is produced by the Australian Government and covers the entire 
health system.  It includes indicators on Aboriginal and Torres Strait Islander specific services 
and programs, as well as mainstream services and contains indicators from the full continuum 
of the WHO framework, from inputs and processes, outputs, outcomes and impacts.  The 
report is divided into three sections: health status and outcomes, determinants of health and 
health system performance. In each section are a number of indicator topic areas.  Examples of 
topic areas are: 
 Health status and outcomes: Low birth weight 
 Determinants of health: Health behaviours in pregnancy 
 Health system performance: Antenatal care. 
In total the Health Performance Framework contains 68 topic areas and results from the nKPIs 
are used in one, health system performance: chronic disease management. 
3.2 Activities for implementing the nKPI monitoring system 
There are multiple activities that occur from collecting nKPI data to the results being published 
in national reports.  This section describes the activities in the nKPI monitoring system and 
expands on how nKPI reports may be used as a component of CQI. 
3.2a: Collecting, submitting and validating nKPI data 
The process of collecting nKPI data and producing national reports involves a number of steps 
as shown in Figure 3–5. The process begins with entering clinical information into PIRS in a 
format that can be read by data extraction software. Data extraction is then performed which 
collates data for nKPIs and can also collate data for other indicator sets simultaneously. These 
indicators are then submitted to a data warehouse via a secure web portal. From the 
warehouse, nKPI data are separated from other indicators and transmitted to the AIHW.  The 
AIHW then performs a number of checks on the data.  These checks aim to identify reporting 
errors through detecting services with large changes in results between reporting periods or 
inconsistent denominator data. After addressing these reporting errors, the AIHW then 
analyses these data to produce national reports. 
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Figure 3–5: Flow of national Key Performace Indicator data from patient presentation to 
national reports 
The collection and reporting of large amounts of data from Australian PHC services is a 
relatively new process made possible through technological advancements.  While collecting 
data previously required resource intensive chart audits, the uptake of PIRS and data 
extraction software enables more rapid and efficient data collation from thousands of records 
within minutes. These advancements have changed the purpose of PIRS from purely a 
communication tool between clinicians and have added a new function as a data collection 
instrument.  
However, there are limitations in using PIRS for data collection.  For data extracted from PIRS 
to be valid and reliable, clinical information must be recorded in a format that is extractable.  
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This requires a shift from ‘free texting’ (typing information on a patient’s presentation into the 
progress notes) to entering data in defined areas within PIRS that can be identified by data 
extraction software. In a similar way, results from pathology and medical imaging companies 
also need to be coded consistently to enable extraction.  Without these changes the extracted 
data will remain a poor and non-valid reflection of clinical practice: as Donabedian highlighted 
in 1966, we may be simply rating the quality of the medical record, not the quality of care 
provided.33 Results from early reviews of nKPI data quality suggest that there are concerns 
with clinicians correctly recording clinical information and the transmission of test results.34 
These points are expanded in the results for individual indicators (sections 4.3a – 4.3d). 
Although there are concerns with data quality, the nKPI monitoring system has no regular 
process to assess whether the nKPI data are an accurate and valid reflection of clinical practice.  
While the AIHW performs exception reporting, there are no checks on what proportion of 
patients have their diagnoses correctly recorded and we also have little knowledge of what 
proportion of management activities are captured by data extraction software.  These 
differences mean that nKPI data have a number of limitations in comparison to data that is 
collected primarily for research purposes or for national registries. 
3.2b: Reporting on nKPI data 
Following exception reporting of nKPI data, the AIHW produces national and service level 
reports based on the data.  The national reports are written by the AIHW with input from the 
Department of Health who provide all text dealing with policy implications of these data.  The 
sections of the report written by the Department include ‘Opportunities for action’, 
‘Conclusion’ and ‘Implications’.5 The AIHW also produces an individualised report for each 
service.  In these reports their results are compared to averages for the corresponding 
jurisdiction and remoteness category. The preparation of service level reports is intended to 
engage service staff and boards and encourage the use of nKPI data for CQI.35 
3.2c: Continuous quality improvement 
As well as supporting policy and planning, the other stated purpose of the nKPIs is to improve 
PHC service delivery through promoting CQI activity.  CQI is described as ‘an ongoing cycle of 
gathering and analysing data on how well organisational systems, clinical services, and health 
promotion programs are functioning (by comparing performance against external standards or 
benchmarks), and developing improvements—a set of cyclical activities involving examination 
of existing processes, change, monitoring the apparent effects of the change and further 
change.’36  In practical terms CQI has three core components: 
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1. Specification of a desired performance 
2. Measurement 
3. Ways of changing clinical practice 
CQI is most commonly implemented in Australian PHC through applying the ‘model of 
improvement’.  Nolan and colleagues first articulated this model in 1993 and the largest CQI 
program in Australia, the Australian Primary Care Collaborative, encourages services to use it.37 
Figure 3–6 shows how the model aligns with the three core components of CQI. 
 
                                
Figure 3–6: The model for improvement and core components of continuous quality 
improvement 
The nKPI system can be seen as providing two of the three core components of CQI: 
specification of a desired performance and measurement.  The indicators measure a selected 
set of activities and outcomes expected of the PHC service.  For example, the indicator on 
‘clients aged over 50 immunised against influenza’ implies that this activity will be 
implemented in services.  A specification of the desired performance is articulated in the 
AIHW’s national reports that contain a benchmark figure that has been created by the 
Department of Health.  For ‘clients aged over 50 immunised against influenza’ the benchmark 
is 70% of regular clients.5 The health services results for this indicator then provides the 
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measurement component of CQI. The final component of CQI that the nKPI system is missing is 
‘ways of changing clinical practice’.   Training for CQI tools such as ‘plan, do, study, act’ cycles 
were not routinely provided to services along with the implementation of the nKPIs but this 
has recently been addressed with expanded funding for CQI across all ACCHOs.20 
3.3 Resources for implementing the nKPI monitoring system 
The collection, collation and analysis of the nKPIs have involved extensive investment into new 
software and technological expertise.  Collecting the nKPIs from services has involved the 
development of appropriate data extraction software, the creation of a secure data portal to 
send the data, the development of web portals to present results and the expansion of staff at 
the AIHW to analyse data.  The total cost of the software and technology for the nKPI system is 
not clear but the contract for the maintenance of the reporting portal, OCHREStreams, was $9 
million over 3 years38 and a further $1.1 million has been spent on additional improvements 
and reviews of components of the portal since this tender was awarded.39 
In contrast there were initially few resources contributed to the Aboriginal PHC sector to 
facilitate nKPI reporting and CQI.  Consistent funding for CQI was introduced three years after 
the nKPI monitoring system began.  Prior to 2015, support for CQI by the Australian 
Government was sporadic: some services received funding through Healthy for Life but 
Australian Government funding for CQI facilitators was restricted to one state/territory. This 
inequitable distribution of resources was addressed in 2015 when Healthy for Life funding was 
extended to all ACCHOs and funding for CQI facilitators extended to all but one state and 
territory peak bodies (referred to as Affiliates).20 
At a national level, two positions were funded to support the collection and reporting of the 
nKPIs, to encourage their use for CQI and report to the government on any problems with the 
reporting and use of data. These positions were within the National Aboriginal Community 
Controlled Health Organisation (NACCHO).  This is the national peak body representing 
approximately 150 ACCHOs who make up the majority of the PHC services currently reporting 
on the nKPIs and work in conjunction with the state and territory Affiliates. 
Also at a national level an advisory group has been established to provide advice on the 
continuing development of nKPIs.  The group has representation from the Australian 
Government, AIHW, NACCHO as well as experts in PHC.  Its title is the OCHREStreams Advisory 
Group, referring to the web portal that nKPIs are submitted through. The OCHREStreams 
Advisory group provides advice on:  
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 Strategies to improve the quality (validity, reliability, utility) and efficiency of data 
collection, analysis and reporting 
 Stakeholder needs in relation to the OCHREStreams systems and satisfaction with the 
performance of the system 
 Matters relating to intellectual property, privacy, ethics or data governance that 
require attention; 
 Opportunities for collaboration, linkages and synergies with developments in the wider 
health data systems environment, research projects or local initiatives 
 Communication strategies for engaging affected stakeholders. 
3.4: Stage of Development of nKPIs 
The CDC identifies that there are at least three stages in the development of public health 
programs such as the nKPI monitoring system: planning, implementation and effects.2    As 
systems mature and change over time, the CDC recommends the changing maturity be 
considered during evaluation.  The nKPIs monitoring system was introduced in 2012 and there 
has been a gradual increase in both the number of sites collecting data and the number of 
indicators collected as illustrated in Figure 3–7.  The first round of data collection primarily 
included sites that had participated in Healthy for Life and only 11 indicators were collected. 
By December 2014 all services that received Australian Government funding were required to 
report and the number of indicators had doubled.  It is expected that at least 3 indicators will 
be added to the nKPIs and state and territory funded PHC services for Aboriginal and Torres 
Islander people will also report on the indicators.  These developments suggest that the nKPIs 
monitoring system would be categorised within the implementation stage in the CDC’s stages 
of development.  
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Figure 3–7: Staggered rollout of national Key Performance Indicators, 2012-2014 
The CDC recommends that evaluations during the implementation phase should characterise 
real, as opposed to ideal, program activities and aim to improve operations, perhaps through 
revising plans.  The first national report on the nKPIs was released in May 2014, a second in 
December 2014 and a third report was published in October 2015.  In addition there have 
been a number of reports related to the nKPIs.   
 AIHW, 2015. ‘The nKPI data collection: data quality issues working paper 2012–2014’35  
 SMS Management & Technology, 2014. ‘Final Report. National Key Performance Indicators 
Data Quality Review’34 
 The Lowitja Institute, 2014. ‘Final Report. Recommendations for a National CQI Framework 
for Aboriginal and Torres Strait Islander Primary Health Care’.36 
These early reports provided an ideal opportunity to evaluate whether the indicators are 
suitable for addressing the stated goals of the nKPI monitoring system. 
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4. Objectives of the evaluation 
Our objective was to evaluate the quality and usability of the nKPIs to determine whether they 
can be used to meet the goals articulated by the AIHW: 
1. To improve primary health care service delivery by promoting CQI activity among 
service providers 
2. To support policy and planning at the national and state/territory level by monitoring 
progress and highlighting areas for improvement. 
4.1 How stakeholder engagement shaped the objective 
This objective was developed in consultation with stakeholders from the Aboriginal community 
controlled health sector (see Appendix 2). Representatives from the relevant section of the 
Indigenous Health Division of the Department of Health were also approached to provide input 
into the objectives of the evaluation but declined.  As a consequence the objective of this 
evaluation is guided by the interests of PHC services that report on nKPIs rather than by policy 
makers. 
Discussion with stakeholders occurred face to face or via telephone with Public Health Medical 
Officers and CQI coordinators from the state and territory Affiliates as well as with staff from 
NACCHO. Discussions focused on the question ‘what do you believe should be the focus of a 
review of the nKPIs?’ 
With few exceptions those consulted felt the focus of the review should be whether the nKPIs 
are ‘fit for purpose’, that is, can the indicators be used to meet the goals articulated in the 
AIHW reports.   While some felt that the evaluation should also review the process in which 
the nKPIs were developed, this was deemed to be beyond the scope for this evaluation. 
In addition to the consultations, the lead evaluator was embedded within the Aboriginal 
community controlled health sector both as a general practitioner in an ACCHO and as a 
trainee epidemiologist within NACCHO.  In his role with NACCHO he presented and 
participated in a number of CQI workshops and conferences and also sat on the 
OCHREStreams Advisory Group as an observer.  Both his clinical experiences and discussions 
within CQI forums led to the same question on whether the nKPIs can be used to meet their 
stated goals. 
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5. Methods for the evaluation 
5.1 Literature review for evaluation instrument 
To evaluate the quality and usability of the nKPIs required an evaluation instrument to assess 
them against. The appropriate instrument for an evaluation varies depending on the aspect of 
a program being assessed.40 While in some evaluations the appropriate instrument is a 
questionnaire or interviews with target groups, our evaluation focused on the usability and 
validity of indicators. In this context, the most appropriate instrument is a set of criteria 
against which to assess the nKPIs. In order to find an appropriate instrument, we conducted a 
literature search and a scan of the grey literature for indicator criteria. 
The starting point for our literature search was a recent literature review conducted within the 
Sector: ‘A literature review about indicators and their uses’ performed by the Aboriginal 
Health and Medical Research Council (AH&MRC).41 They did a Medline search and a scan of the 
Australian grey literature with a focus on articles on indicators, particularly relating to 
Aboriginal and Torres Strait Islander Health and the PHC setting.  To expand on the AH&MRC 
literature search, we also conducted a scan of international grey literature.  The websites of 
the WHO and OECD were scanned for articles on healthcare quality and indicators.  
Snowballing techniques were used to cross reference bibliographies of selected literature to 
identify any material that was not provided by Medline or grey literature searches.   
This search yielded a number of criteria that have been used in assessing indicator sets in 
Australia and in international settings.  We further refined our search to criteria that were 
developed to assess national data collections, such as the nKPIs, which restricted our results to 
seven criteria.  From Australia the relevant criteria were the National Health Performance 
Authority’s Performance and Accountability Framework42 and the Royal Australian College of 
General Practitioners clinical indicators.43 In international setting there were the indicator 
criteria found within the OECDs Health Care Quality Indicators project23 the European Primary 
Care Monitoring System Indicators44, the Danish National Indicator Project45, the United 
Kingdom National Health Service ‘Good Indicators Guide’1 and criteria used to evaluate the 
United Nations Millennium Development Goal health indicators.46 As noted in the AH&MRC 
review, all of the selection criteria were consistent about relevance, sensitivity to change, 
validity, reliability, specificity, acceptability and being clearly defined and understandable.   
From our literature review, the indicator criteria chosen as our evaluation instrument was the 
National Health Service’s recommendations: ‘Criteria for good indicators and good indicator 
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sets’ as defined in ‘The Good Indicators Guide’ (Table 3-4).1 What distinguished the NHS 
instrument from the others were the inclusion of criteria on ‘Meaning’ and ‘Implications’. 
These attributes are particularly important given the goals of the nKPIs: to improve PHC service 
delivery through CQI and to support policy and planning.  The NHS guide also evaluates the 
indicator set as a whole.  It is important to assess the nKPI set as theses 24 indicators have 
been chosen to monitor and evaluate the complexity of PHC and Aboriginal and Torres Strait 
Islander health. The evaluation instrument also aligns with criteria for selecting priority 
indicators to better inform health statistics46 as shown in Table 3-5.  Murray cited that 
‘thousands of indicators recommended but few measured well... Priority indicators should be 
selected on the basis of public-health significance and several dimensions of measurability’. 
The NHS instrument shows strong concordance with Murray’s criteria. 
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Table 3–4: National Health Service’s Criteria for good indicators and good indicator sets. 
Source: Penchon, 2008. 
Attribute Criteria 
A: Importance 
and Relevance 
A1. Does this indicator measure a sufficiently important question/service? 
(Importance) 
A2. Is it a balanced indicator set? (Balance) 
A3. Is the set of indicators likely to clarify the consensus on the objectives of the 
system? (Consensus) 
B: Validity B1. Does this indicator really measure the issue? (Validity) 
C: Possibility C1. Are sufficiently reliable data available at the right time, for the right 
organisations, with the right comparators? (Reliability) 
D: Meaning D1. Will the indicator be able to detect and display a variation that is important 
enough to warrant further consideration? (Variation) 
D2. If the indicator is high or low, what does it actually tell you, and does it give 
enough accurate and precise information for you to be able to investigate 
further and take any necessary action? (Readily interpretable) 
D3. Can the indicators be deconstructed in order to understand the particular 
reasons for the results? (Sufficient data to deconstruct results) 
D4. Can the implications of the indicator results be communicated to, and 
believed by the right audience? (Communicable) 
E. Implications E1. Is there sufficient understanding of the system so that any issues identified 
can be investigated further and addressed effectively? (Actionable) 
E2. Are the results likely to induce perverse incentives and unintentional 
consequences? (Suspect to perverse incentives) 
E3. Can the indicator monitor the issue regularly enough so that further 
investigation and action can be taken before the issue is revisited? (Actionable 
within monitoring period) 
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Table 3–5: Comparison between 'The Good Indicators Guide' and 'Towards good practice for 
health statistics: lessons from the Millennium Development Goal’s health indicators'  
The Good Indicators Guide 
 (Penchon, 2008) 
Towards good practice for health statistics 
(Murray, 2007) 
 
Importance and relevance 
(Importance, balance, consensus) 
What is the proposed indicator intended to 
measure? 
What is the public-health significance of the 
indicator? 
Validity How well does the indicator measure the 
quality of interest? 
Possibility 
(Reliability) 
Is there a practical measurement strategy? 
 
Meaning 
(Variation, readily interpretable, able to 
deconstruct results, communicable) 
Is the indicator value readily interpretable? 
Implications 
(Actionable, perverse incentives, actionable 
within monitoring period) 
Nil 
Nil How should equity dimensions of an indicator 
be captured? 
 
 66 
5.2 Methods: nKPI set as a whole 
The indicator set as a whole was evaluated through questions A2 ‘Is it a balanced indicator set’ 
and A3 ‘Is the set of indicators likely to clarify the consensus on the objectives of the system’.  
The definition of a balanced indicator set is not clearly defined in the evaluation instrument.  It 
explains ‘Measurement often concentrates unduly on some parts of a system at the expense of 
other important parts of the system’.  Given the complexity of PHC systems and Aboriginal and 
Torres Strait Islander health there is the potential for an imbalance in the measurement of 
both areas.  Because of this, we asked two questions to determine the balance of the nKPI set. 
1. Are the nKPIs balanced in their coverage of PHC systems? 
2. Are the nKPIs balanced in their coverage of issues of importance in Aboriginal and 
Torres Strait Islander PHC? 
To assess the nKPI set we set standards related to each evaluation question.  These standards 
are outlined in Table 3-6 and the rationale for their use is described in the results for each 
evaluation question.    
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Table 3–6: Standards set to assess the national Key Performance Indicator (nKPI) set against 
the evaluation instrument 
Evaluation question Standard 
A2 ‘Is it a balanced indicator set’: Are the 
nKPIs balanced in their coverage of PHC 
systems? 
 
Coverage of nKPIs against WHO ‘Framework for 
Health Systems Strengthening’15 and Tilton (2012) 
‘Structure of the core functions of PHC: a 
framework for the Northern Territory’.47 
A2 ‘Is it a balanced indicator set’: Are the 
nKPIs balanced in their coverage of issues 
of importance in Aboriginal PHC? 
 
Coverage of nKPIs against priorities identified in 
the Australian Governments ‘National Aboriginal 
and Torres Strait Islander Health Plan’48 and cost-
effective intervention identified in Vos et. al’s 
(2010) ‘Assessing Cost-Effectiveness in 
Prevention’.49 
A3 ‘Is the set of indicators likely to clarify 
the consensus on the objectives of the 
system’ 
Coverage of nKPIs against outputs within COAG’s 
National Indigenous Reform Agreement17 that are 
related to PHC. 
 
Reporting of health outcomes and impacts in 
AIHW national reports reflects the multiple 
determinants of these indicators. 
 
Accommodates approaches to services delivery 
that contribute to Closing the Gap while being 
appropriate to local community needs.  
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5.3 Methods: Individual indicators 
The remainder of the evaluation instrument was used to assess individual nKPIs.  One indicator 
was assessed in each of the four topic areas covered by the nKPIs.  These nKPIs were selected 
to encompass the indicator domains of the WHO M&E framework from outputs to impacts.   
1. Maternal Health: Birth weight result (WHO indicator domain: Impact) 
2. Diabetes care: Diabetics with an HbA1c measured (Outputs) 
3. Preventative Health care: Health check performed (Outputs) 
4. Chronic disease risk factors: Smoking status result (Outcomes) 
The results for the four indicators are presented in the same format.  Firstly, the AIHW’s 
definition for the nKPI is presented, followed by a Theory of Change for the health impact 
related to the indicator.  The indicator is then assessed against the evaluation instrument with 
the results presented in the format in Table 3-7. 
5.3a Theory of Change 
We applied a Theory of Change to each indicator to better understand the steps involved for 
PHC to impact on health outcomes.  Theory of Change is a process of identifying long-term 
goals and the conditions that are believed to be required to unfold for those goals to be met.50 
Conceptualisation of the PHC system through this Theory of Change approach aids better 
understanding of the reasons for an indicator result. This was achieved by mapping out the 
conditions required to improve health outcomes related to each indicator (i.e. the long-term 
goal). We could then map these conditions to the domains of the WHO M&E Framework 
(Figure 3–4, p. 51) and identify those influenced by health care quality and those influenced by 
determinants beyond those under the direct control of clinical services, such as ‘social 
determinants’. This understanding was required to answer questions against the evaluation 
instrument.   
5.3b Specifying the audience 
We divided the response to some evaluation questions into two groups: ‘In the service’ and ‘In 
national reports’.  This division reflects differences in the two main audiences for nKPIs: PHC 
services and policy makers.  These audiences have access to different levels of nKPI data and a 
varying ability to act on results.    
PHC services are able to view results at the patient level in addition to service level data in 
national reports.  This patient level data enables the use of nKPIs in patient care.  As an 
example, a service could use nKPI data to assist follow-up by identifying diabetics that have not 
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had a recent HbA1c test performed and initiating a recall. This results in different requirements 
of the data in terms of their availability, their ability to detect variation and how results are 
communicated.  For this reason the following questions in the evaluation instrument have a 
response for ‘In the service’ and ‘In national reports’:  
 C1 ‘Are sufficiently reliable data available at the right time, for the right organisations, 
with the right comparators’ 
 D1 ‘Will the indicator be able to detect and display a variation that is important 
enough to warrant further consideration?’ 
 D4 ‘Can the implications of the indicator results be communicated to, and believed by 
the right audience?’ 
5.3c Sources of evidence 
The evidence to support the findings against the evaluation instrument was drawn from 
multiple sources, in particular:  
 AIHW’s national nKPI reports5-7 
 AIHW’s Metadata Online Registry ‘Indigenous primary health care key performance 
indicators (2015)’4  
 AIHW ‘The nKPI data collection: data quality issues working paper 2012–2014’35 
 SMS Management and Technology ‘Final Report. National Key Performance Indicators 
Data Quality Review’.34 
In some instances there was no published evidence to support our findings.  An example is for 
the evaluation question E3 ‘Can the indicator monitor the issue regularly enough so that 
further investigation and action can be taken before the issue is revisited?’ In these cases the 
finding represents a consensus among the evaluation team and the explanation for this finding 
is provided in the table. 
Table 3–7: Presentation of results of individual national Key Performance Indicators against 
the evaluation instrument 
Evaluation question Results Evidence/explanation 
E.g. E3. Can the indicator monitor the 
issue regularly enough so that further 
investigation and action can be taken 
before the issue is revisited? 
Yes Measurement of HbA1c is a process of care 
that a health service can address rapidly if 
they understand the causes behind not 
testing.   
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6. Results:   
Can the indicators be used to meet the goals stated within 
national reports? 
The following section is an assessment of the quality and usability of the nKPIs using the NHS 
evaluation instrument. The findings for the questions on the indicator set as a whole are 
presented first, followed by evaluation of four individual nKPIs. 
6.1: Is it a balanced indicator set?  
(Are all the important areas covered without undue emphasis on any one area?) 
6.1a: Are the nKPIs balanced in their coverage of PHC systems? 
Standards used:  
Coverage of nKPIs against WHO ‘Framework for M&E of Health Systems Strengthening’15  
Coverage of  Tilton’s (2012) ‘Core functions of PHC: a framework for the Northern Territory’47 
To answer questions on ‘coverage’ requires a conceptual framework of the components of 
PHC systems.  We used the WHO framework for the Monitoring and Evaluation of Health 
System Strengthening (Figure 3–4, p. 51).15 This framework was developed originally for 
‘crosscutting interventions not aimed at specific diseases’, making it applicable in the PHC 
context.  To assess the nKPI’s coverage of PHC systems we distributed the indicators across the 
four domains of this framework.  
Figure 3–8, using the management of diabetes as an example, highlight’s the importance of 
having indicators spread across the framework domains from inputs to impact.  The central 
column of this figure outlines a Theory of Change; that is the key actions required to improve 
health outcomes for patients with Type II diabetes mellitus (T2DM).  The first column aligns 
these steps with the domains of the WHO framework and the third column identifies factors 
influencing each step in the theory of change.  The figure demonstrates how PHC service 
inputs (staffing, resources) influence health outputs (recording of blood pressure (BP) & 
haemoglobin A1c (HbA1c)), which in turn affect intermediate diabetic outcomes (BP & HbA1c 
on target) and eventually improve health outcomes.  The figure also incorporates health 
determinants beyond those under the direct control of clinical services, such as ‘social 
determinants’, that influence ongoing care of, and outcomes for, the patients. To enable an 
understanding of PHC systems, the ideal balanced indicator set for PHC would capture at least 
one of each of aspect of the inputs and processes, outputs, outcomes and impacts.
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Figure 3–8: Steps required to improve health outcomes in diabetic patients in the context of 
the World Health Organization (WHO) Framework for Monitoring and Evaluation of Health 
Systems Strengthening and the determinants related to each step 
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nKPIs and WHO M&E framework 
The first row in Table 3–8 categorises the nKPIs into six columns from inputs to impact, 
consistent with the WHO M&E framework. Given the focus of the nKPIs is to help to improve 
service delivery, the indicator domains that are more strongly influenced by quality of care, i.e. 
‘outputs’ and ‘outcomes’ have two columns in the WHO framework.  This allows analysis of the 
coverage of the domains identified to be influences by quality of care in Figure 3–8: 
‘Intervention access and service readiness’, ‘Intervention quality, safety’ and ‘Coverage of 
interventions’.   By contrast, ‘inputs and process’ and ‘impact’ have only one column each 
because they are largely influenced by factors outside of the control of clinical services.  A 
balanced indicator set for PHC would have included at least one indicator in each column for 
the four topic areas: maternal health, preventative health, chronic disease care and chronic 
disease risk factors. Table 3–8 shows how coverage for each topic area varied from two to four 
of a possible six columns, while there were no indicators for ‘inputs and processes’ 
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Table 3–8: Categorisation of national Key Performance Indicators (nKPIs) within the World 
Health Organization (WHO) Framework for Monitoring and Evaluation of Health Systems 
Strengthening 
Major topic 
area of nKPI 
 
(Number of 
WHO 
indicator 
domains 
covered) 
Major indicator domains in the WHO framework 
Inputs 
and 
processes 
Outputs Outcomes 
 
Impact 
Intervention 
access and 
service 
readiness 
Intervention 
quality, 
safety 
Coverage of 
interventions 
Prevalence 
risk 
behaviours 
and factors 
Maternal 
health  
 
(4 domains) 
Nil Date of first 
antenatal 
visit 
Birth weight 
recorded 
Nil Smoking in 
mothers 
who gave 
birth in 
past 12 
months 
Birth weigh 
result 
Preventative 
health 
activities 
 
(2 domains) 
 
  
Nil Nil Health check 
performed 
 
 
 
Children who 
are fully 
immunised 
 
Clients ≥50 
immunised 
against 
influenza 
 
Cervical 
screening 
performed 
Nil Nil 
Chronic 
disease care  
 
(4 domains) 
Nil Nil HbA1c 
recorded* 
 
BP 
recorded* 
 
Renal 
function test 
recorded* 
 
GPMP/TCA 
Clients with 
T2DM or 
COPD 
immunised 
against 
influenza 
 
HbA1c 
result on 
target 
 
BP result 
on target 
 
 
Renal 
function test 
result 
(T2DM/CVD 
with end 
stage renal 
disease) 
Chronic 
disease risk 
factors 
 
(2 domains) 
Nil Nil Smoking 
status 
recorded 
 
Alcohol 
status 
recorded 
 
CVD risk 
assessment 
recorded* 
Nil Smoking 
status 
result 
 
Alcohol 
status 
result 
 
Obesity  
 
CVD risk 
result 
Nil 
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* The indicators of clinical measurements (e.g. HbA1c recorded) are categorised as outputs because 
they reflect intervention quality, rather than as outcomes that reflect coverage of interventions in the 
community; this way they indicate a service’s ability to follow best practice guidelines.  
BP = Blood Pressure, COPD = Chronic Obstructive Pulmonary Disease, CVD = Cardiovascular Disease, 
GPMP = General Practice Management Plan, HbA1c Haemoglobin A1c, T2DM = Type II Diabetes Mellitus, 
TCA = Team Care Arrangement 
nKPIs and Aboriginal PHC core functions 
In addition to indicators of the quality of clinical care, an indicator set for Aboriginal PHC needs 
to capture aspects of comprehensive PHC.   The Aboriginal Community Controlled Health 
Sector has a comprehensive definition of health that includes ‘not just the physical well-being 
of an individual but refers to the social, emotional and cultural well-being of the whole 
Community in which each individual is able to achieve their full potential as a human being 
thereby bringing about the total well-being of their Community’.22 This holistic view will not be 
captured by clinical services alone and a balanced indicator set should include measures that 
reflect elements of comprehensive PHC as defined above. 
The framework of core functions for comprehensive Aboriginal PHC developed in the Northern 
Territory47 (Figure 3–9) extended the WHO framework by including indicators on some 
elements of comprehensive health care, namely ‘health promotion’, ‘advocacy, knowledge & 
research, policy & planning’ and ‘community engagement, control and cultural safety’.  While 
the nKPIs cover only ‘Domain 1: Clinical services’ indicators in areas of comprehensive PHC are 
captured by other data collections including the OSR. 
 
 75 
 
Figure 3–9: Core functions of primary health care: a framework for the Northern Territory. 
Source: Tilton, 2012 
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Conclusions to the question: ‘Are the indicators balanced in their coverage of PHC systems’ 
The nKPIs are unbalanced in their coverage of the PHC system.  While ideal coverage would 
include indicators from each of the 6 indicator domains outlined in Table 3–8, data for only 2 
to 4 of these domains are collected for each topic area.  Indicators on input and processes are 
not collected for any topic area, and only maternal health contains an indicator on 
‘intervention access and service readiness’.  The absence of indicators across the WHO 
framework makes it difficult to understand and explain the causes of a poor indicator result in 
the context of the resources and processes of the PHC service, and therefore to identify how 
best to strengthen the service. 
In addition, the nKPIs cover only one of the domains of the core functions of PHC framework 
for the NT shown in Figure 3–9.  This limits assessment of Aboriginal PHC services to a narrow 
range of clinical activities and not the broader range of activities for which they are funded. 
Alternative sources of these data 
However, the nKPIs are not the only data collection related to Aboriginal and Torres Strait 
Islander PHC.  The OSR and NHPA: Healthy Community Reports are potential sources of data 
for indicator domains not covered by the nKPIs.  The OSR, like the nKPIs, is reported at the PHC 
service level while NHPA data is available down to small geographic regions. Table 9 shows the 
coverage of the WHO M&E framework when the data from these three collections are 
combined. 
The coverage of both the WHO framework and the core functions of PHC framework for NT 
are greatly improved when nKPIs are combined with OSR and NHPA: Healthy Community 
reports.  This results in a more balanced coverage of comprehensive PHC with ‘Intervention 
access and service readiness’ the only indicator domain with a significant measurement gap.   
While NHPA data are not available at the PHC service level, this may be more appropriate for 
indicators on health impacts.  As shown in Figure 3–8, there are multiple determinants on 
health outcomes and impacts that lie outside the control of a PHC service.  Reporting on these 
indicator domains by region helps clarify that the results of these indicators are not attributed 
to health service performance alone. This point is expanded on in the sections 4.1c ‘Is the set 
of indicators likely to clarify the consensus on the objectives of the system?’, 4.3c ‘Smoking 
status result’ and 4.3d ‘Birth weight’. 
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Table 3–9: National Key Performance Indicators (nKPIs), Online Services Report and National 
Health Performance Authority indicators distributed across the World Health Organization 
(WHO) Framework for Monitoring and Evaluation of Health Systems Strengthening 
M
aj
o
r 
to
p
ic
 a
re
a 
o
f 
n
K
P
Is
 
Inputs and 
processes 
Outputs Outcomes Impact 
Intervention 
access and 
service 
readiness 
Intervention 
quality, 
safety 
Coverage of 
interventions 
Prevalence 
risk 
behaviours 
and factors 
M
at
e
rn
al
 h
e
al
th
 
Provides 
antenatal 
care(a) 
 
Midwife 
available(b) 
 
Shared care 
arrangements(c) 
Date of first 
antenatal 
visit 
Birth weight 
recorded 
 
 
Nil 
 
 
 
 
Smoking 
status in 
mothers 
who gave 
birth in 
past 12 
months 
Birth weight 
result 
P
re
ve
n
ta
ti
ve
 h
e
al
th
 a
ct
iv
it
ie
s 
Provides 
childhood 
immunisation 
(d)  
 
Clients per PHC 
staff(e)  
 
Practice 
accreditation (f) 
 
 
Nil Health check 
performed 
 
 
 
Children who 
are fully 
immunised 
 
Clients ≥50 
immunised 
against 
influenza 
 
Cervical 
screening 
performed 
Nil Potentially 
avoidable 
hospitalisation: 
vaccine-
preventable 
conditions 
 
 
C
h
ro
n
ic
 d
is
e
as
e
 c
ar
e
 
Access to 
diabetes allied 
health and 
specialist 
staff(g) 
 
 
 
 
Nil HbA1c 
recorded 
 
BP recorded 
 
Renal 
function test 
recorded 
 
General 
Practice 
management 
plan 
 
Team Care 
arrangement 
 
Clients with 
T2DM or 
COPD 
immunised 
against 
influenza 
 
 
HbA1c 
result 
 
BP result 
 
 
Renal function 
test result  
(T2DM/CVD 
with End Stage 
Renal Disease) 
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C
h
ro
n
ic
 d
is
e
as
e
 r
is
k 
fa
ct
o
rs
 
Clients per 
Substance 
misuse/drug 
and alcohol 
worker(e) 
Nil Smoking 
status 
recorded 
 
Alcohol 
status 
recorded 
 
CVD risk 
assessment 
recorded 
Number of 
group 
sessions for 
- tobacco 
prevention 
- alcohol 
misuse 
prevention 
- physical 
activity / 
healthy 
weight(h)  
 
Smoking 
status 
result 
 
Alcohol 
status 
result 
 
Number of 
obese 
adults 
 
CVD risk 
result 
Potentially 
avoidable 
hospitalisation: 
chronic 
conditions 
Red = existing Online Service Report (OSR) indicator 
Blue = existing National Health Performance Authority (NHPA) indicator 
(a) OSR indicator P7-A: Does the PHC service provide antenatal care 
(b) OSR indicator W-2, W-4: Does a midwife work at the service (paid by PHC service or paid by another 
organisation) 
(c) OSR indicator MCH-4:  Does the PHC service have effective antenatal shared care arrangements with 
the local hospital  
(d) OSR indicator CS-8: Does the PHC service provide immunisation 
(e) OSR indicator W-2, W-4 with nKPI data: Ratio of regular clients to full time equivalent health staff 
(f) OSR indicator AC-1a, AC-2a:  Does the PHC have current RACGP and/or organisational accreditation 
(g) OSR indicator CS-5a:  Does the PHC service provide on-site access to a diabetes educator/ 
dietician/podiatrist/optometrist/diabetes specialist 
(h) OSR indicator HP-1a: Number of group activities for health promotional activities were conducted 
BP = Blood Pressure COPD = Chronic Obstructive Pulmonary Disease,  CVD = Cardiovascular Disease, 
HbA1c = Haemoglobin A1c, T2DM = Type II Diabetes Mellitus 
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Recommendation 1 Create integrated Aboriginal and Torres Strait Islander PHC reports 
The AIHW should seek advice from relevant experts on a combined 
report for Aboriginal and Torres Strait Islander PHC services. The 
report could combine relevant results from nKPIs, OSR and NHPA: 
Healthy Community reports to create a comprehensive picture of PHC 
systems.  These reports could be generated both at a national and 
PHC service level. 
Recommendation 2 Rationalise the nKPI set 
The Indigenous Health Division (IHD) of the Department of Health 
should consider abandoning the collection of some nKPIs.  An 
integrated PHC service report will enable the best available data to be 
used for the indicator domains ‘Outputs’ and ‘Impacts’.  This may not 
be nKPI data and in these cases the indicator should be dropped from 
the indicator set. 
What indicators could be retained or dropped is elaborated in the 
sections 6.2 ‘Is the set of indicators likely to clarify the consensus on 
the objectives of the system?’ and in the individual indicators 6.3c 
‘smoking status result’ and 6.3d ‘birth weight’ 
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Recommendation 3 Consideration of additional indicators: ‘Intervention access and 
service readiness’ 
The IHD should consider additional indicators in the indicator domain 
‘Intervention access and service readiness’.  Within an integrated PHC 
service report this is the indicator domain with the least data. 
Any consideration of additional indicators needs to take into account 
the large reporting burden faced by Aboriginal and Torres Strait 
Islander PHC services.  However, it is possible for indicators in this 
domain to be extracted from PIRS.  Possible examples: 
For the topic area chronic disease care 
 Recent access for chronic disease clients: What proportion of 
regular clients with T2DM, CVD, COPD have accessed the 
service in the previous 6 months.  Results could be 
disaggregated by sex and 10 year age groups 
Or alternatively 
 Practice Incentive Payment target access for chronic disease 
clients: What proportion of regular clients with T2DM, CVD, 
COPD have accessed services 5 times or more in the past 12 
months as per the targets set by the Australian Government 
through the Indigenous Health Practice Incentive Payment.  
Results disaggregated by sex and 10 year age groups. 
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6.1b Are the nKPIs balanced in their coverage of issues of importance in Aboriginal and 
Torres Strait Islander PHC? 
Standards used:  
Coverage of nKPIs against priorities identified in the Australian Government’s National 
Aboriginal and Torres Strait Islander Health Plan.48  
Coverage of cost-effective intervention identified in Vos et al. (2010) ‘Assessing Cost-
Effectiveness in Prevention’.49 
To answer this question requires understanding the health issues of importance to Aboriginal 
and Torres Strait Islander communities and the issues that can be addressed by PHC.  The 
focus of the nKPIs should include the health priorities identified by Aboriginal and Torres Strait 
Islander communities, consistent with the United Nations Declaration on the Rights of 
Indigenous Peoples.51 These rights underpin the governance structure of ACCHOSs and 
empower community members to lead the focus of their PHC service.  In addition to these 
priorities, the health issues of importance are those with feasible and cost-effective solutions.  
Roberts and Jackson (2014) argued that the focus of health programs should be driven by 
issues that have cost effective solutions, rather than by burden of disease: ‘because of budget 
limits, a decision to invest in a particular set of interventions means that we are implicitly 
deciding not to invest in others. By prioritising cost-effective interventions we make the most 
of available resources.’52 In a similar way, the health issues included in the nKPIs have been 
prioritised ahead of other issues in PHC services.  As an example, there are 10 nKPIs related to 
Type II diabetes mellitus and none on depression.  A balanced indicator set of would include 
indicators on the health priorities identified by Aboriginal and Torres Strait Islander 
communities and for which we have cost-effective interventions. 
To assess the nKPIs coverage of community priorities with cost-effective interventions we 
distributed the indicators based on two reports.  Firstly, the National Aboriginal and Torres 
Strait Islander Health Plan (NATSIHP) was used to determine community priorities. The 
NATSIHP was released in 2015 following consultations with the Aboriginal and Torres Strait 
Islander community that included 17 community meetings, attended by 770 individuals, 141 
written submissions, 3 expert forums and 5 themed roundtables.48 Thus the priorities within 
the plan can be seen as representative of those in the Aboriginal and Torres Strait Islander 
community.  Secondly, the report by Vos et al. (2010) ‘Assessing Cost-Effectiveness in 
Prevention’ was used to identify coverage of cost-effective interventions.49 nKPIs with a 
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balanced coverage of health issues would include those identified as priorities in the NATSIHP 
and that Vos et al. showed to have cost-effective interventions. 
nKPIs and National Aboriginal and Torres Strait Islander Health Plan   
Not all of the priorities within NATSIHP are amenable to measurement through the nKPIs.  The 
indicators are populated by data extracted from health service PIRS and this is not suitable for 
generating indicators in some NATSIHP priority areas.  An example is the priority ‘Health 
enablers: A culturally respectful and non-discriminatory health system’.  Indicators for this 
priority are better measured through collections such as the Australian Aboriginal and Torres 
Strait Islander Peoples Health Survey and OSR. The health survey has questions on experiences 
of discrimination in the health system and the OSR contains a series of questions on cultural 
safety.  We assessed each NATSIHP priority and determined those that could be measured 
through nKPIs based on our knowledge of PIRS and data extraction software.  
Table 3-10 lists the priorities that can be measured through nKPIs and describes their coverage 
by the nKPI set.  One priority, ‘mental health and social and emotional well-being’, has no 
nKPIs while the priorities ‘Health enablers: Health system effectiveness and clinically 
appropriate care’ and ‘Adolescent and youth health’ have only partial coverage. 
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Table 3–10: Coverage of priorities in the National Aboriginal and Torres Strait Islander Health 
Plan (NATSIHP) by the national Key Performance Indicators (nKPIs) 
NATSIHP Priority Coverage by 
nKPIs 
Rationale 
Health enablers: 
Health system 
effectiveness and 
clinically appropriate 
care 
 
Partial Indicators on chronic disease care planning  
 
Indicators on best-practice population screening:  
Smoking, alcohol consumption, renal disease in 
patients with chronic disease and CVD risk 
 
No indicators on best-practice interventions 
 
Indicators on best-practice treatment targets 
Mental health and 
social and emotional 
well-being 
None No indicators 
Maternal health and 
parenting 
Covered Indicators on timing of first antenatal visit and smoking 
after pregnancy  
Childhood health and 
development 
Covered Indicators on birth weight, childhood immunisation 
and health checks  
Adolescent and youth 
health 
Partial Indicators on risk factors include people aged 15 years 
and older: Smoking and alcohol consumption 
 
All indicators on chronic disease management include 
people aged 15 years and older. 
 
The indicator on health checks excludes people aged 
5–24 years.  Indicator on obesity excludes people <25 
years old. 
Healthy adults Covered Indicators on preventative health activities: Health 
checks, CVD screening, pap smears  
 
Indicators on chronic disease risk factors: smoking, 
alcohol consumption, obesity 
 
Chronic disease management: care planning, 
measurement of HbA1c/BP, influenza vaccination in 
chronic disease, screening for renal disease 
Healthy ageing Covered Included in all indicators listed for ‘Healthy adults’. 
 
One indicator specifically targeting this group – 
influenza vaccination > 50 years old. 
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nKPIs and cost-effective interventions 
nKPIs that do not contain all of the Aboriginal and Torres Strait Islander community’s priorities 
may be justified if they emphasise cost-effective PHC interventions.  The report by Vos et al. 
(2010) analysed the cost-effectiveness and health impact of 150 interventions for either the 
Australian public health or PHC setting.  This included analysis of 31 interventions specifically 
for the Aboriginal and Torres Strait Islander population in the areas of cardiovascular disease, 
diabetes, kidney disease and Hepatitis B.  Table 3–11 demonstrates how Vos et al. categorised 
cost-effectiveness and health impact.  The analyses for the Aboriginal and Torres Strait Islander 
specific interventions expanded assessment of health impact to include community health gain, 
equity and cultural sensitivity in order to better capture the Aboriginal definition of health.  A 
balanced set of nKPIs would include the cost-effective interventions identified in this report 
that have a medium to large health impact. 
Table 3–11: Categorisation of cost-effectiveness and health impact. Source: Vos et al., 2010 
Aspect Categories 
Cost-effectiveness Dominant:  cost saving 
Very cost-effective:  <$10,000 per Disability Adjusted Life Year 
(DALY) 
Cost-effective: $10,000-$50,000 per DALY 
Not cost-effective:  >$50,000 per DALY 
Dominated: interventions with worse health outcomes at a cost; 
or more cost-effective alternatives are available 
Health impact  
(General population) 
Large: >100,000 DALYs 
Medium: 10,000-100,000 DALYs 
Small: 0-10,000 DALYs 
Health impact  
(Aboriginal and Torres 
Strait Islander population) 
Large: >5,000 DALYs 
Medium: 500-5000 DALYs 
Small: <500 DALYs 
 
Table 3–12 and 
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Table 3–13 are league tables of cost-effectiveness and health impact taken from Vos et al. 
(2010) and the last column reflects the link with specific nKPIs.  From the 150 interventions 
within the report the tables included interventions that could be introduced in the current 
funding environment and excluded interventions that were not cost-effective or had a small 
health impact. This was achieved by applying 4 criteria to each intervention: 
1. Intervention could be introduced by PHC services with funding from the Medicare 
Benefits Schedule or Pharmaceutical Benefits Schedule 
2. Cost-effective, very cost-effective or dominant 
3. Medium or large health impact 
4. Consistent with current clinical practice guidelines (see Box 2) 
 
As a limited number of diseases were covered in the analyses of Aboriginal and Torres Strait 
Islander data (Table 3–12) cost-effective interventions with medium to large health impact in 
the general population are also shown (Table 3-13). The two tables highlight a number of nKPIs 
linked to screening; however there are no indicators on actions following a positive screen and 
no indicators on mental health interventions. 
Box 2: Recommendations from ‘Assessing Cost-Effectiveness in Prevention’ that are 
inconsistent with current guidelines 
Vos et al (2010) contained a number of interventions that were assessed as cost-
effective but are inconsistent with current guidelines.   
The Aboriginal and Torres Strait Islander analyses contained a number of interventions 
on the prescription of cardiovascular medications to all Aboriginal people 35 years and 
older, regardless of CVD risk.  While these interventions were found to be dominant or 
very cost effective, a population wide approach is not consistent with existing 
guidelines, nor is it funded through the PBS. Due to this, CVD treatment is included in 
cost-effective interventions for the general population in 
Table 3–13 where treatment is guided by CVD risk. 
Similarly there were a number of recommendations for medications for pre-diabetes 
for both the general population and Aboriginal and Torres Strait Islander people that 
are not consistent with existing guidelines or funded under the PBS. 
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Table 3–12: Cost effective interventions for the Aboriginal and Torres Strait Islander 
population identified by Vos et al. (2010) aligned with national Key Performance Indicators 
(nKPIs) 
Intervention Cost-effectiveness Health Impact nKPI 
Universal infant 
Hepatitis B 
vaccination 
Cost saving Medium Children who are 
fully immunised 
Screening for kidney 
disease and 
prescription of ACEi1, 
ages 25+ 
Cost saving Medium Renal function test 
recorded1 
Screening for pre-
diabetes and referral 
to dietician and/or 
and exercise 
physiologist 
Very cost-effective Large Health check1 
1 Does not assess action following positive screen 
ACEi = Angiotensin Converting Enzyme Inhibitor 
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Table 3–13:  Cost effective interventions for general population identified by Vos et al. 
(2010) aligned to national Key Performance Indicators (nKPIs) 
Intervention Cost-effectiveness Health Impact nKPI 
Screen women aged 70+ 
and prescribe alendronate 
Dominant Medium Nil 
Prescription of smoking 
cessation aids1 
Very cost-effective Medium Smoking status2 
Prescription of diuretic if 
absolute CVD risk >5% 
Very cost-effective Large CVD risk 
assessment2 
Individual/group CBT for 
major depressive episodes 
Very cost-effective Medium Nil 
Dietary counselling3 by if 
absolute CVD risk >5% 
Cost-effective Medium CVD risk 
assessment2 
Prescription of statins if 
CVD risk >5% 
Cost-effective Large CVD risk 
assessment2 
Prescription of B-Blockers 
if CVD risk >5% 
Cost-effective Medium CVD risk 
assessment2 
Prescription of CCB if CVD 
risk >5% 
Cost-effective Large CVD risk 
assessment2 
Prescription of ACEi if CVD 
risk >5% 
Cost-effective Large CVD risk 
assessment2 
Exercise physiologist +/- 
dietician if pre-diabetes 
Cost-effective  Medium Health check2 
Maintenance TCA/SSRI 
following major depressive 
episodes 
Cost-effective Medium Nil 
Maintenance 
individual/group CBT 
following major depressive 
episodes 
Cost-effective Medium Nil 
1 Smoking cessation aids assessed were varenicline, bupropion or nicotine replacement therapy 
2 Does not assess action following a positive screen 
3 Dietary counselling by either a dietician or a GP  
CBT = cognitive behavioural therapy, CCB = calcium channel blocker, CVD = Cardiovascular disease, SSRI 
= selective serotonin reuptake inhibitor, TCA = tricyclic antidepressant 
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Conclusion to the question: ‘Are the indicators balanced in their coverage of issues of 
importance in Aboriginal PHC’ 
The nKPIs are unbalanced in their coverage of issues of importance in Aboriginal PHC.  An ideal 
indicator set would include issues identified as priorities by the Aboriginal and Torres Strait 
Islander community and for which there are cost-effective interventions.  However, the nKPIs 
do not include indicators on mental health, identified as a priority in the NATSIHP and for 
which there are several cost-effective interventions (Table 3-13).  Not including indicators for 
issues identified as priorities by the community risks failures in addressing them effectively and 
widening existing gaps in service provision.  Collecting and analysing data through the nKPI 
monitoring system encourages Aboriginal and Torres Strait Islander PHC services to focus on 
what is being measured and this may be to the detriment of issues outside of the indicator set. 
The nKPIs also have an unbalanced coverage of indicators for cost-effective PHC interventions.  
While nKPIs include screening for renal disease, CVD and pre-diabetes, there are no indicators 
on treatment for any of these conditions.  Poor implementation of appropriate treatment 
following screening has been highlighted by an Australian study of cardiovascular disease 
treatment53 that revealed 50% of individuals with high risk of cardiovascular disease were not 
prescribed recommended medications.  Screening for these conditions without coupling the 
efforts to effective follow-up will not improve health outcomes. 
Recommendation 4 Consideration of additional indicators: ‘Mental health and social and 
emotional well-being’ 
The IRD should explore options for indicators on ‘mental health and 
social and emotional well-being’ to be collected with data extraction 
software.  An example of an indicator that could be developed within 
data extraction software is: 
 Billing of a mental health care plan for patients with 
depression (enabling subsidised access to a psychologist) 
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Recommendation 5 Consideration of additional indicators: ‘Interventions following 
screening’ 
The IRD should consider possible indicators for interventions following 
positive screening.  This could include indicators that are already 
collected by data extraction software: 
 Prescription of statin for people with high risk cardiovascular 
disease.   
 Prescription of ACEi or angiotensin II receptor blocker for 
patients with proteinuria.   
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6.2: Is the set of indicators likely to clarify the consensus on the 
objectives of the system? 
Standards used: 
The coverage of the nKPIs against outputs within COAG’s National Indigenous Reform 
Agreement.17 
The reporting of nKPIs on health outcomes and impacts reflects the multiple determinants of 
these indicators. 
The nKPIs accommodate approaches to services delivery that contribute to Closing the Gap 
while being appropriate to local community needs. 
The Closing the Gap initiative has articulated an objective for Aboriginal and Torres Strait 
Islander health and the approach required to achieve this. The objective is for governments to 
work together with Aboriginal and Torres Strait Islander people to close the gap in 
disadvantage, for which there are two health targets: 
1. Closing the life expectancy gap within a generation;  
2. Halving the gap in mortality rates for Indigenous children under five within a decade17 
In addition to these targets, the ‘Closing the Gap’ documents outline a set of core service 
delivery principles (Box 3).  These principles include the ‘Priority Principle’, which reflects the 
community led approach of ACCHOs.  However, while there is consensus on the overall 
objective and methods for Aboriginal and Torres Strait Islander health, the role of Aboriginal 
and Torres Strait Islander PHC in Closing the Gap is less clear.  An ideal nKPI monitoring 
systems would help clarify this by setting indicators in areas where Aboriginal and Torres Strait 
Islander PHC can contribute to the ‘Closing the Gap’ while remaining appropriate to 
community needs. 
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nKPIs coverage of National Indigenous Reform Agreement 
The ‘Closing the Gap’ National Indigenous Reform Agreement describes outputs to be 
delivered in order to achieve the specified targets. A number of outputs relate to how PHC 
services are expected to contribute to the health targets and are listed in Table 3-14 alongside 
relevant nKPIs. These outputs are described as ‘criteria’ using language consistent with NHS’s 
‘Good Indicators Guide’ (Box 4). The guide stresses that a criterion ‘needs at some point to be 
made quantifiable as a standard, indicator or target’.  It follows that a set of nKPIs that aligned 
with these criteria would be a starting point to help clarify the role of PHC in ‘Closing the Gap’. 
Table 3-14 shows that, with the exception of adolescent sexual health and breast-feeding, all 
the criteria within ‘Closing the Gap’ have associated nKPIs.  
Box 3: Service Delivery Principles for Services for Indigenous Australians (Council of 
Australian Governments, 2011) 
Priority principle: Programs and services should contribute to Closing the Gap by meeting 
the targets endorsed by COAG while being appropriate to local community needs.  
Indigenous engagement principle: Engagement with Indigenous men, women and children 
and communities should be central to the design and delivery of programs and services.  
Sustainability principle: Programs and services should be directed and resourced over an 
adequate period of time to meet the COAG targets.  
Access principle: Programs and services should be physically and culturally accessible to 
Indigenous people recognising the diversity of urban, regional and remote needs.  
Integration principle: There should be collaboration between and within Governments at 
all levels and their agencies to effectively coordinate programs and services.  
Accountability principle: Programs and services should have regular and transparent 
performance monitoring, review and evaluation.  
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Box 4: Glossary of terms from ‘The Good Indicators Guide’ (Penchon, 2008) 
Criterion: ‘An area or issue which, according to good evidence, is related to the 
overall objectives and outcomes of the system or organisation being measured. It 
needs at some point to be made quantifiable as a standard, indicator or target.’ 
Indicator: ‘A summary measure that aims to describe, in a few numbers as much 
detail as possible about a system, to help understand, compare, predict, improve, 
and innovate.’ 
Standard: ‘The level at which a criterion is set.’ 
Target: ‘Whereas indicators imply only direction, targets imply direction, speed, and 
destination.’ 
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Table 3–14: National Indigenous Reform Agreement (Closing the Gap) outputs related to 
primary health care and the national Key Performance Indicators 
Closing the Gap primary health 
care outputs (criterion) 
National Key Performance Indicators  
Increased provision of maternal 
and child health services for 
Indigenous children and their 
mothers  
Date of first antenatal visit  
Birth weights  
Childhood immunisations  
Health check performed 
Increased provision of sexual and 
reproductive health services for 
Indigenous teenagers  
Nil 
Improved quality and coverage of 
primary health services 
GPMP/TCA for chronic disease  
HbA1c recorded 
HbA1c result  
BP recorded  
BP result  
Renal function test recorded  
Renal function test result 
Clients with chronic disease immunise against 
influenza 
Prevention, early detection and 
management of major chronic 
diseases 
Health check performed (>25yo) 
CVD risk assessment performed 
CVD risk assessment 
Reduction in alcohol use and 
smoking within a decade 
Smoking status recorded 
Smoking status result 
Alcohol status recorded 
Alcohol status result 
Smoking status in mothers who gave birth in past 12 
months 
Address key behavioural chronic 
disease risk factors 
Levels of obesity 
Promotion of breast-feeding Nil 
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Reporting of nKPIs on health outcomes and impacts 
However, aligning with the above criteria is, on its own, insufficient to clarify the role of PHC 
services. PHC is only one of many influences on some of the above criteria.  For example, 
within the criterion ‘address key behavioural chronic disease risk factors’, the highest impact, 
cost-effective interventions for obesity lie outside PHC.  Vos et al. (2010) found that 
introducing a 10% tax on unhealthy food and gastric banding for severe obesity would each 
have a lifetime health impact of over 100,000 DALYs.  Taxation was assessed as dominant 
(cost-saving) while gastric banding was very-cost effective.  In comparison, the PHC service 
interventions (counselling on low-fat diet and exercise) were less cost-effective, with an 
estimated impact of fewer than 10,000 DALYs. The influence of multiple determinants on 
obesity and other chronic disease risk factors such as smoking and alcohol consumption is why 
they are listed in ‘Closing the Gap’ as performance indicators of the Australian, state and 
territory governments, as shown in Table 3-15. The government’s performance indicators also 
include birth weight and indicators on antenatal care, reflecting the collective effect of PHC, 
hospital care and social determinants on these indicators. These government performance 
indicators have previously been reported at the regional level, but by shifting reporting to the 
PHC service level it implies that these indicators are now measures of PHC service performance.  
To clarify PHC’s role in ‘Closing the Gap’, the nKPI monitoring system should be explicit on 
which indicators measure the performance of PHC services, and which the performance of 
government. 
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Table 3–15: Comparison between nKPIs and performance indicators for the Australian, state 
and territory governments within Council of Australian Governments (COAG) National 
Indigenous Reform Agreement 
National Key Performance Indicators 
 
 
Performance Indicators for Aboriginal and 
Torres Strait Islander Primary Health Care 
Organisations 
COAG National Indigenous Reform 
Agreement 
 
Performance Indicators for Australian, state 
and territory Governments 
Number and proportion of regular clients 
with a smoking status result (PI10a/b) 
 
Number and proportion of regular clients who 
had an AUDIT-C result within specified levels 
(PI17a/b) 
 
Number and proportion of regular clients who 
are classified as overweight or obese 
(PI12a/b) 
 
Number and proportion of Indigenous babies 
born within the previous 12 months whose 
birth results were low, normal and high 
(PI02a/b) 
 
Number and proportion of regular clients who 
gave birth in the past 12 months with a 
smoking status of ‘current smoker’, ‘ex-
smoker’, or ‘never-smoked’ (PI11a/b) 
 
Number and proportion of regular clients who 
had their first antenatal visit within specified 
periods (PI13a/b) 
Rates of current daily smokers 
 
 
Levels of risky alcohol consumption 
 
 
 
Prevalence of overweight and obesity 
 
 
 
Proportion of babies born of low birth weight 
 
 
 
 
Tobacco smoking during pregnancy 
 
 
 
 
Antenatal care 
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The AIHW’s national reports attempt to distinguish which indicators are most relevant to PHC 
service performance.  Within the latest report there is a chapter ‘Individual organisation 
performance against process-of-care indicators’.5 The results presented in this chapter exclude 
all the indicators of government performance listed in Table 3-15, with the exception of the 
antenatal care indicator.  However, outside of this chapter, the reporting of government 
performance indicators fails to acknowledge that actions may be taken outside of PHC services 
to improve these results. The text within ‘Opportunities for action’ for the obesity indicator 
(Box 5) demonstrates that the focus of this government performance indicator is on PHC 
services alone. While there is recognition that factors outside of PHC services influence 
government performance indicators, it is not clear that interventions outside of PHC may be 
required to improve these results. 
 
The Good Indicators Guide also highlighted that using indicators to clarify to consensus 
involves ‘Using indicators that measure the right data; in the right parts of the system’. This 
raises the issue of whether PHC services are the right part of the system to be measuring 
government performance indicators.  Progress in ‘Closing the Gap’ is measured by the 
difference between Aboriginal and Torres Strait Islander and non-Indigenous indicators.  By 
contrast, the nKPIs are measured only in Aboriginal and Torres Strait Islander people and can 
therefore not be compared with data for the non-Indigenous population. While similar 
indicators from alternative sources are available for non-Indigenous people, differences in 
Box 5: Reporting of nKPI on ‘Overweight and Obese’ in AIHW’s nKPI report December 2014 
‘Opportunities for action  
• BMI is influenced by a range of social determinants and lifestyle factors outside the 
control of organisations. A high number or proportion of clients who are overweight 
or obese does not indicate poor organisational performance.   
• Organisations could review whether sufficient attention is being paid to preventative 
programs that target nutrition and physical activity.   
• Reversal of obesity is difficult, even in the absence of environmental and social 
barriers. Therefore, early intervention to prevent the onset of excessive weight gain 
is likely to be the most effective strategy (Thurber et al. 2014).   
• Research shows that opportunities exist for obesity prevention in young children 
through practice-nurse brief interventions (Denney-Wilson et al. 2014).’ 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study population and data collection render these data unusable for comparison. The study 
population for nKPIs are regular clients of PHC services and the primary purpose of data entry 
is not for data collection, but for clinical care. Table 3-16 outlines the study population and 
data collection methods in similar Aboriginal and Torres Strait Islander datasets and the 
difference in indicator results. Without comparing nKPIs to appropriate non-Indigenous data it 
is not clear whether results are on track to help close the gap.   
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Table 3–16: National Key Performance Indicator (nKPI) results December 2014 and 
alternative national indicators. 
Indicator Component nKPI data  Alternative data Alternative source 
Aboriginal 
and Torres 
Strait 
Islander 
Non-
Indigenous 
Smoking 
status 
Current 
Smoker 
52.4% 43.0% 16.9% Australian Aboriginal and 
Torres Strait Islander Health 
Survey 2012-13 
Study population 
Nationally representative 
sample of Aboriginal and 
Torres Strait Islander people 
Data collection 
Obtained by trained ABS 
interviewers, through 
Computer Assisted Personal 
Interview 
BMI Overweight 
and obese 
70.1% 72.6%  66.7% Australian Aboriginal and 
Torres Strait Islander Health 
Survey 
See above 
First antenatal 
visit 
Within first 
trimester 
35.9% 46.0%  57.5% National Perinatal Data 
Collection 2012 
Study population 
All Australian births > 20 
weeks gestation or >400gm 
Data collection  
Entered by midwives at time 
of birth.  Mandatory 
component of collection 
Birth weight 
result 
Low birth 
weight 
12.6% 10.5%  4.5% National Perinatal Data 
Collection 
See above 
Immunisation Fully 
immunised 
at 5 years 
63.8% 92.1%  91.5% Australian Childhood 
Immunisation Register 2012-
13 
Study population 
All Australian children 
Data collection 
Entered by clinicians at time 
of immunisation 
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nKPIs  and community needs 
In addition to setting indicators where PHC can contribute to ‘Closing the Gap’, an ideal 
monitoring system would provide a framework where progress can be measured while 
remaining appropriate to community needs. The case study in Box 6 describes an ACCHO that 
has focused its service provision on the needs of its community.  These services align with 
three ‘Closing the Gap’ criteria: 
 Improved quality and coverage of primary health services 
 Prevention, early detection and management of major chronic diseases 
 Address key behavioural chronic disease risk factors   
However, none of the activities described in Box 6 contribute to nKPI results.  This highlights 
that a service may be addressing ‘Closing the Gap’ criteria through focusing on community 
priorities but may perform poorly in the nKPIs.  
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Box 6: Case study.  Gurriny Yealamucka Health Service: Focused on young adults. 
Gurriny Yealamucka is an Aboriginal Community Controlled Health Organisation in the 
community of Yarrabah, a former Anglican mission on hour from Cairns with a population of 
2409.  In response to the needs of the community it has established two innovative 
programs– the Life Promotion Program and the Young Persons Health Check.  
 
Life Promotion Program 
The Life Promotion Program was established in response to the high suicide rate within the 
community.  In the 90’s there were 17 suicides in a six-year period and this program was 
established in response to this tragedy.  It is a set of community-developed strategies for 
suicide prevention, intervention and aftercare and includes a volunteer network of crisis 
counsellors available at all times.  Following the introduction of the program there were no 
suicides for the following eight years.54 
 
Young Persons Health Check 
Yarrabah has an extremely young population with 55.1% (1327 of 2409) of the population 
less than 25 years of age.  There is also a high incidence of chronic disease with the rate of 
end stage renal disease over 8 times the national average.55 There is also anecdotal evidence 
of early ischaemic heart disease in addition to the well-known mental health problems.  In 
response to these challenges the community identified engaging young adults in their health 
as a vital intervention and established an annual young person’s health check.  The check 
focuses on 16-25 year olds and does screening for chronic diseases including hypertension, 
diabetes and chronic renal disease as well as screening for depression and sexually 
transmitted infections.  The importance of the health check is promoted by young 
community leaders, namely the local rugby league side.  As a result the community has a high 
proportion of young adults who have had a health check performed and screened 
appropriately for sexually transmitted infections.   
 
The nKPIs do not capture any of the activity of either of these innovative programs.  There 
are no indicators on mental health and the indicator for health checks looks only at adults 
older than 25 years old. 
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Conclusion: Clarifying consensus 
The nKPIs do not help clarify the role of Aboriginal and Torres Strait Islander PHC services in 
contributing to ‘Closing the Gap’.  Although the nKPIs are aligned to ‘Closing the Gap’ criteria, 
the inclusion of government performance indicators creates confusion on the expected impact 
of PHC.  By collecting indicators from services and labelling them ‘Key Performance Indicators’ 
the default assumption is that they are measuring service performance.  However, the ‘Closing 
the Gap’ documents show that many nKPIs are indicators of government performance.  The 
reporting of the results of these indicators within the nKPI monitoring system does not go far 
enough to clarify how interventions outside of PHC can influence these results.   
The absence of comparable non-Indigenous data for nKPIs also confuses progress towards 
‘Closing the Gap’.  It is difficult to interpret the implications of nKPI results in government 
performance indicators due to the nKPI study population and data collection methods.  It is 
therefore uncertain what these results add to existing population level data. 
Recommendation 6 Clearly delineate between nKPIs of performance of PHC services and 
those of government. 
The AIHW should clearly delineate between these two groups of 
indicators within national reports and reports back to PHC services. 
Recommendation 7 Include broader public health initiatives in ‘areas for action’ 
The IRD should include advice from relevant experts on non-PHC 
interventions for those indicators influenced by areas outside of 
health service performance alone. 
 
This also supports an existing recommendation 
 Recommendation 2: ‘Rationalise the indicator set’. 
The nKPIs also fail to clarify the role of local approaches to achieving the Closing the Gap 
targets.  The narrow range of indicators implies that all services should focus on the same 
areas: maternal health, chronic disease care (predominately in diabetes), reducing chronic 
disease risk factors and preventative health activities (but not among adolescents and young 
adults).  This prescriptive approach discourages services that address priorities identified by 
the community. 
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Recommendation 8 Enable PHC services to select priority indicators. 
The IRD should seek advice from relevant experts on a system 
whereby a PHC service can select indicators in topic areas based on 
community priorities.  This may include some ‘mandatory’ indicators 
reflecting national priorities. 
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6.3 Analysis of individual indicators 
While the previous sections evaluated the nKPI set as a whole, in this final section we assess 
individual indicators against the evaluation instrument.   
6.3a Diabetes care: Diabetics with HbA1c measured 
Definition (from AIHW) 
‘The number and proportion of regular clients who are Indigenous, have Type II diabetes and 
who have had an HbA1c measurement result recorded at the primary health care service 
within the previous 6 months AND number and proportion of regular clients who are 
Indigenous, have Type II diabetes and who have had an HbA1c measurement result recorded 
at the primary health care service within the previous 12 months.’ 
A Theory of Change to improve outcomes of diabetes 
Figure 3–8 (p. 71) demonstrates the steps required to improve health outcomes for people 
with diabetes in the context of the WHO M&E framework (inputs, processes, outputs, 
outcomes and impacts) and the determinants related to each step. 
Achieving improvements in diabetic morbidity and mortality through the PHC system is 
dependent on multiple steps and appropriate indicators should be measured at each step.  
Within PHC services progression towards improved health outcomes is measured though 
intermediate health outcomes such as BP and HbA1c levels.  For these outcomes to improve, 
an individual must adopt the interventions recommended by the health service following 
appropriate screening. This can only occur if the patient attends the clinic and the health 
service has the infrastructure in place to provide best practice care.  This includes appropriate 
staff at the level required to provide quality care, infrastructure such as clinical space, efficient 
systems to enable recalls and care planning and equipment like point of care HbA1c testing.  
The availability of these resources is in turn dependent on funding and influenced by the 
service’s governance.  
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Table 3–17: Assessment of the nKPI 'HbA1c measured' against National Health Service’s 
criteria for good indicators and good indicator sets 
Evaluation question Result Evidence/explanation 
 
A1: Does the indicator 
measure a sufficiently 
important question? 
 
Yes 
 
The measurement of HbA1c at regular intervals is a 
requirement of good diabetic care and management to 
maintain its level within normal limits is associated with 
improved diabetic outcomes.56 
 
B1: Does this indicator 
really measure the 
issue? 
 
Partially 
 
The quality being assessed is whether the service is 
providing good diabetes care; HbA1c measurement is one 
component for assessing the quality of care.  Other 
elements of quality diabetic care are shown in Figure 3–8 
(p. 71) 
 
There are some concerns with recording the value of the 
indicator highlighted by the SMS Management & 
Technology review (2014). They found that incorrectly 
formatted or coded pathology results do not get picked up 
for nKPIs.  The reasons for this include 
 Not all pathology providers are using the standard 
format for pathology messaging (Health Level 7 
[HL7]) 
 Pathology providers are incorrectly or 
inconsistently applying standard language for 
medical laboratory observations (Logical 
Observation Identifiers Names and Codes [LOINC])  
 Limited understanding of where to record 
information to be detected for nKPI results.  This 
means that HbA1c measured through a ‘Point of 
Care’ machine may be recorded in the patient 
record but not in a location where it can be 
detected by the data extraction software.34  
  
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C1: Are sufficiently 
reliable data available 
at the right time, for 
the right 
organisations, with the 
right comparators? 
 
 
Partially 
 
 
 
 
No 
 
In the service 
The concerns with incorrectly formatted or coded 
pathology results means that these data are not 
sufficiently reliable in some services. 
 
In national reports 
The concerns with incorrectly formatted or coded 
pathology results means that these data are not 
sufficiently reliable. 
 
The comparison of the result across services in national 
reports is inappropriate as there is no consideration of the 
resources available at each clinic.  Figure 3–8 
demonstrates how measuring HbA1c is dependent on 
appropriate resources at the health service.  Aboriginal 
and Torres Strait Islander PHC services have a wide variety 
in capacity due to factors relating to remoteness, staffing, 
funding and governance.  In addition, in the AIHW’s 
analysis of data quality issues, they found 29 of 167 
(17.4%) of services reported ‘0’ in their denominator data, 
indicating that they do not see any clients with Type II 
diabetes mellitus.  Comparing HbA1C across regions 
without reference to the resources available each clinic is 
inadequate. 
 
D1. Will the indicator 
be able to detect and 
display a variation that 
is important enough 
to warrant further 
consideration? 
 
 
 
 
Yes 
 
 
 
Yes 
 
 
 
 
 
In the service 
There is no variation as the question in only whether the 
test is performed or not, i.e. a ‘yes/no’ result. 
 
In national reports 
The latest AIHW report shows large variation in results 
with the top 25% of PHC services reporting more than 73% 
of clients had a HbA1c recorded in the past 6 months while 
the bottom 25% had less than 42% of clients with a HbA1c 
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D2. If the indicator is 
high or low, what does 
it actually tell you, and 
does it give enough 
accurate and precise 
information for you to 
be able to investigate 
further and take any 
necessary action? 
 
D3. Can the indicator 
be deconstructed in 
order to understand 
the particular reasons 
for the results? 
 
 
 
 
 
 
 
 
 
D4. Can the 
implications of the 
indicator results be 
communicated to, and 
believed by the right 
audience? 
 
 
 
Yes 
 
 
 
 
 
 
 
 
 
No 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes 
 
 
 
 
 
 
 
 
recorded in the same time period.5 
 
If the indicator is low this highlights that the HbA1c is 
either not being recorded correctly or testing is not 
occurring within recommended timeframes.  The indicator 
is disaggregated by sex and ten year age groups in order to 
provide precise information if certain demographics are 
disproportionately affected.57 
 
 
 
 
Figure 3–8 shows the diverse types of data that needs to 
be collected to understand reasons for not testing.  
Measuring HbA1c is not only dependent on a health 
practitioner ordering the test at the appropriate time but 
the patient needs to attend the clinic and agree to have 
the test. 
 
There are no indicators on the amount of times a diabetic 
patient has attended the clinic in the relevant period (i.e. 
past 6 or 12 months), nor are there any indicators on 
factors that may influence a patient’s decision to follow 
through with a test, such as patient satisfaction. 
 
 
At the service 
Clinicians have a good understanding of the role of HbA1c 
measurement in the management of type II diabetes 
mellitus.  It is highlighted within a number of clinical 
guidelines including Royal Australian College of General 
Practitioner’s guidelines for the management of type II 
diabetes mellitus.56 
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No In national reports 
The language within the AIHW reports does not reflect an 
understanding of the possible implications of a low result.  
The report states ‘(a result of 73% or higher) appears 
achievable by organisations regardless of their size or 
location’.  They make no reference to the resources (e.g. 
staffing) required to achieve this result. 
 
E1. Is there sufficient 
understanding of the 
system so that any 
issues identified can 
be investigated further 
and addressed 
effectively?  
 
 
 
 
E2. Are the results 
likely to induce 
perverse incentives 
and unintentional 
consequences? 
 
E3. Can the indicator 
monitor the issue 
regularly enough so 
that further 
investigation and 
action can be taken 
before the issue is 
revisited? 
 
Yes 
 
 
 
 
 
 
 
 
 
 
No 
 
 
 
 
 
Yes 
 
There is a good understanding of systems that enable 
improved regularity of HbA1c testing.  One approach is 
establishing a multidisciplinary diabetes clinic. A study in 
an urban ACCHO found that those that attended the 
Services diabetes clinic were significantly more likely to 
have a HbA1c tested in the past 6 months compared and 
those that did not (59% vs. 25%, p<0.05).58   
 
Understanding of systems to improve testing will hopefully 
increase with additional CQI training in PHC services. 
 
There does not appear to be any perverse incentives or 
unintentional consequences for this indicator. 
 
 
 
 
Measurement of HbA1c is a process of care that a health 
service can address rapidly if they understand the causes 
behind not testing.   
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Strengths of indicator 
The measurement of HbA1c is an important process of diabetic care (as shown in Figure 3–8) 
and for many services the data for this indicator is of acceptable validity and reliability. 
Weaknesses of the indicator 
The main weakness is that insufficient data are collected to explain a result of a low frequency 
of testing.  As shown in Figure 3–8, a patient needs to attend a clinic and also undertake an 
ordered test before HbA1c is recorded.  There are no indicators on access for diabetic patients 
or factors that may influence adopting a health service’s advice, such as patient satisfaction. 
Alternative sources of these data 
There is no reliable alternative for the collection of data on HbA1c measurement in diabetics.  
The diabetic status of an individual is unable to be identified through commonly used 
administrative datasets, such as MBS data.  
Conclusion: nKPI ‘Diabetics with HbA1c measured’ 
Recommendation 9 Continue to collect the indicator ‘HbA1c measured’ through the 
nKPIs 
 
The indicator ‘HbA1c measured’ should continue to be collected as an nKPI. However, the 
reporting of HbA1c by all pathology companies in a standard format would improve the 
validity of the indicator, as would standard reporting from ‘Point of Care’ machines to PIRS. 
Recommendation 10 Standardise pathology reports 
The eHealth division of the Department of Health should work with 
the Royal Australian College of Pathologists to implement 
standardised reporting of pathology results (LOINC language with HL-7 
messaging).  
 
 110 
 
Recommendation 11 Standardise reporting from Point of Care machines 
The eHealth Division to work with the RACP and software vendors to 
develop reliable and extractable recording of the results of ‘Point of 
Care’ testing. 
 
It is important to consider measures that will help explain possible reasons for non-testing, for 
example, health service resources, patient satisfaction and access.   
This supports two existing recommendations: 
 Recommendation 1: Create integrated Aboriginal and Torres Strait Islander PHC 
reports 
 Recommendation 3: Consider additional indicators: ‘Intervention access and service 
readiness’. 
nKPIs with similar features 
‘Diabetics HbA1c result’, ‘Diabetics with BP recorded’, ‘Diabetics BP result’, ‘Clients aged 
over 50 immunised against influenza’, ‘Clients with diabetes or chronic pulmonary 
obstructive disease immunised against influenza’, ‘Clients with diabetes or cardiovascular 
disease with kidney function test performed’, ‘Clients with diabetes kidney function result’,  
All these indicators provide unique and important information in relation to PHC outputs and 
outcomes that cannot be collected from other data sources.  The common limitation with 
these indicators is that we do not collect data to enable an explanation of an abnormal result, 
as demonstrated for ‘HbA1c measured’ in Figure 3–8. The interpretation of all these indicators 
would be improved through measures of indicators of the determinants shown in the last 
column of Figure 3–8, e.g. patient access and satisfaction.  For the indicators ‘Diabetics HbA1c 
result’ and ‘Diabetics BP result’ additional indicators on prescribing patterns would also aid 
interpretation of a result by showing whether appropriate action has been taken to an 
abnormal result. 
This reinforces two existing recommendation 
 111 
 Recommendation 1: Create integrated Aboriginal and Torres Strait Islander PHC 
reports 
 Recommendation 3: Consider additional indicators: ‘Intervention access and service 
readiness’. 
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6.3b Preventative care: Health check recorded 
Definition (from AIHW) 
‘Number and proportion of regular clients who are Indigenous, aged 0-4 years and for whom a 
Medicare Benefits Schedule (MBS) Health Assessment for Aboriginal and Torres Strait Islander 
People was claimed within the previous 12 months AND number of regular clients who are 
Indigenous, aged 25 years and over and for whom an MBS Health Assessment for Aboriginal 
and Torres Strait Islander People was claimed within the previous 24 months.’ 
A theory of change for preventative health checks 
Figure 3-10 demonstrates the steps required to perform this process of care and what must 
follow in order for a health check to contribute to improved health outcomes. 
Achieving improved health outcomes following a health check requires treating conditions 
identified in the check and using the check to provide anticipatory guidance on healthy lifestyle 
options. Whether a condition identified in the check is effectively treated depends on the 
patient’s decision to adopt a recommended change and also the availability of an intervention.  
Risk factors such as obesity are difficult to treat and the ability of a PHC service to impact 
weight is dependent on access to appropriate allied health staff (e.g. dieticians) and 
procedures such as gastric banding.  Prior to recommending interventions, a service must 
undertake appropriate screening within the check, which varies with the age and sex of the 
patient.  As health checks are commonly done opportunistically, the readiness of a service to 
undertake them requires appropriate staffing and systems within the service to enable 
screening. 
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Figure 3–10: Steps required to improve health outcomes following a preventative health 
check in the context of the World Health Organization Framework for Monitoring and 
Evaluation of Health Systems Strengthening and the determinants related to each step. 
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Table 3–18: Assessment of indicator 'health check performed' against National Health 
Service’s criteria for good indicators and good indicator sets 
Evaluation question Result Evidence/explanation 
 
A1: Does the indicator 
measure a sufficiently 
important question? 
 
Partially 
 
An increase in health checks is identified as a performance 
benchmark in the Australian ‘Closing the Gap’ campaign. It 
is seen as a core component of the priority area ‘Primary 
health care services that can deliver’.13 
 
However, the evidence of the effectiveness of health 
checks in improving health outcomes is limited.  A meta-
analysis of health checks in non-Indigenous adults found 
that while they increase diagnosis of new conditions, there 
is a lack of an effect on morbidity and mortality.59 
Australian studies have reported that the effectiveness of 
health checks is dependent on appropriate follow-up.60 
 
B1: Does this indicator 
really measure the 
issue? 
 
No 
 
The quality of interest is whether a comprehensive 
preventative health assessment has occurred.  The 
measure looks only at whether a service has billed 
Medicare for this service.  While Medicare requires a 
number of mandatory components be completed in the 
check, there is little concern beyond these components for 
the quality of the health check.   
 
A health check may also be performed but not billed by a 
service in a few instances: 
 
 The health assessment may be undertaken by an 
Aboriginal Health Worker or nurse but is unable to 
be claimed to Medicare because a doctor is not 
available at the clinic.  
 The health assessment may have been performed 
at another clinic and not billable at a second. 
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The AIHW data quality issues working paper identified this 
nKPI as having the most reporting errors.   Their report 
contains in-depth analysis of health checks and found that 
10.8% of services reported insufficient doctors within their 
clinic to claim the item, with a further 6% reporting that 
they performed health checks but did not claim them 
through Medicare.35 
 
The indicator also misses an important time for 
preventative health activities: the 5-24 years age group.57  
 
C1: Are sufficiently 
reliable data available 
at the right time, for 
the right 
organisations, with the 
right comparators? 
 
 
No 
 
 
 
 
No 
 
In the service 
The AIHW analysis found that 13.8% of services had 
problems with recording this indicator within their PIRS or 
extracting the data through Pen CAT.35 
 
In national reports 
National comparisons do not take into account the 
resources in the PHC service. As highlighted above, 10.8% 
have insufficient doctors and a further 14.5% also reported 
that they did not do this activity at all. 
 
Comparisons would be improved by including an indicator 
for health checks completed, but not billed. This is possible 
and is an indicator within the NT Aboriginal Health Key 
Performance Indicators. 
 
D1. Will the indicator 
be able to detect and 
display a variation that 
is important enough to 
warrant further 
consideration? 
 
 
Yes 
 
 
 
Yes 
 
 
 
In the service 
Services are able to easily review whether a health check 
has been performed in the service and the time since the 
last check.  
In national reports 
There is a large degree of variation in the latest nKPI 
report.  The median coverage is 42%, IQR 25% - 57%5 
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D2. If the indicator is 
high or low, what does 
it actually tell you, and 
does it give enough 
accurate and precise 
information for you to 
be able to investigate 
further and take any 
necessary action? 
 
D3. Can the indicator 
be deconstructed in 
order to understand 
the particular reasons 
for the results? 
 
 
 
 
 
 
Yes 
 
 
 
 
 
 
 
 
 
No 
 
 
 
 
 
 
 
 
 
 
If the indicator is low this indicates that either health 
checks are not being performed or not being billed.  The 
indicator is disaggregated by ten year age groups and sex 
in order to provide precise information if certain 
demographics are disproportionately affected. 
 
 
 
 
 
There is insufficient information to understand the reason 
for poor performance.  As indicated by the AIHW’s analysis 
of this indicator, there are a number of reasons for poor 
performance including not having the doctors to bill and 
performing the check but not billing. 
 
Like other nKPIs, performing a health check is dependent 
on patients accessing a service and indicators on access by 
age and sex as well as patient satisfaction would aid the 
interpretation of results. 
 
E1. Is there sufficient 
understanding of the 
system so that any 
issues identified can 
be investigated further 
and addressed 
effectively?  
 
E2. Are the results 
likely to induce 
perverse incentives 
and unintentional 
consequences? 
 
Yes 
 
 
 
 
 
 
 
Yes 
 
 
 
 
 
There growing body of literature on the barriers and 
enablers to the uptake of health checks within Aboriginal 
PHC services.60,61 Barriers identified include lack of clear 
clinical systems and time pressures for staff, reinforcing 
the theory of change model in Figure 3-10.  Additional 
barriers include the sensitivity of questions and concerns 
with confidentiality. 
 
The indicator encourages the billing of health checks but 
there are no measures on the quality of checks or on 
actions following them.  An evaluation of the Indigenous 
Chronic Disease Package found that ‘the way that health 
assessments are being conducted in some locations 
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E3. Can the indicator 
monitor the issue 
regularly enough so 
that further 
investigation and 
action can be taken 
before the issue is 
revisited? 
 
 
 
 
 
 
Yes 
appears more oriented to income generation for Health 
Services through Medicare than to provision of high-
quality care’ they also found evidence that follow-up after 
a health check is poor.60  
 
Performance of health checks is a process of care that a 
health service can address rapidly if they understand the 
causes behind a result.   
 
 
Strengths of indicator 
Undertaking health checks has been identified by the Australian Government as a key 
intervention in ‘Closing the Gap’ in health outcomes.  The performance of health checks is a 
measure influenced directly by the health service and there is a growing body of literature for 
services to identify how they may improve the number of checks performed. 
Weaknesses of the indicator 
There are some concerns with the validity of the indicator.  A health check may be completed 
and not billed at a service either because they do not have access to a doctor or the health 
check was performed elsewhere.   
There are concerns that the indicator encourages the performance of health checks with little 
attention paid to the quality of care provided and referral for appropriate follow up. 
Alternative sources of these data 
The billing of health checks is also monitored through MBS data.  MBS data on health checks is 
already reported by the AIHW at the PHN level each quarter.62 It is the possible that these data 
could be reported at a smaller geographical area, as has been done with birth weight and 
immunisation data by the NHPA. 
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Conclusion: nKPI ‘Health check recorded’ 
Recommendation 12 Continue to collect the indicator ‘Health check recorded’ through the 
nKPIs 
 
It is essential to develop measures to assess if follow-up is performed following a health check.  
The evidence shows that a health check needs to have appropriate follow-up in order to 
impact upon health outcomes. There is currently poor follow-up after a health check and the 
absence of indicators of follow-up encourages services to simply tick the box to say a health 
check has been performed. This supports an existing recommendation 
 Recommendation 5: Consideration of additional indicators: ‘Interventions following 
screening’ 
It is essential to develop measures that can help explain possible reasons for non-completion. 
E.g. performed but not billed, performed elsewhere, patient satisfaction and access.  This can 
be achieved through implementing an existing recommendation 
 Recommendation 3: Consider additional indicators: ‘Intervention access and service 
readiness’  
Given the high number of reporting errors with this indicator, a change to the nKPI definition is 
also recommended. 
Recommendation 13 Consider modifying the nKPI to include ‘Alternative health checks’ 
 
For services that lack staff to bill Medicare there should be the 
capacity to report on health checks that have been performed but not 
billed. A similar indicator exists within the Northern Territory 
Aboriginal Health Key Performance Indicators and its inclusion within 
the nKPI set would assist in national comparisons. 
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A high proportion of services (14.5%) do not conduct health checks.  The inclusion of these 
services data negatively impacts national comparisons. 
Recommendation 14 Adopt module-based nKPI reporting 
The AIHW data quality working paper highlighted that ‘many of the 
new services that are contributing to the nKPI collection don’t fit the 
ACCHO primary health care model (i.e. do not provide comprehensive 
primary health care), but they are asked to provide data on the full 
suite of indicators’.35 They have suggested a modular approach to 
reporting so that services are only asked to provide data for indicators 
that are applicable to their service. 
 
nKPIs with similar features 
‘Diabetics that have a general practice management plan (GPMP)’ and ‘Diabetics that have a 
team care arrangement (TCA)’ 
Chronic disease care planning, like health checks, has been identified as a priority area in the 
‘Closing the Gap’ campaign.  GPMP’s and TCA’s are intended to be the gateway through which 
comprehensive chronic disease care is accessed but there are no indicators that monitor 
whether multidisciplinary care is occurring.  
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6.3c Chronic disease risk factors: Smoking status result 
Smoking status is measured in two ways through the nKPIs.  There is an indicator on whether 
smoking status has been recorded, and a second indicator on the smoking status result.  This 
section of the evaluation looks at the nKPI on smoking status result. 
Definition (from AIHW) 
‘Number (and proportion) of regular clients who are Indigenous, aged 15 years and over and 
whose smoking status has been recorded as one of the following:  
 current smoker; 
 ex-smoker or; 
 never smoked.’ 
A theory of change to improve health outcomes through smoking cessation 
Figure 3-11 demonstrates the steps required to improve health outcomes for smokers in the 
context of the WHO M&E framework and the determinants related to each step.  The 
association between smoking and poor health outcomes, such as premature mortality due to 
cardiovascular disease, is well established.   For a health service to support an individual to quit 
smoking, that person must first want to quit; only then will there be a chance of change with 
appropriate supports.  Before this occurs, the patient must attend the clinic and be questioned 
on their smoking status, often when the patient has presented for a completely different 
reason.  The services ability to perform opportunistic screening such as this is influenced by 
their staffing and the systems established within the service. 
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Figure 3–11: Steps required to improve health outcomes through smoking cessation in the 
context of the World Health Organization Framework for Monitoring and Evaluation of 
Health Systems Strengthening and the determinants related to each step 
(1) As recommended in the Royal Australian College of General Practitioners and National Aboriginal 
Community Controlled Health Organisation’s ‘National guide to a preventative health assessment’, 2012 
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Table 3–19: Assessment of 'smoking status result' against National Health Service’s criteria 
for good indicators and good indicator sets 
Evaluation question Result Evidence/explanation 
 
A1: Does the indicator 
measure a sufficiently 
important question? 
 
Yes 
 
Smoking is one of the main causes of the gap in life 
expectancy.  It is estimated to contribute to 10% of all 
DALYs lost in Aboriginal and Torres Strait Islander people10 
and there is a large gap in smoking prevalence between 
Aboriginal and Torres Strait Islander and non-Indigenous 
Australians.29 
 
B1: Does this indicator 
really measure the 
issue? 
 
No 
 
 
 
 
 
 
 
 
 
 
The indicator result is subject to a number of selection 
biases.   
 
The quality being assessed is the number of smokers within 
the Aboriginal and Torres Strait Islander community served 
by the PHC service. However, what is measured is the 
smoking status of those who regularly attend the service 
and have had their smoking status recorded.   
 
It is likely that smokers are more likely to be regular 
attenders of a clinic than non-smokers and to have their 
status recorded. These biases may explain why the nKPI 
result was markedly elevated compared to that found in 
Australian Aboriginal and Torres Strait Islander Health 
Survey (current smokers, nKPI: 52.1% vs. AATSIHS: 41%).29 
 
C1: Are sufficiently 
reliable data available 
at the right time, for 
the right 
organisations, with the 
right comparators? 
 
Yes 
 
 
 
 
 
 
Within the clinic 
Smoking status can be viewed both within a consultation 
and in service audits.  No concerns with the indicator were 
raised in the SMS review. 
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 No In national reports 
The results of this indicator are likely to be influenced by 
the proportion of people with their smoking status 
recorded.  Thus comparisons should not be made between 
services where few people have had their smoking status 
recorded.  The latest nKPI report showed that smoking 
status was recorded in only 79% of the regular clients with 
a quarter of services reporting less than 70% with smoking 
status recorded.5 
 
D1. Will the indicator 
be able to detect and 
display a variation that 
is important enough to 
warrant further 
consideration? 
 
 
 
 
 
 
 
 
 
 
 
D2. If the indicator is 
high or low, what does 
it actually tell you, and 
does it give enough 
accurate and precise 
information for you to 
be able to investigate 
further and take any 
 
Yes 
 
 
 
 
 
 
No 
 
 
 
 
 
 
 
 
 
Yes 
 
 
 
 
 
 
 
 
Within the services 
The indicator has categories for never smoked, ex-smoker 
and current smoker.  This is consistent with the collection 
of smoking status in other national collections such as the 
Australian Aboriginal and Torres Strait Islander Health 
Survey.  
 
In national reports 
The latest nKPI report shows some variation in current 
smokers between services (median 52%, IQR 47%-59%) but 
this variation does not follow the patterns seen in national 
surveys.5  The Australian Aboriginal and Torres Strait 
Islander Health Survey showed a clear geographical 
gradient of smoking status with a 12% difference between 
non-remote and remote regions (40% vs. 52%).29  This is not 
evident in the nKPI results. 
 
The three categories of smoking status (never smoked, ex-
smoker and current smoker) in addition to the ability to 
disaggregate results by sex and 10 year age groups provide 
precise information on which groups to target further 
action.  
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necessary action? 
 
D3. Can the indicator 
be deconstructed in 
order to understand 
the particular reasons 
for the results? 
 
 
 
No 
 
 
 
 
 
 
There are multiple factors that influence Aboriginal and 
Torres Strait Islander’s smoking including socioeconomic 
factors63 and levels of stress.64  None of these are measured 
by the nKPIs.  Nor are there measures on what proportion 
of current smokers have been offered support to quit 
smoking (e.g. counselling, nicotine replacement therapy). 
 
 
E1. Is there sufficient 
understanding of the 
system so that any 
issues identified can 
be investigated further 
and addressed 
effectively?  
 
 
 
E2. Are the results 
likely to induce 
perverse incentives 
and unintentional 
consequences? 
 
E3. Can the indicator 
monitor the issue 
regularly enough so 
that further 
investigation and 
action can be taken 
before the issue is 
revisited? 
 
Yes 
 
 
 
 
 
 
 
 
 
Yes 
 
 
 
 
 
No 
 
 
There have been a number of studies of programs to 
address smoking in Aboriginal and Torres Strait Islander 
people. Lessons learnt from studies of interventions 
include the importance of local development, ownership 
and participation, health worker professional development 
and support, and operating within a framework of cultural 
safety.9 However, many of the most effective interventions 
are outside of the control of the PHC service i.e. taxation 
and advertising. 
 
While there is no evidence of this at present, health 
services may elect not to enter the smoking status of a 
smoker in order to improve the results of the smoking 
status nKPI. 
 
 
The elevated smoking levels in Aboriginal and Torres Strait 
Islander people have persisted for many decades.  It is 
unlikely that there will be any significant changes between 
the six-month reporting periods. 
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Strengths of indicator. 
Smoking is a significant cause of morbidity and mortality in the Aboriginal and Torres Strait 
Islander community.  The smoking nKPI provides a potential way to gather data on smoking 
prevalence from a large sample in a rapid manner. 
Weaknesses of indicator. 
The indicator is subject to a number of selection biases that will result in artificially elevated 
smoking prevalence unless improvements are made in the recording of smoking status. 
Smoking is a public health indicator and it should be made clear that smoking levels are not a 
reflection of the quality of service provision. 
Alternative sources of these data 
Smoking status is collected through two large national surveys of Aboriginal and Torres Strait 
Islander people – the Australian Aboriginal and Torres Strait Islander Health Survey and the 
Australian Aboriginal and Torres Strait Islander Social Survey. These occur every five years with 
a sample size of around 10,000 and cover most regions of Australia. 
The process for collecting nKPIs means these data may complement existing surveys.  While 
the health survey and social survey are not subject to the same selection biases as the nKPIs, 
they are expensive, have a five-year turn around and provide less geographical detail than the 
nKPIs.  The nKPIs could possibly provide a more efficient data collection and enable a view of 
smoking prevalence at a level that would allow a more targeted approach to smoking cessation 
support services. 
Conclusion: nKPI ‘Smoking status result’ 
Recommendation 15 Continue to collect the indicator ‘Smoking status result’ through the 
nKPIs 
 
It is essential that any reporting is explicit that this is as a public health indicator.   This 
supports an existing recommendation. 
 Recommendation 6: Clearly delineate between nKPIs of performance of PHC service 
and those of the government 
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Given the impact of selection bias, consideration should be given to withhold services results 
on smoking status from national reports until the proportion with a smoking status recorded 
has reached a certain level.   
Recommendation 16 Reporting of health outcomes and impacts: 
Mitigating selection bias  
The AIHW should consider not incorporating results from PHC services 
on public health indicators such as smoking status, alcohol intake, 
obesity and overweight until a threshold has been reached in the 
recording of these measurements.  This would improve the validity of 
the reported figures. 
 
nKPI’s with similar features 
‘Number of obese adults’,  ‘Alcohol consumption result’ 
Like smoking, obesity and excess alcohol consumption are both important public health issues 
for Aboriginal and Torres Strait Islander people and non-Indigenous Australians.  Elements of 
the nKPIs mean that they may be a preferred source of data than current national surveys.  
However, these measures are also susceptible to selection bias and an overestimation of true 
levels of obesity and dangerous alcohol consumption.  The interpretation of the nKPI on 
obesity is not even facilitated by a measure on the level of screening.  While the nKPI data 
collection may provide a more timely and efficient method of gaining data on obesity and 
alcohol consumption, there needs to be improvements in the collection of these data. \ 
‘Smoking status recorded’, ‘Alcohol consumption recorded’ 
Both these indicators provide information on the level of the population screened.  Aside from 
being an indicator of quality care, as shown in Figure 3-11, these measures aid interpretation 
of the results for ‘smoking status result’ and ‘alcohol consumption’. 
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6.3d Maternal Health: Birth Weight Result 
Definition (from AIHW) 
‘Number and proportion of Indigenous babies born within the previous 12 months whose birth 
weight results were categorised as one of the following: 
 Low (less than 2,500 grams) 
 Normal (2,500 grams to less than 4,500 grams) 
 High (4,500 grams and over).’ 
A theory of change to improve birth weight result 
Figure 3-12 demonstrates the steps required to improve birth weight in the context of the 
WHO M&E framework (inputs, processes, outputs, outcomes and impacts) and the 
determinants related to each step. 
Birth weight is influenced by a number of determinants as shown in only some of which can be 
modified by PHC services.  For a service to impact upon modifiable risk factors a mother must 
adopt interventions that have been recommended following appropriate screening.  The 
capacity of the service to undertake screening and implement these interventions is 
dependent on the availability of staff and the capacity to support the mother to attend regular 
antenatal appointments.  This capacity is in turn influenced by funding and governance. 
Outside of the provision of quality antenatal care, reproductive choice impacts on birth weight.   
Young maternal age and high parity have both been associated with lower birth weight in 
Aboriginal and Torres Strait Islander infants.65 Both factors can be influenced by the provision 
of culturally appropriate sexual education and access to affordable contraception and 
termination.  Access to these services is affected by health policy as well as the quality of care 
provided by the service. 
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Figure 3–12: Steps required to improve birth weight in the context of the World Health 
Organization Monitoring and Evaluation Framework for health systems strengthening and 
the determinants at each step 
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Table 3–20: Assessment of the national Key Performance Indicator 'HbA1c measured' against 
National Health Service’s criteria for good indicators and good indicator sets 
Evaluation question Result Evidence/explanation 
 
A1: Does the indicator 
measure a sufficiently 
important question? 
 
Yes 
 
Birth weight is an important health outcome and has a 
significant impact on Aboriginal health. Lower birth weight 
is associated with increased risk of infant morbidity and 
mortality.66 It is also associated with developmental delay 
and an increased risk of chronic disease.67 
 
B1: Does this indicator 
really measure the 
issue? 
 
No 
 
 
 
 
 
 
 
 
 
 
The intention of measuring birth weight is to assess the 
number of poor birth outcomes within a service.  By 
recording birth weight with no consideration of gestational 
age the majority of poor birth outcomes amongst term 
infants are missed.  The latest Australian birth weight 
percentiles show that in a term infant, the cut off for small 
for gestational age is 3090gm in males and 2975gm in 
females, yet the nKPI only counts births less than 
2500gm.68 Likewise many large for gestational age births 
are missed as the cut off for term males is 4190gm and 
4030gm for females whereas the nKPI counts only births 
greater than 4500gm. 
 
The nKPI may also include birth weights of children whose 
mother received no antenatal care from the reporting PHC 
service.  This is because the denominator for this indicator 
is the number of children born in the last 12 months who 
attend the clinic.57 Thus a mother may not attend the PHC 
service at all during her pregnancy but the outcome of that 
pregnancy will be measured as an indicator of the PHC 
service performance.  It is even possible that a high 
performing service that provides good follow-up of at risk 
infants may be referred low birth weight children from 
elsewhere. 
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C1: Are sufficiently 
reliable data available 
at the right time, for 
the right 
organisations, with the 
right comparators? 
 
 
No 
 
 
 
 
 
No 
 
 
 
 
 
 
 
In the service 
The SMS report found that ‘services are not consistently 
capturing birth weight of new babies in the expected 
location’.34  This means that these data are of insufficiently 
reliable to be used for patient follow-up and CQI. 
 
In national reports 
The comparison of this indicator across regions does not 
take into account the provision of antenatal care within 
the service.  The latest OSR report stated that only ‘two-
thirds of organisations providing maternal and/or child 
health services provided antenatal care’.  It is not 
appropriate to compare results from these services with 
established antenatal teams to those without.  
 
D1. Will the indicator 
be able to detect and 
display a variation that 
is important enough to 
warrant further 
consideration? 
 
 
 
 
 
D2. If the indicator is 
high or low, what does 
it actually tell you, and 
does it give enough 
accurate and precise 
information for you to 
be able to investigate 
further and take any 
 
Yes 
 
 
 
Partially 
 
 
 
 
 
 
No 
 
 
 
 
 
 
 
 
In the services 
Births outside of the range of 2500 – 4500gm are certainly 
important enough to warrant further consideration. 
 
In national reports 
The latest nKPI report shows relatively little variation.  The 
median proportion of low birth weight was 13% (IQR 10% 
– 17%).5  There were some outlying services with a high 
proportion of low birth weight but the AIHW report 
identified these as services with small denominators. 
 
Low birth weight can be due to either prematurity or 
intrauterine growth restriction (or both).  These have 
different causes and require different strategies to prevent 
them.65  By recording birth weight with no consideration of 
gestational age it is not possible to differentiate between 
these two causes and thus determine the action required 
to prevent future low birth weight, either at the individual 
or population level. 
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necessary action? 
 
D3. Can the indicator 
be deconstructed in 
order to understand 
the particular reasons 
for the results? 
 
 
No 
 
 
Figure 3-12 highlights the multiple factors that influence 
birth weight including maternal BMI, smoking, alcohol 
consumption, date of first antenatal visit and gestational 
diabetes.  In addition to these factors, birth weight is also 
influenced by risk factors such as maternal age, parity and 
community level socioeconomic disadvantage.69 The nKPIs 
only measure two factors that influence birth weight.  
 
E1. Is there sufficient 
understanding of the 
system so that any 
issues identified can 
be investigated further 
and addressed 
effectively?  
 
 
 
 
E2. Are the results 
likely to induce 
perverse incentives 
and unintentional 
consequences? 
 
 
 
 
 
 
 
 
 
Partially 
 
 
 
 
 
 
 
 
 
 
Yes 
 
 
 
 
 
 
 
 
 
 
 
 
 
There is a great deal of knowledge around the 
determinants of low birth weight and a body of evidence 
on interventions that services and governments can 
make.9 However, the evidence of what works for 
Aboriginal and Torres Strait Islander women in addressing 
these determinants is limited.   One of the biggest 
modifiable risk factors is maternal smoking and a recent 
meta-analysis of maternal smoking cessation in Indigenous 
communities that found limited evidence of effective 
interventions.70 
 
A health services may elect not to enter abnormal birth 
weights in order to avoid having an abnormal birth weight 
result.  The latest nKPI results suggest that this may be 
occurring.  Only 69% of birth weights were entered and 
more than 25% of organisations reported no low birth 
weight infants5, whereas the national average for low birth 
weight is 12.6% of all Aboriginal and Torre Strait Islander 
births.9 
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E3. Can the indicator 
monitor the issue 
regularly enough so 
that further 
investigation and 
action can be taken 
before the issue is 
revisited? 
No 
 
The gap in birth weight between Aboriginal and Torres 
Strait Islander and non-Indigenous Australians has 
persisted for many decades.  It is unlikely that there will be 
any significant changes between the six-month reporting 
periods. 
 
 
 
Strengths of indicator 
Birth weight is an important health outcome that has impacts on infant morbidity and 
mortality as well as adult chronic disease.  If the Closing the Gap targets in early childhood 
mortality and life expectancy are to be met, there needs to be an improvement in this 
indicator. 
Weaknesses of the indicator 
When the indicator is measured at the PHC level it can be interpreted as a measure of 
antenatal care but is influenced by many factors outside of the health service.   
A mother may receive no care from a PHC service but her child’s birth weight will be recorded 
as a ‘Key Performance Indicator’ of the service.    
Without collecting data on gestational age, the majority of small for gestational age and large 
for gestational age infants will be missed. 
Alternative sources of these data 
Birth weight is already collected through the National Perinatal Data Collection.   The 
advantages of using these data are: 
 Comprehensive dataset with almost all births in Australia recorded 
 Birth weight data is collected contemporaneously 
 The dataset contains data on multiple determinants of birth weight such as gestational 
age, mother’s body mass index, maternal diabetes status and total number of 
antenatal visits.   
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 The dataset can provide a high level of geographic detail as the mother’s suburb is one 
of the variables collected 
Conclusion: nKPI ‘birth weight result’ 
Birth weight result is a poor nKPI for Aboriginal PHC services.  While there is no doubt that 
birth weight is an important indicator, an indicator derived from PHC services is not populated 
with the best available data and a service has limited ability to impact the indicator result.  This 
current indicator is ineffective in promoting appropriate CQI action or supporting policy and 
planning. 
nKPI’s with similar features 
‘Children who are fully immunised’ and ‘cervical screening performed’ 
The nKPIs on childhood immunisations and pap smears have similar features to the indicator 
‘birth weight result’.  They are unquestionably important public health indicators but data on 
them is collected through other datasets.  In the case of childhood immunisations, this is 
collected through the Australian Childhood Immunisation Register and reported at postcode 
level by the NHPA, while for pap smears this is collected through state based pap smear 
registries 
The question is whether the nKPIs are the best way to collect data for these indicators. 
Immunisations and pap smears are often administered by multiple organisations, not simply 
one PHC service.  The data in Australian Childhood Immunisation Register and pap smear 
registries are entered in a contemporaneous manner, whereas data for the nKPI may be 
entered retrospectively, possibly based on a patient’s recollection. This strongly suggests that 
the best available data is not available from individual PHC services.   
However, in contrast to the nKPI birth weight results, it may be argued that recording 
immunisation and cervical screening within a service’s PIRS is an important process of care in 
itself.   The presence of these indicators highlights to the service that entering immunisation 
status and pap smears within the PIRS should be done in addition to entering data in the 
Australian Childhood Immunisation Register and state based pap smear registries.  The 
rationale is that this then ensures the PIRS is of the highest accuracy. 
Time series nKPI data suggests that services do not have the capacity, or need, to undertake 
this double data entry.  As shown in 
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Table 3–16, Australian Childhood Immunisation Register data has immunisation coverage for 
Aboriginal and Torres Strait Islander children at five years of age at 92.1%.  In contrast, the first 
national nKPI report had coverage at 66.1%.  This suggests a large gap in recording 
immunisation status within PIRS.  However, there has been no significant improvement in this 
gap over 5 nKPI reporting periods with the latest reported coverage of immunisation at 5 years 
steady at 67.2%.5 Other process of care indicators such as recording of smoking and alcohol 
status have improved significantly in this time, suggesting that there are addition challenges to 
recording immunisation status that mean this indicator may never accurately reflect true 
immunisation coverage. 
This double data entry is an inefficient use of service staff’s time. There is the capacity to 
enable linkages between databases such as Australian Childhood Immunisation Register and 
PIRS.  Instead of compelling staff to spend an increased amount of time on data entry, 
technological solutions should be developed to improve the accuracy of PIRSs and improve 
health service delivery.   If these changes occurred, a service’s recall system would match the 
‘source of truth’ and place further impetus to act on outstanding recalls.  
‘Birth weight entered’ 
The nKPI ‘birth weight entered’ is likewise intended to encourage the entering of data into 
service PIRSs.  By having this as an indicator it is intended to improve a health service’s 
awareness of infants that have been born with abnormal birth weight and facilitate improved 
follow-up.  However, without collecting gestational age and without the function within PIRSs 
to adjust for prematurity, a service’s ability to appropriately follow-up the growth and 
development of an infant is limited. 
Recommendations 
Recommendation 2 Rationalise the indicator set:  
Cease collection as nKPI: ‘Birth weight result, childhood 
immunisation and pap smears.’ 
The best available data to populate the indicators for birth weight, 
immunisation and pap smears are not within PHC service records but 
the existing national and state registries.  To enable these indicators 
to be populated with these data there are two options 
Following on from Recommendation 1: ‘Create integrated Aboriginal 
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and Torres Strait Islander reports’, alternative data sources for birth 
weights, immunisations and pap smears could be used in these 
reports at the geographical level required to inform policy, planning 
and health service delivery.   
These data would be derived from 
 National Perinatal Data Collection (birth weight) 
 Australian Childhood Immunisation Register (childhood 
immunisations) 
 State pap smear registries (pap smears) 
Alternative: Continue collection as nKPIs 
If these indicators are to continue being collected from PHC services, 
the data within the clinic needs to match existing registries. The 
eHealth division of the Department of Health should work with 
existing national and state registries and software vendors to facilitate 
secure messaging to the services PIRS.  This would enable the service 
data to match the ‘source of truth’. 
Recommendation 17 Consideration of additional indicators: ‘Maternal health’ 
The IRD should consider indicators in gaps within the current focus 
areas of the nKPIs.   In maternal health there are measurement gaps 
in the WHO M&E framework domains: ‘Intervention quality and 
safety’ and ‘Coverage of interventions’.  nKPIs in these areas could 
include appropriate screening in the first trimester (e.g. Hepatitis B 
serology) and post-natal follow-up (e.g. post-partum glucose 
tolerance test for women with gestational diabetes).  Indicators in 
these areas have been developed by NACCHO and Affiliates but 
require support to introduce them to PHC services. 
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7. Discussion 
Our evaluation found that while the majority of nKPIs are of sufficient quality and usability, a 
number of improvements are needed to the overall monitoring system. Many nKPIs collect 
valuable new information on PHC service delivery but the indicator set focuses on outputs and 
outcomes associated with a small set of conditions.  This narrow focus prevents health services 
and policy makers from understanding the reason for an nKPI result and also fails to measure 
health topics of importance to Aboriginal and Torres Strait Islander people.  The usability of 
the indicators are also impaired by mandated reporting of all nKPIs and issues with data quality. 
For the nKPIs to be used effectively these limitations must be addressed. 
We recommended ongoing collection of three of the four individual nKPIs evaluated.  These 
three indicators shared similar features with a further 12 nKPIs that are also recommended for 
ongoing collection.  These indicators provide important information in relation to PHC that 
cannot be collected from other data sources or add granularity to existing public health 
measurements.  However, for these indicators to be used to meet the purposes of the nKPIs 
there must be improvements in data quality as well as collection of data to enable an 
explanation of abnormal results. 
We made 14 recommendations on improvements to the nKPI monitoring system.  These 
recommendations can be grouped into the four topics. 
1. Improving data quality 
2. Streamlining the data collection 
3. Expanding the indicator set to address measurement gaps 
4. Creating comprehensive primary health care reports. 
Improving data quality 
Table 3–21: Recommendations relating to improvements in data quality for the national Key 
Performance Indicators 
Recommendation 10 Standardise pathology reports 
Recommendation 11 Standardise reporting from Point of Care machines 
Recommendation 13 Consider modifying the nKPI to include ‘Alternative health checks’ 
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A number of data quality improvements are required for the nKPIs to be a valid and reliable 
measure of PHC service activity.  All four nKPIs we evaluated had concerns with the data that 
populates the indicator.  These concerns were due to information not being correctly recorded 
or the indicator specifications not adequately capturing the area of interest.  
Information may be incorrectly recorded due to either human error or transmission of 
pathology reports. Human error should decrease over time as clinicians become familiar with 
using PIRS for data collection, and training on correct data entry is part of the national CQI 
framework.36 However, nKPI data quality is also impaired by pathology data that are provided 
in the incorrect format.  Standardisation of pathology reports is required to ensure these data 
are included within nKPI results.  
Further improvements to data quality can occur if indicator specifications are modified to 
ensure the nKPI captures the area of interest. The indicator ‘health check performed’ could be 
improved through modification of the nKPI definition to capture non-Medicare health checks 
Streamlining the data collection 
Table 3–22: Recommendations relating to streamlining the national Key Performance 
Indicators 
Recommendation 2 Rationalise the nKPI set 
Recommendation 8 Enable PHC services to select priority indicators. 
Recommendation 14 Adopt module-based nKPI reporting 
 
Some information collected through the nKPIs is of little use to either PHC services or policy 
makers.  This is because the indicator is already measured well through another data collection 
or a service is mandated to report on an area where it does not provide care.  To improve the 
nKPI monitoring system the indicators should focus on measurements best captured through 
PHC systems and ensure reporting aligns with service delivery.  
The nKPIs include population health indicators on birth weight, childhood immunisation and 
pap smears that are measured well through national and state based registries. In comparison 
to these registries, these nKPIs are populated with poor quality data and their results create 
confusion on progress in these areas of health. Due to their poor quality and usability, 
 138 
collection of these indicators in the nKPI monitoring system should cease and efforts put into 
improved local level reporting from the registries. 
The usability of the nKPIs would be further improved by module-based reporting. Modules 
would be based on service provision with flexibility to choose indicators in priority areas.  
Reporting the nKPIs in this manor would make the indicators more locally relevant and enable 
services to show progress in the priority areas for their community. 
Expanding the indicator set to address measurement gaps 
Table 3–23: Recommendations relating to measurement gaps in Aboriginal and Torres Strait 
Islander primary health care 
Recommendation 3 Consideration of additional indicators: ‘Intervention access and 
service readiness’ 
Recommendation 4 Consideration of additional indicators: ‘Mental health and social and 
emotional well-being’ 
Recommendation 5 Consideration of additional indicators: ‘Interventions following 
screening’ 
Recommendation 17 Consideration of additional indicators: ‘Maternal health’ 
 
Looking across all data collections relevant to Aboriginal and Torres Strait Islander PHC, there 
are gaps in the measurement of PHC systems and Aboriginal and Torres Strait Islander health 
priorities.  Even when combining nKPIs with other data collections there remain a number of 
components of PHC systems that are not adequately measured.  In particular there are few 
measurements in the domain of the WHO M&E framework ‘intervention access and service 
readiness’ and gaps in the measurement of priority conditions such as mental health. These 
gaps impair services and policy makers understanding of Aboriginal and Torres Strait Islander 
PHC and the usability of the nKPIs to meet their stated goals.   
In some instances, the nKPIs are best placed to collect this missing information. Consideration 
should be given to adding nKPIs where data extracted from PHC services provides the best 
opportunity to collect information on these missing areas.   
 
 139 
Creating comprehensive primary health care reports 
Table 3–24: Recommendations relating to the creation of comprehensive primary health 
care reports 
Recommendation 1 Create integrated Aboriginal and Torres Strait Islander PHC reports 
Recommendation 6 Clearly delineate between nKPIs of performance of PHC services and 
those of government. 
Recommendation 7 Include broader public health initiatives in ‘areas for action’ 
Recommendation 16 Reporting of health outcomes and impacts: 
Mitigating selection bias  
 
An ultimate goal should be the use of nKPI data within comprehensive PHC reports. For the 
nKPI monitoring system to be used to improve PHC service delivery and support policy and 
planning, results must be collated with other data collections on Aboriginal and Torres Strait 
Islander health. Combined reports will help enable understanding of an indicator result in the 
context of the resources and processes of the PHC service, and therefore identify how best to 
strengthen the service. Combined reports would also include indicators across the broad range 
of activities for which services are funded, enabling monitoring of comprehensive PHC. 
Within a combined PHC report, there should be improvements to the reporting of population 
health indicators. nKPI reports contain results of population health indicators that are skewed 
by selection bias and the reports fail to address the impact of non-healthcare determinants of 
health.   To improve reporting of these indicators there should be a minimum requirement for 
screening coverage before results are published and it must be clear that action outside of the 
PHC service is required to improve some nKPI results.  
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7.1 Strengths and limitations of the evaluation 
The strengths of our evaluation were the use of the NHS evaluation instrument and the use of 
multiple sources of evidence to shape our findings.  
The value of the NHS evaluation instrument has been proven throughout the evaluation.  What 
distinguished the instrument from other indicator criteria were its questions on the indicator 
set as a whole and criteria on ‘Meaning’ and ‘Implications’. The questions in these areas 
ensured that the nKPIs were placed in the broader context of priorities for Aboriginal and 
Torres Strait Islander people and that consideration was given to how indicator results can be 
acted upon.  
Multiple sources of evidence were used to reach our conclusions.  The types of evidence 
included key policy documents, published literature and early reviews of nKPI data quality.  
Due to this approach our evaluation has placed the nKPIs within Aboriginal and Torres Strait 
Islander policy priorities as well as the latest evidence relating to PHC.  Our evaluation also 
builds on the finding of existing reviews of the nKPIs ensuring that the findings from each 
review are iterative as we progress towards an improved monitoring system. 
While building upon previous reviews is a strength of our evaluation, a limitation is that we did 
not collect any first hand evidence on the validity and reliability of the nKPIs. This impairs the 
depth of our understanding of these issues, primarily because no review has assessed the 
extent that information is correctly entered into PIRS.  As such we remain unclear on the 
extent that nKPIs capture clinical activity. It may be that due to problems with data entry that 
we are significantly undercounting activities such as the measurement of HbA1c. 
Another limitation of our evaluation was the lack of engagement with the Australian 
Government Department of Health. While we discussed the evaluation with the relevant 
divisions within the Department, they were unable to contribute to the objectives of the 
evaluation. This meant that the focus of the evaluation was very much driven by the Aboriginal 
Community Controlled Health Sector. While the evaluation may address the concerns of the 
PHC services, it may have overlooked areas of importance to policy makers. 
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7.2 Implications for the Australian primary health care system 
The findings of our evaluation have implications outside of Aboriginal and Torres Strait Islander 
health. Monitoring and evaluation of the Australian primary health care system is a focus of 
the current review of the Medicare system71 and many OECD nations have already moved 
towards national reporting of PHC indicators. The NHS’s Quality and Outcomes Framework is 
an example of a monitoring system that shares similarities with the nKPIs and a recent 
discussion paper improving care for chronic and complex patients commissioned by the 
Australian Government highlighted this model.72 It may be that the nKPIs are a forerunner for 
a national PHC monitoring system. 
Our evaluation has highlighted that while individual indicators collected from PHC services may 
be of merit, their value in improving PHC requires high quality data and the measurement of 
indicators across the PHC system. Australia is fortunate to have a number of high quality data 
collections.  However, at present our national reports are based primarily on the mode of data 
collection: workforce surveys, Medicare statistics and national registries are usually reported 
in isolation. Through combining these results with high quality data extracted from PHC 
services this information can better inform PHC service delivery as it meets the challenge of 
managing chronic and complex disease. 
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Appendix 1: The national key performance indicators 
Indicator (METeOR 
number) 
Description1 
Maternal health  
Birth weight recorded 
(PI01a/b) 
Indigenous babies born within the previous 12 months whose 
birth weight has been recorded 
Birth weight result 
(PI02a/b) 
Indigenous babies born within the previous 12 months whose 
birth weight results were low, normal or high 
Smoking in mothers who 
gave birth in past 12 
months (PI11a/b) 
Regular clients2 who are Indigenous, aged 15 years and over, 
who gave birth within the previous 12 months and whose 
smoking status has been recorded as one of the following 
 current smoker 
 ex-smoker, or 
 never smoked. 
Date of first antenatal visit 
(PI13a/b) 
Regular clients who had their first antenatal visit < 13 weeks, 13-
20 weeks, >20 weeks or not recorded 
Preventative health  
Health check performed 
(PI03a/b) 
Regular clients (aged 0-4 years of age and aged 25 years and 
older) who have received a Medicare Benefits Scheme Health 
Assessment within the previous 12 months. 
Children who are fully 
immunised (PI04a/b) 
Indigenous children who are regular clients who are fully 
immunised at 1, 2 and 5 years of age. 
Clients aged over 50 
immunised against 
influenza (PI14a/b) 
Regular clients aged 50 years and over who have received an 
influenza vaccine in the previous year 
Cervical screening 
performed (PI22a/b) 
Regular female Indigenous clients aged 20-69 years who have 
not had a hysterectomy and who have had cervical screening 
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performed within the previous 2, 3 or 5 years. 
Chronic disease care  
Diabetics who have had a 
HbA1c measured (PI05a/b) 
Regular Indigenous clients who have Type II diabetes who have 
had an HbA1c measurement result recorded at the PHC service 
in the previous 6 or 12 monhts. 
Diabetics HbA1c result 
(PI06a/b) 
Regular Indigenous clients who have Type II diabetes and whose 
HbA1c was recorded in the past 6 or 12 months whose HbA1c is 
≤7%, 7-10%, ≥10% 
Diabetics that have a 
general practice 
management plan (GPMP, 
PI07a/b) 
Regular Indigenous clients who have Type II diabetes who have 
received a GPMP (MBS item 721) in the previous 24 months 
Diabetics that have a team 
care arrangement (TCA, 
PI08a/b) 
Regular Indigenous clients who have Type II diabetes who have 
received a TCA (MBS item 723) in the previous 24 months. 
Clients with diabetes or 
chronic pulmonary 
obstructive disease (COPD) 
immunised against 
influenza (PI15a/b) 
Regular Indigenous clients aged 15-49 years who are recorded as 
having Type II diabetes or COPD who have received an influenza 
vaccine in the previous year 
Clients with diabetes or 
cardiovascular disease 
(CVD) with kidney function 
test performed (PI18a/b) 
Regular indigenous clients aged 15 years and over who are 
recorded as having type II diabetes mellitus or CVD and have had 
a blood test for an estimate of glomerular filtration rate AND/OR 
and  urine test for albumin creatinine ratio recorded within the 
previous 12 months. 
Renal function test result 
(PI19a/b) 
Regular indigenous clients aged 15 years and over who are 
recorded as having Type II diabetes 
 
 
 144 
 
Diabetics with BP recorded 
(PI23a/b) 
Regular Indigenous clients who have Type II diabetes who have 
had a blood pressure measurement recorded at the PHC service 
within the previous 6 months  
Diabetics blood pressure 
result (PI24a/b) 
Regular Indigenous clients who have Type II diabetes whose BP 
was recorded in the past 6 months whose BP is ≤130/80 
Chronic disease risk 
factors 
 
Smoking status recorded 
(PI09a/b) 
Regular Indigenous clients aged 15 years and over whose 
smoking status has been recorded at the PHC service  
Smoking status result 
(PI10a/b 
Regular Indigenous clients aged 15 years and over whose 
smoking status has been recorded as one of the following: 
 current smoker; 
 ex-smoker or; 
 never smoked. 
Number of obese adults 
(PI12a/b) 
Regular Indigenous clients aged 25 years and over who have had 
their height and weight recorded in the past 24 months and are 
classified as either overweight or obese 
Alcohol consumption 
recorded (PI16a/b) 
Regular Indigenous clients aged 15 years and over who have had 
their consumption status recorded at the PHC service within the 
previous 24 months. 
Alcohol consumption result 
(PI17a/b) 
Regular indigenous clients, aged 15 years and over, who have 
had an AUDIT-C result recorded in the previous 24 months with 
a score of: 
 greater than or equal to 4 in males and 3 in females; or 
 less than 4 in males and 3 in females. 
Cardiovascular disease 
(CVD) risk assessment 
(PI20a/b) 
Regular Indigenous clients with no know CVD, aged 35 to 74 
yeaars, with information available to calculate their absolute 
CVD risk. 
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CVD risk assessment result 
(PI21a/b) 
Regular Indigenous clients, aged 35 to 74 years and with no 
known history of CVD who have had an absolute CVD risk 
assessment recorded within the previous 2 years and whose CVD 
risk was categorised as one of the following 
 High (greater than 15% chance of a cardiovascular event 
in the next 5 years) 
 Moderate (10-15% chance of a cardiovascular event in 
the next 5 years) 
 Low (less than 10% chance of a cardiovascular event in 
the next 5 years) 
 
1. Every nKPI is presented as both total numbers and as a proportion 
2. A ‘regular client’ is defined as a client who attended a PHC service at least 3 times in 2 
years 
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Appendix 2: Key stakeholders consulted 
There have been a number of changes in positions since the evaluation began. The positions 
listed reflect the stakeholder’s role at the time they were consulted. 
Australian Government  
Department of Health – Indigenous and Rural Health Division 
Dr Masha Somi – Assistant Secretary, System Effectiveness Branch 
Dr Brendan Gibson - Director, Evidence and Data Section, System Effectiveness Branch, 
Department of Prime Minister and Cabinet 
Dr Kirrily Harrison - Senior Advisor, Evidence and Evaluation Branch, Schools, Youth and 
Evidence Division 
NACCHO 
Lisa Briggs – CEO of NACCHO 
Dr Mark Wenitong – Former Public Health Medical Officer (PHMO) during nKPI development 
Dr Sophie Couzos – Former PHMO at NACCHO during nKPI development 
Presented and participated at the following meetings on Continuous Quality Improvement in 
the Aboriginal and Torres Strait Islander Primary Health Care Sector 
Aboriginal Health Council of South Australia (AHCSA) CQI meeting – 29th May 2013 
Aboriginal Health and Medical Research Council (AH&MRC, NSW) data workshop – 18th June 
2013 
NACCHO Health Summit – 21st August 2013 
AH&MRC members meeting – 29th October 2013 
NACCHO Members meeting – 20th November 2013 
Lowitja CQI conference – 17th of March 2014 
AH&MRC CQI meeting – 29th of May 2014 
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NACCHO Health Summit – 24th-26th of June 2014 
AHWCA CQI project meeting – 17th of July 2014 
Lowitja National CQI framework meeting – 23rd July 2014 
Meetings with State and Territory Affiliates within Aboriginal Community Controlled Health 
Sector 
Aboriginal Health & Medical Research Council of New South Wales 
Dr Jenny Hunt – PHMO 
Tanya Waitoka – Team leader, CQI 
Queensland Aboriginal and Islander Health Council 
Dr Katie Panaretto – PHMO 
Dr Aaron Hollins – PHMO registrar  
Aboriginal Health Council of South Australia  
Dr David Scrimgeour – PHMO 
Dr Kushani Marshall – PHMO registrar 
Beth Sturgess –  Team leader, CQI 
Teleconferences with State and Territory Affiliates within the Aboriginal Community 
Controlled Health sector 
Dr Liz Moore – PHMO Aboriginal Medical Service Association Northern Territory  
Dr Nadia Lusis – PHMO Victorian Aboriginal Community Controlled Health Organisation  
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1. Prologue 
1.1 My role 
I was brought into this project as the lead analyst and lead author. The study design was 
developed by my co-authors, Dr John Ferguson, Dr Keith Eastwood and Dr Rodney Givney, at 
Hunter New England Local Health District. My co-authors also oversaw the data extraction 
after obtaining ethics approval. They then approached my academic supervisor, Dr Martyn Kirk, 
at the end of 2014 to enquire if a Master of Philosophy in Applied Epidemiology scholar was 
available to analyse these data. 
My first task in this project was forming a data analysis plan.  After discussing the study 
objectives with the co-authors, I conducted a literature review on the epidemiology of 
methicillin resistant Staphylococcus aureus (MRSA) infections.  This led to a draft data analysis 
plan that was shared and refined before I received the data.  
I performed all data cleaning and analysis for the project.  The data were received in a number 
of excel and text files that I imported into Stata version 14. These datasets were merged and 
multiple new variables were created to produce the dataset for analysis. Preliminary results 
were fed back to the research team and some analyses were refined in accordance with their 
comments. 
This paper was written after the data outputs were finalised with the team. While I was the 
lead author, all co-authors provided significant feedback on the focus and language used 
within the paper. 
1.2 Lessons learned 
This project was my first experience in handling a large dataset and supporting a team of 
clinical experts.  This provided me with an insight into what future work as an epidemiologist 
may involve.  It was intimidating to enter a team with much greater knowledge of the subject 
matter, but I learned that I could make a significant contribution to the project through my 
expertise in data analysis and knowledge of how potential biases may impact upon results. 
In order to maximise the value of my contribution as an epidemiologist I needed to combine 
the findings from my literature review with feedback from the research team. I worked closely 
with Dr John Ferguson throughout the project and at key points sought feedback from the 
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wider team. Through combining the evidence from the literature with this feedback I ensured 
the project followed best practice but was also relevant to the local research needs. 
1.3 Public health importance 
This project has highlighted that MRSA is now mainly isolated in people with no recent 
admissions within public hospital, that is, MRSA is community-acquired. Within the community 
there are groups that are disproportionately affected, with Aboriginal and Torres Strait 
Islander people and residents of aged care facilities significantly more likely to have MRSA 
isolated from clinical specimens than the rest of the population. This means that the focus for 
infection control measures for MRSA must move beyond the hospital and into the community 
setting, particularly for high-risk groups.   
This project demonstrated that the pattern of antibiotic resistance for MRSA is rapidly 
changing. Over the study period, the prevalence of a multi-resistant strain within MRSA 
isolates (AUS-2/3-like) decreased by >25% and was replaced by non-multi-resistant strains. 
This change highlights the importance of ongoing surveillance and provides an opportunity for 
targeted antimicrobial treatment of MRSA. 
Our project highlighted a number of improvements required in data collection for S. aureus. 
Our findings were limited by inconsistent labelling and testing of specimens as well as a lack of 
data from private pathology laboratories. Given the burden of disease caused by S. aureus, our 
results provide further evidence to the Hunter New England Local Health District on the need 
to improve the handling of S. aureus specimens and renew efforts to gain private pathology 
data. Through these changes the region will be better able to understand the burden of the S. 
aureus in the community and respond more rapidly to changing patterns of disease. 
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2. Abstract 
Objectives: To describe changes to the epidemiology of Staphylococcus aureus in the Hunter 
New England Local Hospitals District, with a focus on the demographics, history of 
hospitalisation and antibiogram phenotypes among patients who isolated methicillin resistant 
Staphylococcus aureus (MRSA). 
Design, setting and participants: A retrospective cohort study of 44,150 patients who had S. 
aureus isolated from specimens processed at the Hunter New England Local Health District’s 
main pathology provider between January 2008 and December 2014. 
Main outcome measure: Methicillin sensitive S. aureus (MSSA) and MRSA first positive isolates, 
hospitalisation within a HNE LHD facility and antibiotic susceptibility. 
Results:  There were a total of 81,133 positive S. aureus isolates over the study period with 
MRSA cultured in 20.8% of first positive isolates. Patients where MRSA was isolated were 
younger (mean 42.0 years) than those where S. aureus was methicillin sensitive (mean 49.6 
years, p<0.001). Similarly, a higher proportion of MRSA positive patients were of Aboriginal 
and Torres Strait origin (16.9%) compared to those where MSSA was isolated (7.5%, p<0.001).  
Within patients where MRSA was isolated, the majority (53.8%) had no exposure to the public 
hospital system in the previous 12 months. Non-multi-resistant MRSA antibiogram phenotypes 
predominated in both community-associated and healthcare-associated MRSA and there was 
an increase in the proportion of MRSA that was non-multi-resistant over the study period 
(53.9% - 74.1%, 2 for trend.  2 = 356.2, df =1, p <0.001).   
Of the major hospitals in the region, the two largest had a significant decrease (p<0.05) in the 
rate of hospital origin MRSA isolates. 
Conclusion: MRSA is the region is predominately a community-acquired with the largest 
proportion of isolates from younger people with no recent admission to the public hospital 
system. There have been rapid changes to MRSA antibiogram phenotypes with non-multi-
resistant strains now dominant in the healthcare and community-associated populations.
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3. Introduction 
Staphylococcus aureus is a ubiquitous bacterium that can cause serious infection.  Carriage of 
the organism is detected in approximately one quarter of the adult population2 and it is the 
most common cause of skin and soft tissue infections.3 S. aureus is also responsible for a 
significant burden of more serious disease, such as septicaemia.  In 2013, there were 2010 
cases of S. aureus bacteraemia reported from 26 laboratories participating in the Australian 
Staphylococcal Sepsis Outcome Programme, with an all-cause 30-day mortality of 14.4%.4 
Around 1 in 5 cases of S. aureus bacteraemia were due to methicillin resistant Staphylococcus 
aureus (MRSA) and these infections were associated with more invasive disease and a higher 
case fatality rate.4 MRSA may cause infection in a range of body sites and in the Australian 
outpatient setting it has been found in 15.1% of respiratory and 17.9% of skin and soft tissue S. 
aureus isolates.5 The management of MRSA may pose an additional challenge to the treatment 
of S. aureus infections due to limited antimicrobial treatment options.  
The epidemiology of MRSA is changing in Australia.  While MRSA was initially almost entirely a 
nosocomial infection, results from multiple studies since the early 2000s show it is increasingly 
found in the community.  An Australian survey of 29 laboratories that each submitted 100 
consecutive outpatient S. aureus isolates identified MRSA in 17.9% (510/2,844) in 2012, up 
from 11.5% (296/2,569) in 2000.5 Over the same time period a Queensland study of public 
healthcare laboratories found MRSA rose from 9.1% to 22.8% of S. aureus isolates collected 
from outpatients.6 In the Northern Territory a study of S. aureus samples collected from 
Aboriginal and Torres Strait Islander communities found MRSA rose from 7% to 24% of isolates 
between 1993 and 2012.7 This increase in community-based infection has implications for 
control measures employed against MRSA and empirical treatment options. 
Also changing is the pattern of antibiotic resistance among MRSA isolates.  Prevalent clones of 
MRSA in Australian hospitals before 2000 were multi-resistant (resistant to 3 or more non-β-
lactam antibiotic classes).8 However, most healthcare-associated isolates are now non-multi-
resistant and most MRSA isolated in the community are part of a wide range of other distinct 
non-multi-resistant clones, which usually carry the Panton-Valentine Leucocidin (PVL) toxin.  
Daley et al. (2013) found that non-multi-resistant MRSA clones were responsible for 71.1% of 
community infections in 2012, having risen from 48.4% in 2000.5 They also found a non-multi-
resistant strain originally found in the healthcare setting (ST22-MRSA-IV also knows as 
Epidemic MRSA (EMRSA)-15) had increased from 10.4% to 21.0% of community infections over 
the same time period. In Queensland, non-multi-resistant MRSA have become the dominant 
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clones in both outpatient and hospital settings. These non-multi-resistant clones along with 
the ST22-MRSA-IV have replaced a multi-resistant strain (ST239-MRSA-III also known as AUS-
2/3 EMRSA) that dominated at the start of the century.6 It is clear that the prevalence of MRSA 
in the community and the antibiotics required to treat it are changing rapidly. 
Many Australian epidemiological studies of MRSA are limited by a lack of data on recent 
hospitalisation as a potential explanation for infection.  The US Centers for Disease Control and 
Prevention (CDC) classifies MRSA into three categories based, in part, on hospitalisation in the 
past year (Box 1).  Nimmo et al. (2013) highlighted the importance of this classification, as non-
multi-resistant MRSA clones are now more prevalent than multi-resistant ones in hospital 
settings.6 This study is the only one in Australia to combine the CDC classification with MRSA 
genotyping.  All other Australian studies based classification either on inpatient status or 
genotyping.  Using the CDC classification, Nimmo et al. found that 35.3% of outpatients where 
MRSA was isolated had risk factors that classified their MRSA as healthcare-associated.6   They 
also found that non-multi-resistant MRSA clones accounted for over half of all MRSA infection 
in Queensland hospital inpatients.6 For an accurate understanding of MRSA epidemiology, 
laboratory data must be linked with hospitalisation. 
 
The Hunter New England Local Health District (HNE LHD) has a patient information system that 
enables patient demographics and hospitalisation data to be linked with pathology results.  
This enables classification of MRSA based on exposure to the public hospital system and 
antibiotic phenotypes, from which genotypes can be inferred.  This provides the opportunity 
Box 1:  CDC classification of MRSA 
“A case is classified as hospital-onset (HO) if the MRSA culture was obtained on or 
after the fourth calendar day of hospitalization, where admission is hospital day 1; as 
healthcare-associated community-onset (HACO) if the culture was obtained in an 
outpatient setting or before the fourth calendar day of hospitalization and had one of 
more of the following: 1) a history of hospitalization, surgery, dialysis, or residence in a 
long term care facility in the previous year, or 2) the presence of a central vascular 
catheter within 2 days prior to MRSA culture; and as community-associated (CA) if 
none of the previously mentioned criteria are met.”1 
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to analyse both laboratory and hospitalisation data in a longitudinal fashion to better 
understand the epidemiology of MRSA in this region. 
3.1 Study objectives 
The objectives of this study of patients where MSSA and MRSA were isolated within the HNE 
LHD region from 2008 – 2014 were to: 
 Describe the demographic characteristics of individuals with MSSA, community-
associated and healthcare-associated MRSA in the HNE LHD,  
 Describe the predominant antibiogram phenotypes within MRSA categories,  
 Assess time trends in:  
o The proportion of S. aureus isolates that were MRSA 
o The proportion of MRSA that was community-associated (i.e. not healthcare-
associated) 
o Rates of MRSA detection in hospitalised patients in the six largest HNE LHD 
facilities, 
 Assess individual characteristics associated with community-associated MRSA vs. 
MSSA, and 
 Identify data quality improvements required in HNE LHD to enable more robust 
analysis of MRSA. 
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4. Methods 
4.1 Study setting 
The study was conducted across the HNE LHD—a region in north-eastern New South Wales 
(NSW) that covers 131,785 square kilometers and includes 38 hospitals.9 HNE LHD 
encompasses a major metropolitan center, Newcastle, and a number of regional communities 
including Tamworth, Armidale and Moree (Figure 4–1).  The estimated resident population of 
the region is 873,741, including 34,752 Aboriginal and Torres Strait Islander people, which is 
over 20% of the NSW Aboriginal and Torres Strait Islander population.9 
 
 
Figure 4–1: Hunter New England Local Health District location and facilities. Source: New 
South Wales Local Health Districts web page9 
Pathology North, NSW, provides pathology services for all HNE LHD facilities except for Moree, 
Wee Waa and Narrabri (SydPath) and Gunnedah (Laverty Pathology).  In this study, data were 
not accessible from SydPath or Laverty. Owing to a recent update to the pathology information 
system used in Taree / Manning, it was not possible to access data back to 2008 for this region. 
Pathology data for these sites were therefore excluded.  Data on recent hospitalisation in 
these facilities was still available through the HNE LHD patient database. 
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4.2 Study type 
The study was a case series of individuals where S. aureus was isolated from specimens 
collected between 1st January 2008 and 31st December 2014. 
4.3 Study population 
The study population was any individual who had S. aureus isolated from a pathology 
specimen processed by Pathology North (except in Taree/Manning) during the study period.  
This included all patients whose specimen was collected at a HNE LHD facility (except Moree, 
Wee Waa, Narrabri and Gunnedah) and patients whose general practitioner chose to use 
Pathology North. 
4.4 Outcome factors 
Outcome measures were MSSA and MRSA isolation, hospitalisation within a HNE LHD facility 
at the time of specimen collection, previous hospitalisation within a HNE LHD facility, specimen 
type and antibiotic susceptibility. 
4.5 Definitions and measurements 
MRSA was classified into three epidemiological categories based on hospitalisation within a 
HNE LHD facility.  
1. Hospital onset (HO): Culture was obtained on or after 48 hours following admission to 
hospital or within 48 hours following discharge from hospital 
2. Healthcare-associated community origin (HACO): Culture was obtained within 365 
days of a previous hospital admission or culture was obtained while patient was 
receiving dialysis within the past 365 days, but did not meet the definition for HO 
MRSA 
3. Community-associated (CA): Not HO or HACO. 
 
HO and HACO MRSA were collated in some analyses into the category healthcare-associated 
(HA).  
These categories reflect classification of MRSA by the CDC Active Bacterial Core Surveillance 
(ABCs).   There are some differences between the CDC and our study due to different practices 
in Australia and the limitation of our dataset.  These differences are outlined in Table 4–1. 
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Table 4–1: Comparison of study definition of hospital onset (HO) and Healthcare-associated 
community origin (HACO) methicillin resistant S. aureus (MRSA) compared to the US Centers 
for Disease Control and Prevention (CDC) definition 
MRSA 
category 
Study definition Differences in CDC 
definition 
Rationale for difference 
HO MRSA Culture obtained 
within 48 hours 
following 
admission or 48 
following discharge 
Culture obtained 
within 96 hours of 
admission 
Study definition reflects 
Australian definition of 
hospital-associated infection as 
used in the National Health 
Performance Authority 
reports10 
HACO MRSA Not HO MRSA and 
culture was 
obtained within 
365 days of a 
previous hospital 
admission or within 
365 days of 
receiving dialysis 
Includes patients 
with a central 
vascular catheter 
 
Includes residence 
in a long term care 
facility 
Unable to determine presence 
of central vascular catheter 
from data  
 
In line with Australian 
conventions, the study team 
did not believe long term care 
facilities in the region (i.e. 
nursing homes) should be 
classified as healthcare 
facilities  
 
In the absence of genotype data, MRSA was also classified into four antibiogram phenotypes 
based on susceptibility testing to non-β-lactam antibiotics.  
1. AUS-2/3-like: resistant to at least two of tetracycline, gentamicin and erythromycin  
2. Other multi-resistant: resistant to two or more non-β-lactam antimicrobials 
3. EMRSA-15-like: resistant to ciprofloxacin or to ciprofloxacin and erythromycin only  
4. Other non-multi-resistant: resistant to no more than one non-β-lactam antimicrobials, 
but not EMRSA-15-like 
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Specimens were categorised as sterile site (e.g. blood, cavity fluid), non-sterile site (e.g. pus 
swab, sputum or urine), or screening based on the labeling of specimen type and specimen site 
within the dataset.   A member of the study team (JF), who is a microbiologist from Pathology 
North, categorised specimen data. 
4.6 Data source 
Creating the dataset for our study required combining a number of datasets. 
 Pathology data were obtained from the Pathology North laboratory information 
management system (AUSLAB).  
 Data on patient characteristics and previous hospitalisations were obtained from the 
HNE LHD’s patient administration system, iPM.  iPM records all patient contacts, both 
admissions and emergency department attendances, across the HNE LHD and contains 
data on demographics including Aboriginal and Torres Strait Islander status.  For each 
positive S. aureus swab during the study period a line list was generated that included 
variables on: 
o Facility where the specimen was collected 
o Time and date of specimen collection 
o Patient demographics 
o Patients address 
o Inpatient status at time of collection and the time and date of admission 
o The last admission to a HNE LHD facility prior to specimen collection and the 
time and date of discharge for the previous admission. 
 Data on aged care facilities were provided by the HNE LHD epidemiology team that 
maintains a list of names and addresses of residential aged care facilities in the region  
 Data on dialysis patients were provided by the HNE LHD renal team. The unit 
maintains a database of all patients who have received dialysis or had a renal 
transplant in HNE LHD facilities.   The database contains admission and discharge dates 
from dialysis 
 Denominator data on inpatient bed days was provided by the information unit at the 
HNE LHD.  
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4.7 Data management 
Data were managed and analysed with Stata version 14 
Pathology data from AUSLAB were linked with iPM data via laboratory number.  Residential 
aged care facility status was determined by a string search of key words and addresses 
associated with aged care facilities that were provided by the HNE LHD epidemiology team.  
Dialysis status was linked to the main database via the patients’ HNE LHD Medical Record 
Numbers. 
Classification of rural status was performed according to the Australian Statistical Geographical 
Standards Remoteness Area (RA) levels, 2011.  Postcodes were matched to RA level via a 
geographical correspondence provided by the Australian Bureau of Statistics.11 
To enable classification of MRSA into epidemiological categories, variables were created on 
time since admission and time from last discharge.  These variables were determined from 
time and date of specimen collection and the time and date of admission (or discharge).  
4.8 Statistical Analysis 
Data were analysed using a modified ‘first isolate per patient’ approach.  That is, only the first 
positive isolate for either MSSA or MRSA per patient is included in the analysis.  This approach 
is recommended by the Clinical and Laboratory Standards Institute Guideline “Analysis and 
Presentation of Cumulative Antimicrobial Susceptibility Test Data, fourth edition”.12 While 
using a ‘first isolate per patient’ approach limits increased counts that may occur due to host 
factors (e.g. immunosuppression), it prevents surveillance of the evolution of resistance in an 
individual.  Our study deviated slightly from the ‘first isolate per patient’ approach and 
included analysis of the first isolate of both MSSA and MRSA if they occurred in the same 
individual.  
Chi-square tests were used to determine the significance of differences between groups and 
thus determine covariates for binomial logistic regression.  A Chi-square test for trend was 
performed to determine any significant change in the proportion of distribution of antibiotic 
phenotypes and CA MRSA.  Wilcoxon-Mann tests were used to determine significant 
differences between non-parametric continuous variables.  Linear regression was performed 
on the change in rates of HO MRSA infection per 10,000 inpatient bed days. 
Logistic regression was performed to explore the demographic factors associated with a higher 
probability of isolating MRSA, as opposed to MSSA, in the community population. Univariate 
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logistic regression was performed to confirm variables an association with MRSA before 
including them in the multivariate model. 
4.9 Ethics approval 
The Hunter New England Human Research Ethics Committee provided ethics approval (NSW 
Reference number LNR/12/HNE/474). 
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5. Results 
5.1 Study sample 
There were a total of 81,133 positive S. aureus isolates over the study period with MRSA 
cultured in 20.8% (9,571/46,050) of all first positive isolates (Table 4–2). 
Table 4–2: First positive and repeat isolates for all methicillin sensitive S. aureus (MSSA) and 
methicillin resistant S. aureus (MRSA) positive isolates.  Hunter New England Local Health 
District, 2008 - 2014 
 
A higher proportion of all MRSA isolates were categorised as screening samples in comparison 
to MSSA (Table 4-3), but this difference was not significant when restricting analysis to first 
isolate per patient (Table 4-5).  The number of positive screening isolates and the proportion 
that were MRSA showed over two-fold variation across the study period (Table 4–4). 
 
MSSA (n=61,513) 
 
MRSA (n=19,620)  Total (n=81,133) 
 
n % total 
 
n % total  n % total 
First isolate 36,479 79.2 
 
9,571 20.8  46,050 100.0 
Repeat isolate (<14 days) 12,942 68.6 
 
5,915 31.4  18,857 100.0 
Repeat isolate (≥14 days) 12,092 74.5 
 
4,134 25.5  16,226 100.0 
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Table 4–3: Distribution of specimen categories for all methicillin sensitive S. aureus (MSSA) 
and methicillin resistant S. aureus (MRSA) positive isolates. Hunter New England Local 
Health District, 2008 - 2014 
 
MSSA (n=61,513) 
 
MRSA (n=19,620) 
 
n % 
 
n % 
Screening 6,552 10.7 
 
2,845 14.5 
      Clinical 53,842 87.5
 
16,488 84.0
     
Unable to be classified 1,119 1.8 
 
287 1.5 
 
Table 4–4:  Distribution of screening specimens for first positive isolates of methicillin 
sensitive S. aureus (MSSA) and methicillin resistant S. aureus (MRSA) by year collected.  
Hunter New England Local Health District, 2008 - 2014 
  2008 2009 2010 2011 2012 2013 2014 
MSSA n 325 549 736 867 858 594 246 
 
% 68.9 81.5 85.1 85.0 83.9 78.5 59.1 
 
 
       MRSA n 147 125 129 153 165 163 170 
 
% 31.1 18.5 14.9 15.0 16.1 21.5 40.9 
 
 
       Total n 472 674 865 1,020 1,023 757 416 
 
% 100.0 100.0 100.0 100.0 100.0 100.0 100.0 
The 81,133 isolates came from 44,185 people with the distribution of MSSA and MRSA among 
the sample shown in Figure 4-2.  The vast majority of the study sample cultured either MSSA 
or MRSA only and 1,865 people (4.2%) cultured both MSSA and MRSA during the study period.   
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MSSA	
34,614	
MRSA	
7,706	
Both	
1,865	
 
Figure 4–2: Venn diagram of the distribution of methicillin resistant S. aureus (MRSA) and 
methicillin sensitive S. aureus (MSSA) positivity amongst S. aureus positive individuals. 
Hunter New England Local Health District, 2008 – 2014. 
The median age of the study sample was 47.5 (Inter-quartile range (IQR) 21.4 - 71.7) years and 
there was a slight male predominance (53.9%, n= 23,828).  Aboriginal and Torres Strait 
Islander people made up 9.3% (n=4,104) of the study sample but constitute only 4% of the 
HNE LHD population.9  
There were a number of statistically significant differences in the demographics of MRSA 
positive individuals in comparison to people who cultured MSSA.  The MRSA cohort was 
younger with a higher proportion of Aboriginal and Torres Strait Islander descent.  Despite the 
younger population, the MRSA cohort also had a higher proportion of residents of aged care 
facilities (Table 4-5). 
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Table 4–5: Comparison of demographics and screening of first positive isolates, methicillin 
sensitive S. aureus vs. methicillin resistant S. aureus. Hunter New England Local Health 
District, 2008 - 2014 
 
MSSA (n 35,734)* 
 
MRSA (n=8,451)* 
 
p-value 
 
median IQR 
 
median IQR 
  
        Age 49.6 22.4 - 71.9 
 
38.7 18.8 – 70.2 
 
<0.001
        
 
n  % 
 
n % 
  Male 19,186 53.7 
 
4,642 54.0 
 
0.04
        Aboriginal and/or 
Torres Strait Islander 2,618 7.3 
 
1,486 17.6 
 
<0.001 
Neither 32,719 91.6 
 
6,902 81.6 
  Not stated 397 1.1 
 
63 0.8 
  
        Resident of an aged 
care facility 884 2.5 
 
553 6.5 
 
<0.001 
        Major Cities (RA1) 12,834 35.9 
 
2,917 34.5 
 
0.02
Rural (RA2-RA5) 22,704 63.5 
 
5,466 64.7 
  Inner Regional 8,535 23.9 
 
1,884 22,3 
  Outer Regional 13,925 39.0 
 
3,490 41.3 
  Remote 208 0.6 
 
72 0.9 
  Very Remote 36 0.1 
 
20 0.2 
  Missing 196 0.6 
 
68 0.8 
       
Screening 4,175 11.4  1,052 11.0  0.213 
* Individuals that recorded positive isolates for both MSSA and MRSA during the study period 
are categorised according to the organism that was isolated first. 
 
5.2 Data completeness 
The pathology and iPM data were matched 1:1 via lab number, with no records unmatched.  
There were 104 lab numbers that were duplicated.  These were reviewed and it was found 
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that the duplicate records differed only by a variable on the ward where the person was 
located.  As no analysis was done by ward, these duplicate entries were deleted. 
Antibiotic susceptibility testing of isolates was inconsistent across the different laboratory sites. 
No data on susceptibility testing was available for 47 isolates (0.5% of first positive MRSA 
sample) and a further 139 (1.3%) had susceptibility testing for less than four classes of 
antibiotic.  
The completeness of antibiotic susceptibility testing by year is shown in Figure 4–3. There was 
a statistically significant increase in the proportion of isolates with susceptibility data for 5 or 
more antibiotics, from a low of 69.8% in 2009 to a high of 93.8% in 2014 (2 for trend.  2 = 
684.8, df =1, p <0.001). 
 
Figure 4–3: Number of non-β-lactam antibiotics used in susceptibility testing for first positive 
methicillin resistant S. aureus (MRSA) by year collected. Hunter New England Local Hospitals 
District, 2008-2014 
The most frequently missing susceptibility testing results for isolates were gentamicin (16.4%), 
fusidic acid (14.4%) and rifampicin (13.2%). Figure 4–4 shows the proportion of MRSA isolates 
with susceptibility testing for these antibiotics by year. The majority of samples missing 
gentamicin susceptibility testing (1,149/1,567, 73.3%) were susceptible to all other non-β-
lactam antibiotics.  
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Figure 4–4: Susceptibility testing of first positive methicillin resistant S. aureus (MRSA) 
isolates.  Hunter New England Local Health District, 2008 - 2014 
5.3 MRSA categories 
5.3a Demographics 
There were a number of significant differences between persons with CA and HA MRSA (HO 
and HACO combined).  Those with CA MRSA had a median age more than 30 years younger 
and there were almost double the proportion of Aboriginal and Torres Strait Islander people 
(Table 4-6). 
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Table 4–6: Demographics of first positive isolates of methicillin resistant S. aureus (MRSA).  
Hunter New England Local Health District, 2008 -2014 
 
Community-associated 
MRSA (n = 5,145) 
 
Healthcare-associated 
MRSA (n = 4,426) 
 
p-value 
 
median IQR 
 
median IQR 
  
        Age 26.9 15.6 - 49.1 
 
60.4 30.2 – 80.0 
 
<0.001
        
 
n % 
 
n % 
  Male 2,900 56.4 
 
2,364 53.4 
 
0.004 
        Aboriginal and/or 
Torres Strait Islander 1097 21.3 
 
519 11.7 
 
<0.001 
        Residents of an aged 
care facility 197 3.8 
 
511 11.6 
 
<0.001 
        Major Cities (RA1) 1,683 33.6 
 
1,597 36.1 
 
0.001
 
The relative proportion of MRSA isolates attributed to the three epidemiological categories 
changed with age (Figure 4–5).  The majority of MRSA was community-associated up until the 
50-59 year old age group.  
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Figure 4–5: Epidemiological categories of first positive isolates of methicillin resistant S. 
aureus (MRSA) by age group.  Hunter New England Local Health District, 2008 – 2014. 
Tabulated data available in appendix (supplementary table 4-11) 
5.3b Antibiotic susceptibility 
There were significant differences in the susceptibility to non-β-lactam antibiotics between the 
three epidemiological categories of MRSA (Table 4-7).  The differences between CO and HA 
MRSA were statistically significant for every antibiotic (p<0.001).  The differences between 
HACO and HO were statistically significant (P<0.001) for all antibiotics except fusidic acid and 
rifampicin. 
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Table 4–7: Resistance to non-β-lactam antibiotics, first positive isolates of methicillin 
resistant S. aureus (MRSA).  Hunter New England Local Health District, 2008 - 2014 
 
Community-associated 
MRSA 
(n= 5,145) 
 
Healthcare-associated 
community origin 
MRSA (n=2,556) 
 
Hospital onset 
MRSA (n=1,870) 
 
n % resistant 
 
n % resistant 
 
n % resistant 
         Ciprofloxacin 520 10.1 
 
884 34.6 
 
928 49.6 
         Co-trimoxazole 84 1.6 
 
174 6.8 
 
277 14.8 
         Erythromycin 1,273 24.7 
 
1,113 43.5 
 
998 53.4 
         Fusidic acid 145 2.8 
 
125 4.9 
 
101 5.4 
         Gentamicin 93 1.8 
 
195 7.6 
 
277 14.8 
         Rifampicin 17 0.3 
 
20 0.8 
 
17 0.9 
         Tetracycline 554 10.8 
 
308 12.1 
 
291 15.6 
` 
The different antibiotic susceptibility led to different antibiogram phenotypes/inferred 
genotypes between the epidemiological groups of MRSA.  Within HA MRSA there were 
significantly higher proportions of EMRSA-15-like and multi-resistant isolates compared to CA 
MRSA (P<0.0001).  Other non-multi-resistant MRSA was found in 75.2% of CA MRSA  (Table 4-
8). 
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Table 4–8: Antibiogram phenotypes, first positive isolates of methicillin resistant S. aureus 
(MRSA).  Hunter New England Local Health District, 2008 - 2014 
 
Community-associated 
MRSA (n= 5,145) 
 
Healthcare-
associated 
community origin 
MRSA (n=2,556) 
 
Hospital onset 
MRSA 
(n=1,870) 
 
n % 
 
n % 
 
n % 
         Other non-multi-
resistant 4,088 79.5 
 
1,457 57.0 
 
812 43.4 
         EMRSA-15-like 404 7.9 
 
645 25.2 
 
595 31.8 
         Aus-2/3-like 572 11.1 
 
368 14.4 
 
393 21.0 
       
Other multi-resistant 81 1.6  86 3.4  70 3.7 
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5.3c Time trend 
Screening specimens were excluded from time series analysis due to variation in the annual 
number of tests performed and in susceptibility reporting of some isolates (Table 4–4). After 
excluding samples for screening, the number of MRSA isolates per annum decreased from 
1,372 in 2009 to 967 in 2014. There was a decrease in the proportion of S. aureus positive 
isolates that were MRSA in patients with and without admission to public health care hospitals 
in the past 12 months (Figure 4–6 and Figure 4–7). The larger decrease was seen in the group 
with no admissions in the past 12 months and this change was statistically significant (2 for 
trend.  2 = 70.9, df =1, p <0.001).   
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Figure 4–6: Annual proportion of first positive isolates of S. aureus that were methicillin 
resistant S. aureus (MRSA) among patients with no admissions to the public hospital system 
in the past 12 months.  Hunter New England Local Health District, 2008 – 2014. Tabulated 
data available in appendix (Supplementary Table 4-12) 
 
Figure 4–7: Annual proportion of first positive isolates of S. aureus that were methicillin 
resistant S. aureus (MRSA) among patients admitted to the public hospital system in the past 
12 months. Hunter New England Local Health District, 2008 – 2014. Tabulated data available 
in appendix (Supplementary Table 4-13) 
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There was no statistically significant change in the proportion of MRSA that was community-
associated.   The median annual proportion of first positive MRSA samples that were 
community-associated was 53.3% (range 51.0% – 56.8%). 
The distribution of overall MRSA antibiogram phenotypes/inferred genotypes changed over 
time.  There was a statistically significant increase in other non-multi-resistant MRSA from 
53.9% of isolates in 2008 to 74.1% in 2014 (2 for trend.  2 = 356.2 df =1, p <0.001) and an 
increase in EMRSA-15-like from 13.4% to 19.1% (2 for trend.  2 = 35.2 df =1, p <0.001).  There 
was also statistically significant drop in AUS-2/3-like from 30.2% to 3.8% of isolates (2 for 
trend.  2 = 888.5, df =1, p <0.001).  This change in distribution of antibiogram phenotypes was 
seen in both the community-associated and healthcare-associated groups (Figure 4–8 and 
Figure 4–9). 
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Figure 4–8: Antibiogram phenotypes, first positive isolates of community-associated 
methicillin resistant S. aureus (MRSA) by year collected.  Hunter New England Local Health 
District, 2008 - 2014.   
 
Figure 4–9: Antibiogram phenotypes, first positive isolates of healthcare-associated 
methicillin resistant S. aureus (MRSA).  Hunter New England Local Health District, 2008 – 
2014 
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5.4 Community-Associated MRSA vs. MSSA 
Logistic regression was performed for two groups, those younger than 65 and those 65 and 
older.  This approach was taken as there were two populations with a higher proportion of 
isolates with MRSA but a converse relationship with age: Aboriginal and Torres Strait Islander 
people and residents of aged care facilities.  Using an age cut off of 65-years-old resulted in 
95.9% (3,689/3,847) of Aboriginal and Torres Strait Islander people within the younger cohort 
and 94.3% (1,089/1,155) of residents of aged care facilities in the older cohort. 
Age was included as a continuous variable in both logistic regression models.  However, the 
likelihood of isolating CA MRSA was almost twice as high in the under 65 group (Odds Ratio 1.9, 
95% Confidence Interval 1.8, 2.1) 
The models show that in the younger cohort, Aboriginal and Torres Strait Islander people had 
more than twice the likelihood of isolating MRSA, compared to MSSA (Table 4-9).  In the older 
cohort, residents of aged care facilities were four times more likely to isolate MRSA (Table 4-
10). The relationship between age, sex and MRSA varied between the two groups.  In the 
cohort 65 years or less, younger age and males had a higher likelihood of isolating MRSA while 
there was no relationship for these variables in those aged 65 and over. 
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Table 4–9: Multivariate logistic regression of the effects on isolating methicillin resistant S. 
aureus (MRSA) vs. methicillin sensitive S. aureus (MSSA) in people aged less than 65 with no 
admissions to public hospitals in the past 12 months.  Hunter New England Local Health 
District, 2008 - 2014 
 
MSSA 
(n = 15,777) 
Community-
associated 
MRSA (n=4,401) 
Odds 
ratio p-value 
95% 
Confidence 
interval 
 
n % n %  
  Male  8,706 55.2 2,567 58.3 1.2 <0.001 (1.1, 1.3) 
Aboriginal and/or 
Torres Strait 
Islander 1,649 10.5 1,085 24.7 2.6 <0.001 (2.4, 2.8) 
Residential aged 
care facility 
resident 21 0.1 13 0.3 3.2 0.001 (1.6, 6.3) 
Rural 9,986 63.3 2,955 67.1 1.1 0.007 (1.0, 1.2) 
Age (median) (28.8) (22.6) 0.99 <0.001 (0.989, 0.993) 
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Table 4–10: Multivariate logistic regression of the effects on isolating methicillin resistant S. 
aureus (MRSA) vs. methicillin sensitive S. aureus (MSSA) in people aged 65 and over in 
people with no admissions to public hospital in the past 12 months. Hunter New England 
Local Health District, 2008 – 2014 
 
MSSA 
(n =5,127) 
Community-
associated 
MRSA 
(n=744) 
Odds 
ratio p-value 
95% 
Confidence 
interval 
 
n % n %  
  Male  2,590 50.5 333 44.8 0.9 0.228 (0.8, 1.1) 
Aboriginal and/or 
Torres Strait 
Islander 46 0.9 12 1.6 2.6 0.009 (1.2, 4.5) 
Residential aged 
care facility 
resident 329 6.4 184 24.7 4.4 <0.001 (3.6, 5.5) 
Rural 3,233 63.1 462 62.1 10 0.761 (0.8, 1.1) 
Age (median) (77.5) (77.5) 1.0 0.050 (1.0, 1.0) 
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5.5 Hospital specific rates 
The rates of HO MRSA varied among the six major hospitals in the region (Figure 4–10). Two 
hospitals, John Hunter Hospital and Tamworth Rural Referral Hospital, both had a statistically 
significant decrease in the rates of positive HO MRSA isolated during the study period 
(Supplementary Table 4-4). All hospitals, except Armidale, reported a rate of HO MRSA of 
approximately 2-3 positive isolates per 10,000 bed days by the end of the study period. The 
Armidale Hospital rate remained more than twofold higher throughout the study period.  
 
Figure 4–10: Rate of hospital onset methicillin resistant S. aureus per 10,000 bed days.  
Selected hospitals in Hunter New England Local Health District, 2008-13 financial years. 
Tabulated data available in appendix (Supplementary Table 4-14)   
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6. Discussion 
6.1 Main findings 
Our study has shown a persistently high proportion of MRSA infection in young people within 
the study region with no recent exposure to the public healthcare system.  Specific groups 
appear disproportionately affected; with Aboriginal and Torres Strait Island people and 
residents of aged care facilities significantly more likely to isolate MRSA than the rest of the 
population.  While there was little change in the proportion of S. aureus due to MRSA, there 
were marked changes in the predominant phenotypes with a decrease in AUS-2/3-like and a 
rise in EMRSA15-like and other non-multi-resistant MRSA phenotypes in both community and 
healthcare-associated events. 
Throughout the study, a high proportion of S. aureus isolates were MRSA but this decreased 
over time.  While an average of 20.8% of S. aureus isolates were MRSA, this decreased from 
22.1% per annum in 2008 to 19.5% in 2014 and was accompanied by a decrease in the number 
of MRSA positive isolates. This decrease was predominately seen in isolates from people with 
no admissions to the public hospital system in the past 12 months.  These results are difficult 
to compare with other Australian studies due to the mix of inpatient and outpatient data.  
However, the proportion of MRSA isolated in outpatients (18.5%) was only slightly higher than 
the national average (17.9%) but lower than that seen in NSW (25.5%).5 The significant 
proportional decrease over time, with a small absolute change, has not been documented in 
other Australian studies among outpatients.  This finding was not anticipated by the research 
team and will require ongoing surveillance.  The results confirm that MRSA is a persistent 
potential pathogen within HNE LHD and that the epidemiology of S. aureus continues to 
change. 
The majority of MRSA was seen in younger people with no recent exposure to the public 
hospital system. Among MRSA isolates, the median age was younger than MSSA and this age 
difference was more pronounced in the CA MRSA group.  Aside from younger age it was also 
identified that Aboriginal and Torres Strait Islander people and those living within a residential 
aged care facility were associated with greater likelihood of culturing MRSA in the community.  
Our study is the first large-scale analysis of the characteristics of patients with MRSA in an 
Australian setting.  However, other studies have highlighted the increased representation of 
Aboriginal and Torres Strait Islander people with MRSA positive isolates.6 These results have 
significant implications for the management of MRSA in HNE and lead to consideration of 
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changes to treatment guidelines for some populations, especially given changes to the pattern 
of antibiotic resistance. 
Non-multi-resistant MRSA phenotypes now predominate in both the community and 
healthcare-associated settings. EMRSA-15-like and other non-multi-resistant phenotypes 
accounted for over 90% of MRSA in 2014, regardless of recent hospitalisation.  The 
replacement of multi-resistant strains by non-multi-resistant MRSA has been seen throughout 
Australia6 and in international settings13 and has been attributed to increased virulence factors 
within non multi-resistant MRSA.  This changing pattern of antibiotic resistance, combined 
with the ubiquity of MRSA in the community warrants consideration of empirical treatment for 
kin and soft tissue infections that provides appropriate coverage for MRSA. 
Now that the vast majority of MRSA isolates are non-multi-resistant, treatment of MRSA and 
MSSA can be more targeted.  Due to the changing epidemiology of S. aureus in the community, 
alternative approaches to treating skin and soft tissue infections are being trialled, including 
non-antibiotic approaches to management. The HNE LHD has established a web resource for 
general practitioners with information on MRSA management, which includes advice on 
incision and drainage as first line management for localised boils.14 Outside of the region, a 
study on the use of co-trimoxazole (trimethoprim and sulphamethoxazole) in a remote 
Aboriginal and Torres Strait Islander community found that it was as effective as conventional 
treatment for skin and soft tissue infections that cultured either Streptococcus pyogenes or S. 
aureus with fewer adverse events.15 Similar approaches could be considered in the HNE 
Aboriginal and Torres Strait Islander population as less than 2% of CA MRSA isolates were 
resistant to co-trimoxazole. 
Our findings on hospital onset MRSA were varied.  Hospital specific rates significantly 
decreased in the two largest hospitals but one hospital with higher rates showed no change 
over time.  Downward trends in rates of HO MRSA have been documented elsewhere in 
Australia and have been attributed, in part, to national hand hygiene initiatives.16 A possible 
reason for our varied results despite improved hand hygiene is the increasing role of non-
multi-resistant MRSA. We found that eMRSA15-like and other non-multi-resistant phenotypes 
now predominate in HO isolates and this finding is consistent with other Australian studies.5,6 
The hospital with the highest rates of HO isolates also had a higher proportion of isolates that 
were other-non-multi-resistant MRSA than the rest of the HO MRSA cohort (48% vs. 41%). It is 
believed that transmission of non-multi-resistant MRSA in Australian hospitals is rare (ref # 
33,34 in Coombs 2014) which suggests non-multi-resistant MRSA identified as hospital onset 
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were probably present on the individual prior to admission.  Hence, screening of individuals 
undergoing at-risk procedures may need to be strengthened. 
6.2 Study strengths 
The study’s strengths include a large dataset with data linkage, the completeness of 
demographic data and the classification of MRSA using characteristics of both the host and 
organism. 
The study included a sample equivalent to almost 5% of the population within HNE LHD.  This 
large sample has led to a high degree of precision with most significant results having a p-value 
of less than 0.001. 
The completeness of demographic information allowed us to identify the high proportion of 
Aboriginal and Torres Strait Islander people within positive MRSA isolates.  Identification of 
Aboriginal and Torres Strait Islander status is often not possible with pathology data due to a 
lack of an Indigenous identifier on many pathology request forms.17 In contrast, Aboriginal and 
Torres Strait Island status was missing for less than 1% of all isolates in our study.  By linking 
laboratory data with the iPM database the limitation of using pathology data alone was 
overcome and identified an at-risk group in the region. 
Another limitation of pathology data that has been overcome in the study is the classification 
of community versus healthcare origin MRSA.  While previous studies have relied on 
classification by antibiotic phenotype or genotyping, this study has shown non-multi-resistant 
MRSA phenotypes now predominate in healthcare-associated infections.  This indicates that 
the origin of infection can no longer be deduced from antibiotic susceptibility patterns or 
genotyping alone. 
6.3 Study limitations 
Our study is the first attempt to use the HNE LHD patient information system with pathology 
data to understand the patterns of disease in the region.  While the study has shown the 
benefits of these data, there are a number of improvements that could be made to the 
databases to improve the validity of results.    
The main limitation of the study is that it mainly includes data from public hospitals. As shown, 
MRSA in HNE is primarily of community origin and many people with skin and soft tissue 
infections present to general practices (GPs), not hospital.  The latest GP activity data suggest 
3.7% of all reasons for encounters with general practitioners are for skin conditions that could 
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involve S. aureus infection.18 Pathology specimens from GP presentations are often processed 
in private pathology laboratories and are unavailable for analysis. The exclusion of these data 
introduces a possible selection bias that would differentially impact CA MRSA and non-multi-
resistant MRSA phenotypes, decreasing their count and possibly moving time series results 
toward the null hypothesis.   
Conversely, the exclusion of private hospital admission data differentially impacts HACO MRSA.  
The absence of private admissions data introduces a potential measurement bias where 
isolates may be incorrectly categorised as community-associated, rather than healthcare-
associated.  The impact of this bias on HACO MRSA is potentially large as private hospitals 
contribute to 37.5% of all separations in the Hunter New England region.19  
While it is impossible to weigh these two biases against one another to determine the impact 
upon the results, it is clear that a change is required in data collection systems.   To better 
understand the epidemiology of MRSA it is necessary to move towards data systems based on 
the region under surveillance, not the funding source of the service. Surveillance may be 
improved if MRSA becomes a notifiable disease, as it is in Western Australia.  In lieu of a 
national registry, the HNE LHD could explore a pragmatic surveillance approach e.g. where the 
large private pathology companies submit positive S. aureus swabs occurring in the first week 
of each month. 
As our study was a case series, we were unable to describe incidence and risk.  Our study 
design only permitted us to report on the proportion of individuals that had MRSA isolated, 
their characteristics and compare this to individuals who had MSSA or changes over time.  
With complete data on exposures and outcomes we would have been able to report the 
incidence of MRSA in at-risk populations in HNE LHD and their relative risk compared to the 
general population.  This would help clarify the groups are at greatest risk of infection and 
would also add depth of understanding to our results.  For example, while we found MRSA was 
predominately found in those without a recent hospitalisation, it is likely the relative risk of 
having MRSA isolated following hospitalisation is still significantly higher than in the general 
community. This would emphasise the need for infection control measures in hospital need to 
continue alongside expanded community control measures.  Sharing data across private and 
public providers would help facilitate these analyses.  
The inconsistent testing of antibiotic susceptibility introduces another potential measurement 
bias. However, the impact of this bias appears to be minimal through analyses of missing 
susceptibility data.  The antibiotic with the lowest susceptibility testing was gentamicin, with 
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data missing for 16.4% of first positive MRSA isolates.   The majority of these samples were 
susceptible to all other non-β-lactam antibiotics (73.3%) and resistance to gentamicin was 
found in only 5.9% of MRSA isolates.  This suggests in those isolates missing gentamicin testing, 
the antibiogram phenotype would remain unchanged even if results were available.  HNE LHD 
has already recognised the importance of consistent susceptibility testing across the region 
and has implemented protocols for testing of MRSA: however, this does not overcome the 
issue of consistent data collection from private laboratories. Ideally a national approach to 
susceptibility testing of MRSA is indicated. 
A factor that has yet to be fully addressed in HNE LHD is the inconsistent labelling of samples 
according to specimen site and classification of clinical versus screening samples.   This 
prevented the analysis of results by specimen site.  There were 30 terms used to identify 
specimens as ‘screening’ pathology in the database. A consistent term would facilitate analysis 
of this group.  Similarly, consistent labelling of specimen site would enable more robust 
analysis of sterile vs. non-sterile samples.  Over 250 terms with multiple permutations were 
used to describe the specimen site in the database.  A system where these terms were 
aggregated into clear groups by the laboratories would assist in future analyses. 
Analysis of screening samples was also impaired by variations in testing for MSSA.  For some 
types of screening, MSSA was not reported from screening samples.  This practice varied 
across years and explains the wide variation in the proportion of S. aureus positive screening 
samples that were MRSA.  The results on HO MRSA highlighted that the majority of HO 
infections were due to non-multi-resistant MRSA and possibly present at admission.  This 
emphasises the need for consistent practices in labelling, testing and reporting of screening 
specimens in order to understand future changes to the epidemiology of S. aureus. 
Our results used antibiotic phenotype rather than genotyping to classify MRSA clones.  While 
this approach has limitations, it is the most pragmatic method for a large sample.  Some of the 
antibiotic phenotypes in the study have also been found to have a relative high sensitivity and 
specificity for their equivalent genotypes.  An Australian study showed the definition of 
EMRSA-15-like isolates used in our study had a sensitivity of 0.90 and a specificity of 0.98.6 
However, the changing pattern of antibiotic resistance indicates that there is a need for 
surveillance of genotypes. HNE LHD could explore a systematic approach to genotyping a 
regular sample of MRSA isolates from both the inpatient and outpatient settings in order to 
monitor change. 
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A final limitation is that over the study period, different standards were used for antimicrobial 
susceptibility testing across the HNE LHD.  The New England region covered by Path North 
used Calibrated Dichotomous Susceptibility testing while Hunter region used the Clinical and 
Laboratory Standards Institute Guidelines for antimicrobial susceptibility testing. Whilst this 
did not affect the detection of MRSA, there may be minor differences in detection of other 
resistances due to slightly different clinical breakpoints. To address this limitation a consistent 
approach is being implemented across the region. 
6.4 Conclusion 
Our study has shown that MRSA is now predominately a community-based problem within the 
HNE LHD. While most major hospitals have decreased their rates of hospital origin isolates, the 
greatest number of isolates of MRSA were found in the outpatient setting among patients with 
no recent public hospital admissions. In both the community and healthcare-associated groups, 
there has been rapid change in the predominate antibiogram phenotypes with the proportion 
of non-multi-resistant MRSA strains increasing by over twenty percentage points in seven 
years. However, our understanding of MRSA in the region was impaired by inconsistencies in 
specimen labelling and processing. The rapid changes in antibiotic resistance and the 
predominance of community-associated infections means there are a number of 
improvements required to the collection and analysis of MRSA data if we are to effectively 
meet the challenges faced by this changing pathogen. 
The findings from our study lead to a number of recommendations on the surveillance and 
treatment of S. aureus in the region. 
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7. Recommendations 
7.1 Surveillance 
Recommendation 1 Rationalise and standardise the list of valid specimen types across all 
laboratories and ensure that requests are clearly distinguished 
between screening and clinical samples 
Recommendation 2 Ensure that the laboratory handling of screening samples 
encompasses detection and reporting of both MSSA and MRSA  
Recommendation 3 Ensure that the same basic panel of antibiotics are tested against all 
MSSA and MRSA strains.  These include cefoxitin, ciprofloxacin, 
erythromycin, fusidic acid, gentamicin, mupirocin, rifampicin, 
tetracycline, trimethoprim-sulphamethoxazole, vancomycin 
Recommendation 4 Store new patient MRSA isolates at 12 month intervals across all lab 
sites 
Recommendation 5 Determine a prospective process to periodically genotype a 
representative sample of new MRSA strains from across the district 
Recommendation 6 Embed classifications for HO, HACO and CA into surveillance software 
so that consistent data is available from across Hunter New England 
Local Hospitals District 
 Continue to exclude RACF from the HACO classification; 
include central line and dialysis exposure criteria as per 
CDC 
 For CA events record residential aged care exposure(s) 
within the previous 12 months and Aboriginal and Torres 
Strait Islander status 
Recommendation 7 Prepare annual cumulative antibiograms that sub classify MSSA and 
MRSA isolates by region and CDC category. Reports on phenotype and 
genotype trends for MRSA 
Recommendation 8 Provide a regular reports to Population Health of MRSA detections 
sub classified by CDC category. For CA events, include subtotals of 
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Aboriginal and Torres Strait Islander and RACF associated events.   
7.2 Preventative actions (applicable to healthcare and community) 
Recommendation 12 Ensure antimicrobial stewardship programs exist in all settings – 
community, aged care, and hospitals.  This should be established 
through joint approaches with HNE Population Health, Infection 
Protection Service, HNE Pharmacy, general practice groups and the 
National Prescribing Service 
Recommendation 13 Promotion of environmental cleaning standards – especially in 
residential aged care facilities, hospitals and shared public facilities 
such sporting locations, gymnasiums. 
Recommendation 14 Promotion of hand hygiene  
Recommendation 15 Promotion of hygienic wound management and procedures for 
maintaining good skin integrity in hospitals and residential aged care 
facilities 
7.3 Therapeutics/ Clinical management 
Recommendation 16 Promotion of the Hunter New Engalnd Local Health District’s 
HealthPathways website for evidence based approaches to MRSA and 
recurrent staph infection amongst general practitioners,  
Recommendation 17 Ensure that hospital clinicians obtain Infectious Diseases consultation 
for management of patients with complex MRSA infection 
Recommendation 18 Promote non-antibiotic management of localised boils 
Recommendation 19 Publicise cumulative antibiogram results together with 
recommendations about best empiric treatment antibiotics 
 
Appendix 
Supplementary Table 4–11: Epidemiological categories of first positive isolates of methicillin resistant S. aureus (MRSA) by age group. Hunter New 
England Local Health District, 2008 - 2014 
  
0-4 5-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90+ Total 
              Hospital onset n 82 23 70 98 89 133 159 237 373 469 137 1,870 
 
% 15.6 5.0 4.7 8.0 9.6 15.9 22.2 30.7 36.4 38.7 34.5 19.5 
              Healthcare-associated 
community origin n 172 37 174 252 225 205 201 262 394 479 155 2,556 
 
% 32.7 8.0 11.8 20.6 24.4 24.5 28.1 33.9 38.4 39.6 39.0 26.7 
              Community-associated n 272 400 1,235 874 610 499 355 273 259 263 105 5,145 
 
% 51.7 87.0 83.5 71.4 66.0 59.6 49.7 35.4 25.2 21.7 26.5 53.8 
              All MRSA n 526 460 1479 1224 924 837 715 772 1026 1211 397 9571 
 
 
 199 
Supplementary Table 4–12: Proportion of first positive isolates of methicillin sensitive S. aureus (MSSA) vs. methicillin resistant S. aureus  (MRSA) 
in patients with no admissions to the public hospital system in the past 12 months by year collected. Hunter New England Local Health District, 
2008 - 2014 
  
2008 2009 2010 2011 2012 2013 2014 Total 
          MSSA n 2,589 2,570 2,644 2,765 2,731 2,810 2,615 18,724 
 
% 78.1 77.2 77.1 78.8 80.8 81.5 83.5 79.5 
          Community-associated MRSA n 725 759 786 743 649 637 517 4,816 
 
% 21.9 22.8 22.9 21.2 19.2 18.5 16.5 20.5 
          Total n 3,314 3,329 3,430 3,508 3,380 3,447 3,132 23,540 
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Supplementary Table 4-13: Proportion of first positive isolates of methicillin sensitive S. aureus (MSSA) vs. methicillin resistant S. aureus (MRSA) in 
patients admitted to the public hospital system in the past 12 months by year collected. Hunter New England Local Health District, 2008 - 2014 
  
2008 2009 2010 2011 2012 2013 2014 Total 
          MSSA n 2332 2066 1901 1886 1763 1805 1819 13,572 
 
% 77.4 75.1 75.4 76.6 73.9 79.0 77.9 76.4 
          Hospital onset MRSA n 238 258 209 204 215 157 165 1,446 
 
% 8.1 9.6 8.6 8.3 9.5 7.0 7.3 8.4 
          Healthcare-associated community 
origin MRSA n 383 355 317 378 285 268 279 2,265 
 
% 13.0 13.3 13.1 15.3 12.6 12.0 12.3 13.1 
          Total n 2,953 2,679 2,427 2,468 2,263 2,230 2,263 17,283 
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Supplementary Table 4-14: Linear regression, rates of hospital onset methicillin resistant S. aureus (MRSA) per 10,000 bed days. Selected hospitals 
in Hunter New England Local Health District, 2008-13 financial years 
Hospital Coefficient 95% confidence interval R2 p-value 
Armidale 0.144 (-0.619, 0.907) 0.064 0.628 
Belmont 0.218 (-0.558, 0.994) 0.133 0.478 
Calvary Mater -0.389 (-0.809, 0.030) 0.624 0.062 
John Hunter  -0.293 (-0.453, -0.132) 0.831 0.007 
Maitland 0.059 (-0.601, 0.719) 0.015 0.816 
Tamworth -0.940 (-1.583, -0.298) 0.805 0.015 
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1. Prologue 
1.1 My role 
During my Master of Philosophy in Applied Epidemiology I was never an employee of a public 
health unit.  As such my access to outbreaks was limited and I was brought into this outbreak 
investigation to assist Queensland Health during a busy period. My primary roles were: 
 To analyse notifications of Salmonella Saintpaul from 2010-2014 and compare this 
with the characteristics of the present outbreak  
 To review Queensland Health’s draft S. Saintpaul hypothesis-generating questionnaire 
and make amendments as required 
 To conduct hypothesis-generating interviews with notified cases 
 To analyse these data and identify a potential source. 
 
In addition to these roles I participated in team meetings regarding the outbreak and provided 
Queensland Health with a short report of our investigations findings. 
1.2 Lessons learnt 
This outbreak was spread throughout Queensland, a state that is bigger than many countries.  
When I am next asked to investigate an outbreak that is widely spread by person, place or time 
I would spend more time refining the case definition prior to conducting hypothesis-
generating interviews.  This refinement could occur either through further typing of specimens 
or by focusing interviews on groups within the outbreak that are clustered by geography or 
demographics.  By doing this I would hope to increase the chance of identifying a common 
source. 
The other lesson learnt was the difficulty of administering hypothesis-generating 
questionnaires.  The period of time covered by the questionnaire was at least 11 days prior to 
the interview.  This was due to the need to ask about food consumption 4 days prior to the 
illness onset, in addition to delays in presenting for treatment and typing of the Salmonella spp.   
This delay resulted in most cases being unable to answer the four-day food history and instead 
relying on the trawling questionnaire.  
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1.3 Public health impact 
Our investigation did not identify a source of the outbreak but still had a public health impact. 
While it may seem strange that an outbreak investigation of a common organism that found 
no cause could have an impact, this was the case in our investigation due to our use of 
Multiple Locus Variable-number Tandem Repeat Analysis (MLVA). The use of MLVA in a S. 
Saintpaul outbreak has only been published once before and in our investigation this analysis 
provided further evidence that the increase in notifications were not due to a single source. 
This highlights the role that further sub-typing of S. Salmonella Spp. can play in assisting 
outbreak investigations. 
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2. Abstract 
On January 30th, 2015 an increase in notifications of S. Saintpaul in Queensland was identified 
in the OzFoodNet weekly Salmonella report. This increase in notifications followed clusters of S. 
Saintpaul in Victoria and South Australia in late 2014 leading to concerns of a possible multi-
jurisdictional outbreak. 
To identify a source of the increased notifications in Queensland two methods were used: 
hypothesis-generating interviews with cases and additional laboratory testing of samples 
through Multiple Locus Variable-number Tandem Repeat Analysis (MLVA). 
From January 1st to February 18th 2015 there were 82 notifications of S. Saintpaul in 
Queensland with notifications spread across the state.  The highest numbers of cases were in 
Metro North Hospital and Health District (HHSD), Gold Coast HHSD and Wide Bay HHSD. There 
was no clear clustering of cases in time and the epidemic curve showed a pattern most 
consistent with a common source outbreak with intermittent exposure Compared to data on 
from the previous 5 years (n=1,021), the cases in this current outbreak were older (median age 
19 vs. 13 years) with a higher proportion of males (58.5 vs. 51.0%). 
We conducted hypothesis-generating interviews with 23 cases (28.8% of notifications). The 
interviews failed to identify a clear common exposure with the highest proportion of cases 
reporting consumption of chicken and carrot (15/23, 65.2%). 
MLVA was performed on the specimens of 22 interviewed cases. This revealed 8 different 
MLVA types among these cases suggesting that notifications may not be due to a single source.  
The cost of MLVA was comparable to the cost of a traditional epidemiological investigation. 
This investigation has highlighted the role of sub-typing of Salmonella spp. in outbreak 
investigation. 
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3. Introduction 
3.1 Salmonella Saintpaul infection 
Salmonella Saintpaul is a serotype of Salmonella enterica subspecies enterica that is frequently 
isolated within Queensland.  From 2007-2011 there were 1021 notified cases of S. Saintpaul 
notified in Queensland and it is the third most frequently notified serotype of Salmonella in 
this region.1 
Like other Salmonella spp. S. Saintpaul is carried asymptomatically in the intestines or gall 
bladder of many animals, and is shed in their faeces.2 In Australia, S. Saintpaul is ubiquitous 
and has been identified in a number of animal, environmental and food sources by the 
National Enteric Pathogen Surveillance System (NEPSS).  From 2000-2015 the NEPSS identified 
289 unique non-human isolates of S. Saintpaul in Australia with the organism most frequently 
identified in bovine and canine animal specimens, with the highest numbers of positive food 
swabs isolated in goat meat and nuts.3  
S. Saintpaul is mainly transmitted by the faecal-oral route and water contaminated with animal 
faeces has been associated with infections in Queensland.  There have been 3 reported 
outbreaks of S. Saintpaul in Queensland since 1999 and all have identified contaminated water 
as the source of the outbreak.4 Taylor et al. (2000) conducted a case control study of 28 cases 
of gastroenteritis amongst a large construction site. S. Saintpaul was identified as the causative 
organism and contaminated tank water identified as the source through environmental 
sampling and confirmed by epidemiological investigations.5 Following this outbreak there have 
been 2 more outbreaks reported in Queensland involving 25 cases in total with S. Saintpaul 
isolated from water sources in both instances.4 Outside of Queensland the largest Australian 
outbreak was associated with rockmelon consumption6, while the two largest outbreaks 
internationally were due to jalapeño peppers7 and paprika.8 
Like Infection with other non-typhoidal Salmonella spp., S. Saintpaul is typically characterised 
by a self-limiting gastroenteritis.2 While the incubation period for Salmonella spp. is typically 
12-72 hours, incubation periods of up to 7 days were reported in confirmed cases of S. 
Saintpaul during a recent outbreak.7 Although Salmonella spp. infection is normally self-
limiting, it can progress to septicaemia and antibiotic treatment is recommended in infants 
less than 3 months, patients aged over 65, the immunocompromised and those with signs of 
systemic infection.9 
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3.2 Background to outbreak 
A possible outbreak of S. Saintpaul in Queensland was detected through an increase in 
notifications within OzFoodNet’s weekly Salmonella report on the 30th of January 2015. 
Further analysis of notification data in the following week showed a continued high number of 
notifications (Figure 5–1), which was an increase in baseline notifications for January (Figure 
5–2). 
 
Figure 5–1: Salmonella Saintpaul notifications by week in Australian states and territories. 
National Notifiable Diseases Surveillance System, 01/01/2013 to 06/02/2015 
 
 214 
 
Figure 5–2: Salmonella Saintpaul notifications by month in Australian states and territories. 
National Notifiable Diseases Surveillance System, January 2006 - January 2015 
At this time the Queensland Health was investigating a number of outbreaks due to Salmonella 
Typhimurium in addition to a high profile, multi-jurisdictional outbreak of Hepatitis A virus.  
Responding to these simultaneous outbreaks required a lot of resources within Queensland 
Health and the National Centre for Epidemiology and Public Health offered to assist by 
providing two Masters of Philosophy (Applied Epidemiology) scholars to conduct the 
investigation into the increased notifications of S. Saintpaul. 
There was concern that the cluster of S. Saintpaul within Queensland was part of a multi-
jurisdictional outbreak. Figure 5–1 shows 2 clusters prior to the increased cases in Queensland: 
in South Australia beginning week 47 of 2014, and in Victoria beginning week 48.  An 
investigation into the South Australian cluster revealed a high proportion of females (92%) 
with a high median age (43.5 years old).  Hypothesis-generating interviews were conducted 
with 11 cases, which identified beef as the most common food consumed (10/11, 90.9%) with 
nine cases specifying steak.  The Food Safety and Nutrition Branch of South Australian Health 
further investigated the possibility of steak as the source of this outbreak.  They concluded 
steak was an unlikely source as there were at least 5 slaughter establishments and a multitude 
more boning rooms involved in the production of the 9 steaks.  There were no additional 
findings available from the Victorian cluster.  Due to the possibility of a multi-jurisdictional 
outbreak, OzFoodNet arranged a teleconference with all jurisdictions to discuss appropriate 
next steps.   
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From this teleconference it was agreed that the major focus was an investigation to identify a 
potential common source of S. Saintpaul and that there was insufficient evidence to identify 
appropriate control measures at this time. To identify a source of the outbreak two methods 
were recommended; hypothesis generating interviews with Queensland cases and further 
laboratory testing of samples through Multiple Locus Variable-number Tandem Repeat 
Analysis (MLVA). 
MLVA is a polymerase chain reaction (PCR) based typing method based on the amplification of 
five variable number tandem repeat (VNTR) loci that exist on the Salmonella enterica 
subspecies enterica genome.  Each of the loci contain short repetitive DNA sequences that 
varying in length at each of these sites, enabling further discrimination of Salmonella Spp. than 
is possible through other typing methods such as pulsed-field gel electrophoresis or phage 
typing.10 
A team was arranged to co-ordinate this investigation which comprised of members of 
Queensland Health, OzFoodNet and National Centre for Epidemiology and Public Health 
 Russell Stafford: Senior Epidemiologist, OzFoodNet, Communicable Diseases 
Branch, Queensland Health 
 Ben Polkinghorne:  Coordinating Epidemiologist, OzFoodNet, Office of Health 
Protection, Australian Government Department of Health 
 John Bates: Chief Scientist, Public Health Microbiology, Public and Environmental 
Health, Forensic and Scientific Services, Queensland Health 
 Martyn Kirk: Convenor, Master of Philosophy in Applied Epidemiology, National 
Centre of Applied Epidemiology, Australian National University  
 Kerry Viney: Research Fellow. National Centre of Applied Epidemiology, Australian 
National University 
 Leone Malamoo: Master of Philosophy in Applied Epidemiology scholar 
 Jason Agostino: Master of Philosophy in Applied Epidemiology scholar. 
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3.3 Objectives 
The objectives of the investigation were to:  
 Describe the epidemiology of S. Saintpaul in Queensland from 2010-2014 in terms of 
person, place and time 
 Describe the current outbreak of S. Saintpaul by person, place and time 
 Refine Queensland Health’s hypothesis-generating questionnaire for S. Saintpaul 
 Interview cases using Queensland Health’s hypothesis-generating questionnaire to 
identify potential causes for the increase in infections  
 Summarise details of interviewed cases 
 Suggest appropriate next steps. 
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4. Methods 
4.1 Descriptive epidemiology S. Saintpaul notifications 2010-2014 
Line listed data of notifications of S. Saintpaul in Queensland from 1st January 2010 to 31st of 
December 2014 were analysed in Epi Info 7 to describe the characteristics of these 
notifications by person, place and time.  
Queensland Health provided estimated resident population for Queensland, disaggregated by 
Hospital and Health Service Districts (HHSDs), in order to calculate annual rates by region.  In 
addition to HHSDs, Queensland Health also divides the state into three geographical zones and 
these were used in some analyses.  Figure 5–3 shows the location of HHSDs with the red line 
delineating the three zones. 
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Figure 5–3: Hospital and Health Service Districts, Queensland, 2015. Source: 
https://www.health.qld.gov.au/maps/ 
4.2 Working case definition 
The working case definition for the investigation was: 
A person with S. Saintpaul isolated from their stool sample with date of onset after 1st January 
2015 in Queensland. 
This case definition ensured that interviewed cases were true positives. As there were no 
control measures being taken, the main priority of the case definition was to ensure cases 
definitely had the organism under investigation.  A broader definition would have captured 
other serotypes of Salmonella and there was a concurrent outbreak with S. Typhimurium.   
In developing the working definition we hoped to narrow the geographical area after analysis 
of the line listed data for this outbreak.   
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4.3 Revising the hypothesis-generating questionnaire 
Prior to starting hypothesis-generating interviews we reviewed a draft S. Saintpaul 
questionnaire created by the Queensland Health.  The questionnaire was compared to 
OzFoodNet’s ‘National Hypothesis Generating Case Questionnaire’ for Salmonella and 
assessed to whether it captured known sources of S. Saintpaul outbreaks and those commonly 
identified in non-human Australian samples supplied by the NEPSS. 
4.4 Hypothesis-generating interviews 
We aimed to complete 30 hypothesis-generating interviews on cases that had been notified to 
Queensland Health by the 18th of February 2015.  Contact was first attempted with recently 
notified cases and we then worked backwards in time through the line list.  This approach was 
in an effort to minimise time between illness and interview and improve recall.  
Data from the hypothesis-generating interviews were analysed in Epi Info 7 to describe the 
outbreak by person, place and time and to describe the frequency of exposures. 
4.5 Multiple locus variable number tandem repeats analysis typing 
MLVA typing was performed by Queensland Health’s reference laboratory.  Five primer pairs 
were used to amplify the 5 VNTR targets (STTR9-STTR5-STTR6-STTR10pl-STTR3) and PCR 
products were sized by capillary electrophoresis. Fragment sizes were assigned a numerical 
code based on the coding system of Lindstedt et. al (2004).11 
Though there are 5 loci on which the final numeric code is based, only three loci (STTR3, STTR5 
and STTR9) are applicable to S. Saintpaul.  The STTR9 tends to be stable for S. Saintpaul and 
does not vary, so discrimination between strains is usually based on STTR3 and STTR5 loci 
only.  
In other Salmonella spp. there are accepted methods for assessing relatedness between 
similar MLVA types.  These methods analyse variation in the STTR5, STTR6, and STTR10pl loci.  
The most commonly used method in Australia considers variation of no more than 2 repeats at 
1 locus to be ‘probably’ related.12   
4.6 Cost analysis 
As MLVA typing of S. Saintpaul is not done routinely, a simple cost analysis comparing MLVA 
typing to the costs involved with a standard epidemiological investigation involving public 
health unit staff was conducted.   
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The Chief Scientist in the microbiology unit provided costs for MLVA, including labor. Wage 
costs were taken from the Queensland health professional award and the hours for the 
epidemiological investigation were estimated from the time taken to conduct and analyse the 
hypothesis generating interviews in addition to the time coordinating the investigation by 
senior staff. 
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5. Results 
5.1 Salmonella Saintpaul in Queensland 2010-2014 
From 1st of January 2010 to 31st of December 2014 there were a total of 1046 notifications of S. 
Saintpaul in Queensland.  These notified cases had a median age of 13 years old (Inter Quartile 
Range (IQR) 2, 41) and a male to female ratio of 1 to 1 (533:513). Over one third of 
notifications were in children age 0 – 4 years (n = 384, 36.7%).    
An epidemic curve of notifications (Figure 5–4) shows a seasonal variation, with a higher 
number of notifications in the summer months.    
 
Figure 5–4: Monthly S. Saintpaul notifications. Queensland 2010-2014 
Figure 5–5 shows that the greatest notifications were in the Townsville, Central and Metro 
South Hospital and HHSD. Dividing notifications into the three zones in Figure 5–3 reveals that 
from 2010-2014 the North had more than twice the number of notifications than would be 
expected for its population size (36.2% (379/1046) of notifications vs. 15.5% of Queensland 
population).  
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Figure 5–5: S. Saintpaul notifications and average annual rate per 100,000 population by 
Hospital and Health Service District. Queensland 2010-2014 
5.2 Current outbreak 
5.2a Demographics 
From the 1st January 2015 to 18th February there were 82 notifications.  
The demographics of this outbreak differed to Queensland data from the previous five years. 
Table 5–1 shows that there were a higher proportion of males and a higher median age.  Cases 
were distributed throughout Queensland with cases in all but one HHSD; however, there were 
a higher proportion of cases from metropolitan districts in South East Queensland.  
Table 5–1: Comparison of selected characteristics S. Saintpaul notifications. Queensland, 
01/01/2015 – 18/02/205 & 01/01/2010 – 31/12/2014 
Variable 2015 (n=82) 2010 - 2014 (n=1046) 
Median age 19 13 
Male   n (%) 48 (58.5) 533 (51.0) 
 Top 5 Hospital and Health 
Service districts 
Metro North 
Gold Coast 
Wide Bay 
Townsville 
Sunshine Coast 
Townsville 
Central  
Metro South 
Mackay 
Wide Bay 
The higher proportion of males was due primarily to notifications amongst the 0-4 year old age 
group (Figure 5–6). 
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Figure 5–6: S. Saintpaul notifications by age group and sex. Queensland, 01/01/2015 – 
18/02/2015 
5.2b Epidemic curve 
An epidemic curve of notifications (Figure 5–7) showed a pattern most consistent with a 
common source outbreak with intermittent exposure.  There was no clear clustering of 
notifications within the three geographical zones. 
 
Figure 5–7: S. Saintpaul notifications by date of onset and zone. Queensland 01/01/2015 – 
18/02/2015 
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5.2c Hypothesis-generating interviews 
Before conducing interviews we revised Queensland Health’s draft S. Saintpaul questionnaire.  
The questionnaire strongly correlated with the OzFoodNet questionnaire and required few 
amendments.  The only significant changes were adjustment to the question on Aboriginal and 
Torres Strait Islander status to meet best practice data collection of this item, and the addition 
of a section on meat consumption due to the concern raised by the South Australian cluster 
that this outbreak may be related to beef products (Appendix A). 
While we aimed to conduct 30 interviews, a cyclone in Queensland interrupted data collection 
and data collection ceased after 23 interviews had been completed.  The 23 interviews 
covered cases with date of onset on the 14th of January through to the 11th of February.   
The median time from onset of illness to time of interview was 20 days (IQR 15, 23).  This was 
due to delay in onset of illness to presentations and then from specimen collection to 
notification and finally from notification to interview (Figure 5–8).  This delay resulted in most 
cases being unable to answer the 4-day food history and instead relying on findings of the 
trawling questionnaire. 
 
Figure 5–8: Days from onset of illness to hypothesis generating interview for interviewed 
cases of S. Saintpaul 
The most common exposures were chicken and carrot which were reported in 65.2% (15/23) 
of the cohort (Table 5-2). Sub-group analysis was done by geographical zone and on the under 
four cohort and this did not reveal any common exposures. 
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Table 5–2: Commonly reported exposures for interviewed cases of S. Saintpaul. Queensland, 
14/01/2015 – 11/02/2015 (n=23) 
Exposure n (%) 
Chicken (fresh) 15 (65.2) 
Carrot 15 (65.2) 
Banana 14 (60.9) 
Iceberg lettuce 13 (56.5) 
Raw tomato 13 (56.5) 
Packaged Ham 12 (52.2) 
Cucumber 12 (52.2) 
Egg 11 (47.8) 
Mince (fresh) 11 (47.8) 
Beef sausage 11 (47.8) 
Packaged Bacon 11 (47.8) 
BBQ chicken  10 (43.5) 
Grapes 10 (43.5) 
Tank water 9 (39.1) 
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5.2d MLVA typing 
MLVA typing was performed on 22 of the 23 interviewed cases.  
Amongst the 22 cases there were 8 MLVA types.  Variation only occurred in the STTR5 locus, 
which varied from 9 to 19 repeats.  Two MLVA types accounted for half of the interviewed 
cases: MLVA 02-16-00-00-490 and MLVA 02-19-00-00-490.  An epidemic curve for the 
interviewed cases shows no clear clustering of these MLVA types (Figure 5–9). 
 
Figure 5–9: Date of onset of interviewed cases of S. Saintpaul by Multiple Locus Variable-
number Tandem Repeat Analysis (MLVA). Queensland, 14/01/2015 – 11/02/2015 
5.3 Review of updated notifications 
Our hypothesis generating interviews found no food or water source on which to focus further 
investigation and MLVA suggested up to eight different types of S. Saintpaul were responsible 
for the increased cases.  Prior to ending the investigation we requested an additional line list 
of data to determine whether the increased cases were continuing. 
Figure 5–10 shows notifications up to the 28th of February.  Aside from a spike on the 19th of 
February, notifications had begun returning to baseline levels.  The 5-year median for 
notifications in February was 34 and there were 44 notifications in February 2015.  This was in 
contrast to January where there were 67 notifications, almost 3 times the 5-year median of 23.   
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Looking more closely at the spike on the 19th of February, the 6 cases were spread across 5 
HHSDs.   Given this return towards baseline levels and no geographical clustering we decided 
to end the investigation. 
 
Figure 5–10: S. Saintpaul notifications by zone. Queensland 01/01/2015-28/02/2015 
5.4 Cost analysis 
The cost of MLVA typing, including staffing costs, was estimated at $150 per specimen.  This 
resulted in an estimated cost of $3,300 for the 22 specimens. 
The staffing costs for the epidemiological investigation were estimated at $4,072 and the 
breakdown of costs is outlined in Table 5-3. In addition to the time conducting and analysing 
the hypothesis generating interviews by junior staff, senior public health staff were involved in 
coordinating the investigation and participating in a number of team meetings. It took two 
junior epidemiologists approximately one week each to conduct the hypothesis generating 
interviews and analyse the data. 
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Table 5–3: Costs of epidemiological staff to conduct hypothesis-generating interviews for 
Salmonella Saintpaul outbreak in Queensland, February 2015. 
Team member Hourly rate Hours Total 
Junior epidemiologist $38 80 $3,040 
Coordinating 
epidemiologist, 
OzFoodNet 
$48 16 $768 
Senior epidemiologist, 
Queensland Health 
$66 4 $264 
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6. Discussion 
In our investigation MLVA typing provided additional evidence that S. Saintpaul notifications 
were not due to a common exposure.  Our hypothesis-generating interviews failed to identify 
a common food or water source and MLVA found at least eight different types were 
responsible for the increased notifications.  This raises the question ‘should MLVA have been 
performed before the hypothesis-generating interviews?’ 
MLVA is a relative quick and cheap procedure.  The cost per sample is approximately $150 and 
typing can be performed within 48 hours.  When comparing the costs of MLVA to a 
‘traditional’ epidemiological investigation, the comparative costs were similar but conducting 
interviews came at an opportunity cost for epidemiologists.  Due to increasing time pressures 
placed on public health units, it seems an attractive option to perform MLVA prior to other 
investigations into increased S. Saintpaul notifications.   
However, the utility of MLVA for S. Saintpaul is limited due to a lack of evidence on the 
relatedness of different MLVA types.  In other Salmonella spp. it is accepted that outbreak 
strains may be traced to differing, but related, MLVA types.13 However, the research on 
relatedness of MLVA in Salmonella spp. has focused on S. Typhimurium.  In contrast there is 
little information on MLVA of S. Saintpaul with only one investigation that used MLVA 
identified on a Pubmed literature search.  This investigation was of a multi-jurisdictional 
outbreak in Australia that was associated with rockmelon consumption.6 In this outbreak 115 
cases across 6 States and Territories had the same MLVA type (MLVA 01-11-00-00-05) and this 
type was also identified on rockmelon skin from cases place of purchase.  These results suggest 
that outbreak strains of S. Saintpaul may be traced to a single MLVA type.  However this is in 
contrast to accepted practice for other Salmonella spp. in Australia where cases in point 
source outbreaks of S. Typhimurium have had related MLVA types.14 
There are a number of methods for classifying MLVA types of S. Typhimurium as related, based 
on variation in the STTR5, STTR6, and STTR10pl loci.  Dimovski et al (2014) proposed a method 
where any variation restricted to 1 of these loci is described as related.13 However, in Australia 
the most commonly used method was described by Wang (2007) and considers variation of no 
more than 2 repeats at 1 of these loci to be ‘probably’ related.12 If we applied Dimovski’s 
method to our investigation, all of the MLVA types would be considered related, while using 
Wang’s method would result in the most prevalent MLVA type (MLVA 02-16-00-00-490) having 
an additional 6 related cases. This suggests that we could have refined the case definition in 
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our investigation based on MLVA, either by applying Wang’s method or by restricting cases to 
one MLVA type. 
Restricting cases based on MLVA had a mixed impact on our findings. Using Wang’s method, 
the prevalence of exposures showed no change, nor did they change when limiting cases to 
MLVA 02-16-00-00-490 alone. But when restricting cases to the other common MLVA type 
(MLVA 02-19-00-00-490) we identified a geographical cluster with all but one case located 
within the Gold Coast HHSD and the other case also within the South zone. All cases had 
consumed egg, but this finding is limited by a sample size of 5. Despite this small sample, the 
clustering of cases by location is encouraging and suggests MLVA may have a role in 
investigations of S. Saintpaul when used alongside other epidemiological evidence. 
Another finding in support of MLVA was that the 2 cases with the strongest evidence of a 
common source from the hypothesis-generating interviews also had a common MLVA type.  
Two cases from the Darling Downs HHSD were related to one another and lived 30 minutes’ 
drive apart.  In the incubation period they had shared one meal and also shared drinking water 
from the same water tank.  These cases had a common MLVA type (MLVA 02-09-00-00-490), 
which was not identified in any other cases.  While this observation again supports the finding 
that S. Saintpaul may be traced to a single MLVA type, further studies on relatedness are 
required before MLVA of S. Saintpaul could be used independent of other epidemiological 
evidence.  
While there remain some gaps in our knowledge on MLVA of S. Saintpaul, our investigation has 
highlighted the role of MLVA, and other discriminatory techniques, in refining the case 
definition of clusters of Salmonella Spp.  MLVA is routinely used in refining the case definition 
for clusters of S. Typhimurium15 and our findings suggest that it has a role in refining clusters of 
S. Saintpaul prior to conducting hypothesis-generating interviews if used alongside other 
evidence. 
If the eight MLVA types identified in our investigation were unrelated, this explains why the 
hypothesis generating interviews did not identify a potential source.  By categorising all eight 
MLVA types as the same outbreak of S. Saintpaul we have used a non-specific case definition 
and biased the findings towards the null hypothesis.  If our investigation had identified a 
suspected source, the next step would have been to conduct a study to test the hypothesised 
source. The most appropriate study design to test this hypothesis would have been a case-
control study due to the absence of a clear ‘at-risk’ group. 
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This outbreak investigation has highlighted the need to refine a case definition as much as 
possible before beginning hypothesis-generating interviews.  While there were 82 cases in the 
outbreak, these were spread across an area over 7 times the size of the United Kingdom. There 
was some urgency to begin hypothesis-generating interviews due to the concern of a multi-
jurisdictional outbreak and attempting to refine the case definition by geography initially 
appeared unhelpful.  However, we may have had a better chance of identifying a source if we 
restricted interviews to cases in the South East corner of Queensland.   The increased 
notifications in this area were an unusual feature of this outbreak in comparison to historical 
data and this warranted further investigation.  If MLVA had been performed in real time, these 
results may have also identified the cluster in South East Queensland and MLVA may have 
been used to refine the case definition. Our study has highlighted the potential of MLVA as a 
tool in defining cases in future outbreaks of S. Saintpaul. 
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Appendix 
Draft Queensland Health questionnaire for Salmonella Saintpaul 
 
 
 
 
“Hello, my name is ______________________________________ and I’m calling from QLD 
Dept of Health.  
 
May I please speak with ___________________________________________ (name of case 
or parent)?” 
 
QLD Dept of Health is conducting an investigation into a recent increase in cases of Salmonella 
infection in the community. I understand (case name) recently had a gastroenteritis caused by 
a Salmonella infection? Salmonella infections are notifiable to the Qld Dept of Health by doctors 
and laboratories. We would like your assistance in answering some questions regarding your 
(or case’s name) illness, travel history and foods that were eaten prior to becoming ill. It should 
only take 15 – 20 minutes to complete. The information collected is kept confidential and no 
identifying information is released without your consent. Can I proceed with the interview?’ 
 
 
Note: The following preliminary information can be recorded prior to 
interview if known 
 
Personal details 
 
First Name: ____________________________ Address: 
 __________________________________ 
 
Last Name: ____________________________  
 __________________________________ 
 
Telephone: ______________________ (Home)  
 __________________________________ 
 
                    ______________________ (Work) Post Code: _________ 
 
Date of Birth:  _____ / _____ / ________  Age:  ______  Gender:    Male / 
Female  
 
 
Do you identify as being of Aboriginal or Torres Strait Islander Origin.  
 
No / Unknown / Aboriginal / Torres Strait Islander / Both Aboriginal Torres Strait Islander. 
____________________________________________________________________________
__________ 
Medical & diagnostic information 
 
Attempt Date Time Outcome 
 1 ___ / ___ / _______ _______  am / pm _________ 
2 ___ / ___ / _______ _______  am / pm _________ 
3 ___ / ___ / _______ _______  am / pm _________ 
4 ___ / ___ / _______ _______  am / pm _________ 
Interviewer:___________
_____ Call Outcomes 
OC1 – No Answer 
OC2 – Subject not home, 
call back 
OC3 – Appointment to call 
back 
OC4 – Refusal 
OC5 - Interviewed 
 233 
Treating GP: ___________________________________ Telephone:  
______________________ 
 
Medical Practice:  
_____________________________________________________________________ 
 
Salmonella: ____________________________ Phage Type (if known): 
________________________ 
 
Specimen type: _________________________ Collection Date:_____ / _____ / _____ 
Day:________ 
 
 
 
Clinical details 
 
‘We would like to obtain some detail on your Salmonella infection and the symptoms 
you experienced.’ 
 
1. During your illness, did you experience any of the following symptoms? 
 
 
Y
e
s
 
N
o
 
D
K
/N
S
 
 
 
   
 
Vomiting……………………....     
Diarrhoea……….………….....     
Stomach Cramps…….….…...     
Blood in stools………………..     
Nausea…………………...…...     
Fever……………………….….     
Other symptoms……………     
Specify: __________________________________________________ 
 
2. What date and time did (your / your child’s) gastrointestinal symptoms begin?  
 (Vomiting, diarrhoea or stomach cramps only)  
 
    _____/_____/_____ ______   AM  / PM 
    
 
3. For how long did (your / your child’s) diarrhoea or vomiting symptoms last? 
___________  
(Specify in days) 
 
4. (Were you / Was your child) admitted to hospital overnight for this illness? 
  
 Yes……………………………………… 1  Hospital Name: 
_____________________________ 
 No………………………………………. 2   
 Don’t Know / Not Sure……………….. 3   
 
 
 
 
Exposure Information 
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5. In the five days prior to (your / your child’s) illness did (you / your child) have 
contact with anyone with a similar illness such as friends, family members, work 
colleagues, etc…? 
 
 Yes……………………………………… 1 Specify 
 ________________________________ 
 No………………………………………. 2  
 ________________________________ 
 Don’t Know / Not Sure……………….. 3  
 ________________________________ 
 
 
6. CASES 15 YEARS+  
When your symptoms began, were you employed as a health care worker, child-
care worker or food preparer / food handler? 
 
 Yes……………………………………… 1 Specify 
_______________________________ 
 No………………………………………. 2   
 Don’t Know / Not Sure……………….. 3   
 
 
 
 
 
7. CHILDREN <14 YEARS  
Did your child attend childcare, daycare or school in the week prior to illness? 
 
 Yes……………………………………… 1  Name of facility 
_______________________________ 
 No………………………………………. 2   
 Don’t Know / Not Sure……………….. 3   
 
Travel 
 
8. In the five days prior to (your / your child’s) illness, did (you / your child) travel 
overseas, to another state or territory or anywhere within the state? 
 
 Yes……………………………………… 1 Location 
_______________________________ 
 No………………………………………. 2   
 Don’t Know / Not Sure……………….. 3   
 
IF OVERSEAS TRAVEL – END INTERVIEW 
 
Social Events / Functions 
 
In the five days prior to (your / your child’s) 
illness…  
 
Y
e
s
 
N
o
 
D
K
/N
S
  
 
Details 
9. Did (you / your child) attend any large 
gatherings where food was consumed? 
Eg. weddings, social events, clubs, 
church, parties, festivals, fairs or BBQ’s? 
............ 
 
 
 
 
 
 
 
 
 
 
 
___________________ 
 
___________________ 
 
___________________ 
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      Go to 10 
Gathering / Outing Date Location 
 
1. 
____________________ 
___ / 
____ / 
_____ _____________________________________________ 
 
2. 
____________________ 
___ / 
____ / 
_____ _____________________________________________ 
 
 
Food Outlet Exposures 
 
10. In the five days prior to (your / your child’s) illness, did (you / your child) eat food 
from any of the following places? 
  
Y
e
s
 
N
o
 
D
K
/N
S
 
Food Item 
  Food Outlet 
Details  
& Location 
 Restaurant (sit 
down)……..…….    
    
 Takeaway / Fast food 
outlets…..    
    
 Bakery…………………...............        
 Temporary  food stall  
(eg. markets, fetes, 
festivals).….    
    
 Salad / sandwich bar….….…….        
 Other (specify) 
_________________________    
    
         
Fruit & Vegetables 
 
11. In the five days prior to (your / your child’s) illness, did (you / your child) 
consume any of the following? 
 
 
Y
e
s
 
N
o
 
D
K
/N
S
 
Food Item 
Additional Info 
 
 
Place of Purchase / 
Consumption 
/Locality 
Fruits 
    
  
  
 Mangos……………………...        
 Pawpaw……………………..        
 Apples……………………….        
 Apricots……………………..        
 Avocados……………………        
 Bananas…………………….        
 Berries………………………        
 Cherries……………………..        
 Coconut……………………..        
 Oranges……………………..        
 Mandarins…………………..        
 Grapefruits………………….        
 Kiwi fruit……………………..        
 Grapes………………………        
         
 Peaches…………………….        
 Pears………………………..        
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 Pineapples………………….        
 Plums………………………..        
 Water melon………………..        
 Rockmelon / cantellope……        
 Other fruit…………………...        
 
 
 
Y
e
s
 
N
o
 
D
K
/N
S
 
Food Item 
Additional Info 
 
 
Place of Purchase / 
Consumption 
/Locality 
Vegetables 
    
  
  
 Lettuce……………………...        
 Bagged lettuce……………..        
 Other lettuce………………..        
 Uncooked tomatoes……….        
 Semi/sun-dried tomatoes...        
 Raw celery………………….        
 Uncooked broccoli…………        
 Uncooked shallots…………        
 Asparagus…………………..        
 Beans………………………..        
 Beets………………………...        
 Cabbage…………………….        
 Carrots………………………        
 Capsicum        
 Chilli        
 Corn / baby corn……………        
 Cucumber…………………..        
 Eggplant…………………….        
 Alfalfa / bean sprouts………        
 Other uncooked vegetables        
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Y
e
s
 
N
o
 
D
K
/N
S
 Food Item 
Additional Info 
 
 Place of Purchase / 
Consumption 
/Locality 
 Pre-prepared 
coleslaw…….    
  
  
 Pre-prepared salad 
mix……    
  
  
 Pre-prepared potato 
salad.. 
     
  
 Pre-prepared bean 
salad….    
  
  
 
12. Where do you usually purchase fruit and vegetable from? (incl roadside stalls 
and home grown) 
     
    Store      Store Location 
 Woolworths………………………………    
 ___________________________ 
 Coles…………………………………….    
 ___________________________ 
 IGA……………………..………………..    
 ___________________________ 
 Aldi .………………………………………    
 ___________________________ 
 Fruit store / grocery…………………….    
 ___________________________ 
 Food Markets…………………………..    
 ___________________________ 
 Other…………………………………….    
 ___________________________ 
    Don’t Know / Not Sure……..…………..    
 
Meat, poultry & egg consumption 
 
12. In the five days prior to illness, did you / your child consume any … 
 
 
 
Y
e
s
 
N
o
 
D
K
/N
S
 
 
Food Item 
 
 
Place of Purchase / 
Consumption / 
Locality 
    
  
  
 Eggs 
(fried, poached, 
scrambled)    
  
  
 Egg dishes (e.g. 
quiche).....    
  
  
 Foods with raw eggs  
(e.g. egg nog, 
hollandaise sauce, 
mayonnaise)………. 
 
   
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13. Where did (you / your child) obtain the eggs that were eaten in the five days prior 
to illness? 
 Home chickens………….………………   
 Direct from farm….…….……………….  Specify: 
______________________________________ 
 Supermarket …………………………….  Specify: 
______________________________________ 
 Supplied by friend / relative..…………  Specify: 
______________________________________ 
 Other………………………..……………;. Specify: 
______________________________________ 
 Don’t Know / Not Sure………..………..    
 
14. What types of eggs were consumed in the five days prior to illness? 
 Free range……………….………………   
 Organic………..….…….……………….   
 Caged ……. …………………………….   
 Barn laid…..…………………..…………   
 Other ……………………….…………….. Specify: 
______________________________________ 
 Don’t Know / Not Sure………..………..    
15. In the five days prior to (your / your child’s) illness did (you / your child) consume 
any …? 
 
 
 
Y
e
s
 
N
o
 
D
K
/N
S
 
  H
o
m
e
 
c
o
o
k
e
d
 
C
o
o
k
e
d
 
e
ls
e
w
h
e
re
 
Place of Purchase / 
Consumption  
(if other than home) 
  
Chicken…….………..……...    
  
   
 Duck ……….………..……...         
 Turkey .…….………..……...         
 Frozen poultry………..…….         
 BBQ 
chicken…………..……    
  
   
 Chicken 
kebabs……….……    
  
   
 Other chicken dishes          
 Specify: _______________         
 (e.g. wraps, salads etc…) 
 
16. If chicken consumed at home, what type of chicken was purchased? 
 
 
 
Y
e
s
 
N
o
 
D
K
/N
S
 
  P
u
rc
h
a
s
e
d
 
F
ro
z
e
n
 
P
u
rc
h
a
s
e
d
 
F
re
s
h
 
  
Whole chicken……..…………………...    
  
  
 Chicken breast……………..…..……...        
 Chicken pieces (thigh, wing, leg) …...        
 Other _________________________        
 
 
13. Where do you usually purchase chicken from? 
     
    Store      Store Location 
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 Woolworths………………………………    
 ___________________________ 
 Coles…………………………………….    
 ___________________________ 
 IGA……………………..………………..    
 ___________________________ 
 Aldi .………………………………………    
 ___________________________ 
 Fruit store / grocery…………………….    
 ___________________________ 
 Food Markets…………………………..    
 ___________________________ 
 Other…………………………………….    
 ___________________________ 
 Don’t buy chicken……..………………..    
    Don’t Know / Not Sure……..…………..    
17. In the five days prior to (your / your child’s) illness did (you / your child) consume 
any …? 
 
 
 
Y
e
s
 
N
o
 
D
K
/N
S
 
  H
o
m
e
 
c
o
o
k
e
d
 
C
o
o
k
e
d
 
e
ls
e
w
h
e
re
 
Place of Purchase / 
Consumption  
(if other than home) 
  
Pre-frozen hamburger 
patties eaten at home……..    
  
   
 Fresh hamburger patties 
eaten at home (rissoles)....    
  
   
 Anything made with 
minced beef eaten at 
home..……...    
  
   
 Other beef (steak, roast 
etc)…………………………..    
  
   
 Pork         
 Lamb         
 Game meat or offal         
 Seafood (eg fish, shellfish)         
  
 
18. In the five days prior to (your / your child’s) illness did (you / your child) consume 
any …? 
 
 
Y
e
s
 
N
o
 
D
K
/N
S
 
 
 
 
Type/Brand 
Place of Purchase / 
Consumption  
(if other than home) 
 Sausages – prompt 
type 
 
   
 sausages – prompt 
type 
Y / N Beef 
Y / N Lamb 
Y / N Chicken 
Y / N Pork  
 Any pre-packaged 
sliced deli meats 
   
 Y / N ham 
Y / N chicken 
Y / N turkey  
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Y / N corned beef 
Y / N pastrami  
Y / N Roast beef  
Y / N Mortadella 
Y / N Devon 
Y / N Strasburg 
Y / N Kabana 
Y / N Specify Other  
 Any other sliced deli 
meats (not pre-
packaged) 
   
 Y / N ham 
Y / N chicken 
Y / N turkey  
Y / N corned beef 
Y / N pastrami  
Y / N Roast beef  
Y / N Mortadella 
Y / N Devon 
Y / N Strasburg 
Y / N Kabana 
Y / N Specify Other  
 
 Frankfurts      Deli / Pre-packaged.  
 Salami/pepperoni     Deli / Pre-packaged  
 Bacon     Deli / Pre-packaged  
 
Animal & environmental exposure 
 
18. In the five days prior to (your / your child’s) illness, did (you / your child) come in 
close contact or touch any of the following: 
 
 
 
Y
e
s
 
N
o
 
D
K
/N
S
 
Details 
 
 Locality 
Animal Contact 
   
  
  
Farm 
animals………………..…...    
  
 
 
Animals, birds or reptiles 
from a petting zoo or animal 
sanctuary    
  
 
 
Household pets (dogs, cats, 
guinea pigs, reptiles, birds 
etc).    
  
 
 
Native animals (kangaroos, 
possums, wallabies, etc) 
……….    
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Water consumption & contact 
 
 
 
 
Y
e
s
 
N
o
 
D
K
/N
S
 
Details 
 
 Locality 
19. Did (you / your child) drink or have contact with 
water from any of the following sources in the five 
days prior to illness? 
 
 
  
 Drink tank / rain 
water........    
  
  
 Drink river / stream 
water     
  
  
 Drink bore 
water.................    
  
  
 Swimming (ocean, 
pool, lake, river etc.) 
……………..    
  
  
 Bottled 
water………………..    
  
  
 
 242 
On the day the illness began, what was eaten for breakfast, lunch and dinner?                                  
  Mon / Tue / Wed / Thurs / Fri / Sat / Sun         Date:     ____/ _____ / _______ 
  
 
Breakfast 
(Include condiments and sauces) 
Place of Consumption / Purchase 
(Circle home if meal was prepared at home otherwise 
specify) 
 Home  
 Home  
 
  
Lunch 
(Include condiments and sauces) 
Place of Consumption / Purchase 
(Circle home if meal was prepared at home otherwise 
specify) 
 Home  
 Home  
 
 
Dinner 
(Include condiments and sauces) 
Place of Consumption / Purchase 
(Circle home if meal was prepared at home otherwise 
specify) 
 Home  
 Home  
 
On the day before the illness began, what was eaten for breakfast, lunch and dinner? 
   Mon / Tue / Wed / Thurs / Fri / Sat / Sun         Date:     ____/ _____ / _______  
  
 
Breakfast 
(Include condiments and sauces) 
Place of Consumption / Purchase 
(Circle home if meal was prepared at home otherwise 
specify) 
 Home  
 Home  
 
 
Lunch 
(Include condiments and sauces) 
Place of Consumption / Purchase 
(Circle home if meal was prepared at home otherwise 
specify) 
 Home  
 Home  
 
 
Day of Onset of Illness 
1 Day Prior to Onset of Illness 
Snacks eaten: 
Snacks eaten: 
Snacks eaten: 
Snacks eaten: 
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Dinner 
(Include condiments and sauces) 
Place of Consumption / Purchase 
(Circle home if meal was prepared at home otherwise 
specify) 
 Home  
 Home  
 
Etc. for 4 days. 
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Appendix A: Review of literature 
Introduction 
Poor growth from conception to two years of age has lifelong implications for the health of the 
individual. Being underweight in early childhood is associated with increased childhood 
morbidity and mortality1 as well as impaired cognitive function, decreased school completion 
rates, shorter adult height and impaired earning capacity as an adult.2-4  
My research is on early childhood growth in the remote communities of Cape York.  It has four 
main objectives: 
 To assess time trends in the proportion of underweight children in the first two years 
of life. 
 To assess time trends in the proportion of children born Small for Gestational Age 
(SGA)  
 To quantify the proportion of underweight children who were born SGA. 
 To explore whether changes in social policy and health service delivery in these 
communities may be associated with changes in indicators of child growth.  
Research question 
The aim of my literature review was to identify and critique literature on the prevalence of 
underweight amongst Aboriginal and Torres Strait Islander infants.  The research question for 
the review was ‘what is the existing knowledge regarding the prevalence of underweight and 
the timing of growth faltering amongst Aboriginal and Torres Strait Islander infants?’ The 
population of interest is Aboriginal and Torres Strait Islander children aged zero to two years 
old.  For the purposes of this review the term ‘infant’ is used to describe this age group as this 
is consistent with the Medical Subject Heading (MeSH) definition.  The outcome of interest is 
the pattern of growth, in particular the level of underweight infants and the timing of growth 
faltering.  While there was no specific comparison group, infants within the studies are 
compared to growth charts derived from population surveys. 
This review has important implications for my research on early childhood growth in Cape York 
communities.  The research question focuses on the first objective of my study: To evaluate 
time trends in the proportion of underweight children in the first two years of life.   Through 
this review I aim to determine what gaps exist in the literature and how my results on 
underweight infants relate to other studies within Aboriginal and Torres Strait Islander 
communities. 
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Search methods 
 
My literature review involved a systematic search of the published literature as well as a scan 
of the grey literature.  The Pubmed database was searched using the MeSH terms ‘Oceanic 
Ancestry Group’ AND ‘Infant’ AND ‘Growth’. This search yielded 114 results which included 
many results for other Oceanic groups such as Maori and Polynesian.  The keyword ‘Aboriginal’ 
was added to the search which restricted the results to 74 articles.     
The abstracts of these 74 articles were read and additional inclusion criteria were applied.   
These criteria were that the studies were original research, conducted in a community setting 
(i.e. not based on hospital data) and had measurements after birth and before two years of 
age.  Applying these inclusion criteria 16 studies were identified.  For the purposes of this 
literature review, I restricted my analysis to studies published in the last 20 years.  This left five 
studies, with the most recent study published in 2000. 
In an effort to identify more recent results, I conducted a scan of the grey literature.  The 
Aboriginal and Torres Strait Islander sections of the websites for the Australian Bureau of 
Statistics (ABS), the Australian Institute of Health and Welfare (AIHW), relevant State and 
Territory health departments and Edith Cowan Universities Australian Indigenous 
HealthInfoNet were scanned for articles on children, nutritional status and growth and the 
same inclusion criteria as above were applied to potential articles.  This search of the grey 
literature yielded a further article. 
The references from all six articles were scanned for any further relevant literature but yielded 
no results.  However, through my academic network I was aware of a study that was of 
particular relevance for my research but not found in my search strategy as it has not been 
published in the peer reviewed literature.  I was able to locate this thesis and this has been 
included within the literature review. 
A flowchart of the literature search strategy is shown in figure A-1 
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Figure A-1: Flowchart of literature search 
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Table A-1: Summary of studies identified in literature search 
Author, 
year, region 
and sample 
size (n) 
Study Aims Methods Key results  
(relating to growth from 0-24 months) 
Main limitations 
Thurber 
20125 
 
Children 
from 11 sites 
across 
Australia.  
Mix of urban 
and remote.   
 
n = 1719 
To assess the validity of 
the anthropometric data 
collected in the 
Longitudinal Study of 
Indigenous Children 
(LSIC) and explore the 
association between 
birth weight and 
childhood Body Mass 
Index (BMI) in this 
sample. 
Anthropometric data: 
Measured by research 
assistants with standardised 
equipment or transcribed from 
mother’s baby health book.  
However, in up to 22% of 
cases, the parents measured 
weights themselves. 
 
Gestational age and birth 
weight: Mothers recall or 
information in mother’s baby 
health book. 
 
Growth Standards:  
World Health Organisation 
(WHO) growth standards 
Results from first two waves of younger 
cohort. 
 
Wave 1 
Stunted 20% 
Underweight 3% 
Overweight 22% 
 
Wave 2 
Stunted 9% 
Underweight 5% 
Overweight 12% 
 
Overall birth weight and later growth 
A one unit increase in birth weight z-score 
associated with 0.166 increase in BMI for 
age z-score. 
High levels of missing or implausible data.   
Height data – 20% 
Weight data – 16% 
BMI – 24% 
 
Likely systematic measurement bias:  Missing 
data most likely amongst younger children, 
those with highest level of relative isolation 
and Torres Strait Islander.  
 
Likely systematic measurement bias:  First 
wave of study had high prevalence of low 
height for age.  Attributed to difficult to use 
equipment. 
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Health 
Service 
Information 
branch, 
Department 
of Health and 
Families, 
Northern 
Territory 
(NT) 
Government. 
20116 
 
Rural areas 
of NT 
 
n = 3525 
 
To improve the growth 
and nutritional status of 
children 0-5 living in NT 
remote areas. 
 
Intervention: Health under 5 
Kids program.  (An education 
program delivered to health 
staff on assessment and 
treatment of growth and 
nutrition.) 
 
Anthropometric data: Not 
stated how weights and 
heights are collected.  Unclear 
how measurements are 
selected when >1 
measurement exists 
 
Growth standards: Reports 
against both the WHO growth 
standards and the Centres for 
Disease Control (CDC) growth 
standards. 
 
Coverage of 88% of estimated population 
 
Combined results 0-5 
Underweight: 8% 
Stunted: 14% 
Wasted: 5% 
 
By age group 
Underweight 
<12 months: 9% 
1<3yrs: 8% 
Stunted 
<12 months: 13% 
1<3yrs: 17%  
Wasted 
<12 months: 7% 
1<3yrs: 4% 
 
No apparent time trend for underweight, 
stunting or wasting from 2006-2010 
 
 
 
Not clear if premature infants age was 
corrected (i.e. taken from due date rather than 
date of birth) 
 
Poor follow-up of children who were reported 
as underweight, wasted or stunted in 2009.  
15% of children who were underweight, 32% 
of children who were wasted and 26% of 
children who were stunted were not measured 
in 2010. This compares to  
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Smith et al.  
20007 
 
Five remote 
communities 
in Kimberley 
and Pilbara.  
Northern 
Western 
Australia 
 
Sample: 247  
Control: 204 
Intervention: 
43 
 
 
To improve, by culturally 
appropriate means, the 
birth weights and 
growth of children up to 
three years of age 
 
Intervention:  Periodic 
nutritional assessment and 
counselling from (presumably) 
non-Indigenous nutritional 
consultant as well as the 
Strong Women, Strong Babies, 
Strong Culture program 
delivered by local women. 
 
Gestational age: determined 
from hospital records from 
best clinical estimate. 
 
Anthropometric 
measurements: 
Intervention group: Bare 
weight and supine height taken 
by nutritional consultant. 
Control group: All retrievable 
records transcribed from clinic 
files. Unclear how 
measurements are selected 
 
Results divided into preterm and term 
births. 
 
Term births: 
Mean weight for age (WFA) above NCHS 
standards to 6 months of age.  Then 
flattening of growth.  Mean weight up to 
400gm below 25th percentile of NCHS 
standards. 
 
Mean WFA similar to WHO growth 
standards up to 12 months. 
 
Significant (p<0.05) improvement in mean 
WFA amongst intervention group between 
10-18 months for girls.  No difference for 
boys. 
 
Significant (p<0.05) difference at mean 
WFA for both sexes combined at 18 
months (9.11 vs 8.61) 
 
 
Confusing reporting of results.  Two different 
growth charts used.   
 
Not clear if premature infants age was 
corrected (i.e. taken from due date rather than 
date of birth) 
 
Reporting on mean WFA rather than number 
of underweight children. 
 
Potential selection bias: Controls could 
intervention group.  Controls defined as born 
between 1/7/91-30/6/96.  Intervention group 
defined as children up to 36 months at 1/7/96 
or born between 1/7/96-3/9/97.  Children 
born after 1/7/93 could classify for both 
groups. 
 
Potential measurement bias: method for 
collecting anthropometric data different 
between controls and intervention.   
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when >1 measurement exists 
 
Growth standards: 
Reported against both National 
Centre for Health Statistics 
(NCHS) growth charts (0-36 
months) as well as interim 
WHO growth charts for (0-12 
months) 
Preterm infants: 
Up to 3kg below NCHS 50th percentile. 
 
No effect of intervention on growth. 
 
Failure to thrive: 
Diagnosed in 27.1% of population.  
Preterm births over represented. 
Potential measurement bias: use of best 
clinical estimate for gestational age. 
 
No reporting of standard definition of 
underweight.  Only reported on medically 
diagnosed Failure to Thrive.  Criteria for 
diagnosis not defined. 
 
Unable to address objective.  Two 
interventions run concurrently and one is 
potentially not culturally appropriate. 
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Rousham EK, 
Gracey M. 
1998 8 
 
92 locations 
within the 
Kimberley 
 
n = 6231 
Remote: 
1518 
Country 
town: 4713 
 
To compare the growth 
of Aboriginal infants and 
young children in 
country towns with 
those in remote 
communities in the 
Kimberley over the past 
20 years. 
Anthropometric 
measurements: retrieved 
from clinical records at 12 
month intervals from birth to 
five years old.  Weights and 
heights recorded by 
community health nurses.  
Records retrieved if recorded 
within 1 month either side of 
birthday. Unclear how 
measurements are selected 
when >1 measurement exists. 
Prematurity not corrected. 
 
Growth standards: 
NCHS growth standards. 
 
Remoteness: 
Defined by distance from 
gazetted town. Remote defined 
as >1hr from a gazetted town. 
Overall children in towns had significantly 
greater WFA z-score and height for age 
(HFA) at all ages compared to children in 
remote communities. 
 
Comparing two 5 year groups (1979-83, 
1984-88).  Significant improvement in 
WFA z-score and HFA z-score amongst 
remote children in latter cohort. 
 
Overall poor growth of both cohorts in 
comparison to NCHS growth standards. 
Mean WFA and HFA z-scores between 1 
and 1.42 standard deviations below the 
NCHS mean. 
 
Potential measurement bias: Use of routinely 
collected data.  However any bias is likely to be 
non-systematic. 
 
No reporting of abnormal weight.  Only mean 
WFA/HFA. 
 
Use of NCHS growth standards.  These 
standards have been shown to not accurately 
reflect the growth of breast fed children. 
 
Did not correct for prematurity. 
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Rousham EK, 
Gracey M. 
1997 9 
 
92 locations 
within the 
Kimberley 
 
n = 7626 
To establish whether 
there has been a 
reduction in child 
malnutrition since the 
inception of the”0-5’s” 
programme.  
Anthropometric 
measurements: retrieved 
from clinical records from 
birth to five years old.  Weights 
and heights recorded by 
community health nurses.  
Records retrieved if recorded 
+/- 10 days of each month for 
first year of life.  Records then 
retrieved if recorded +/- 10 
days of each 6 month 
milestone (ie 18 and 24 
months).  Unclear how 
measurements are selected 
when >1 measurement exists. 
Prematurity not recorded or 
corrected. 
 
Growth standards: 
NCHS growth standards.  Final 
cohort also compared to cohort 
of breast fed infants from 
North America and Europe. 
24% of children underweight (WFA below 
-2SD) at 12 months. 
 
Deterioration of mean WFA most 
pronounced from 6-12 months of age. 
 
No significant change in WFA across 20 
years of the study. 
 
Deterioration of HFA seen after 2 months. 
 
Deterioration in HFA at 6 and 12 months 
between 1984-88 compared to 1979-88 
 
WFA and HFA at 12 months significantly 
lower when compared to a cohort of 
breast fed infants. 
Potential measurement bias: Use of routinely 
collected data.  However any bias is likely to be 
non-systematic. 
 
Use of NCHS growth standards.  These 
standards have been shown to not accurately 
reflect the growth of breast fed children. 
 
Did not correct for prematurity 
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Kunitz et al. 
199510 
 
Aboriginal 
communities 
in North 
Queensland 
 
n – not stated 
 
Not stated.  Presumably 
to document the growth 
trajectory of Aboriginal 
children and describe 
any improvements over 
the 18 years of the study. 
 
Anthropometric 
measurements: retrieved 
from clinical records.  Unclear 
what method was used to 
determine what weights to 
extract. 
 
Growth standards: Harvard 
growth standards 
 
Mean WFA close to 50th percentile up until 
6 months of age, then falls to around 30th 
percentile. 
 
No statistically significant difference in 
mean WFA between two cohorts (1973-
1981 vs 1982-1990) for boys or girls 
 
No stated objectives. 
 
Statistical methods not explained. 
 
Use of growth charts that were not 
internationally endorsed at time of 
publication. 
 
Not clear if WFA corrected for prematurity. 
 
No reporting of abnormal weight.  Only mean. 
 
Potential measurement bias: Use of routinely 
collected data.  However any bias is likely to be 
non-systematic. 
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Dugdale AE, 
Muller M, 
Alsop-Shield 
L 1994 11 
 
5 Aboriginal 
communities 
in 
Queensland 
 
n: not 
reported 
 
To analyse changes in 
child growth over the 
past 10-40 years. 
 
Anthropometric 
measurements: retrieved 
from clinical records at birth, 1 
year and 5 years of age.  
Weight for 1 year of age taken 
between 9 and 18 months of 
age.  Unclear how 
measurements are selected 
when >1 measurement exists 
 
Records were scanned for 
years 1952-53, 1962-63, 1972-
73, 1992-83. 
 
Growth standards: 
NCHS growth standards.   
 
Mixed results between communities. 
 
Cherbourg: significant improvement 
(p<0.01) in mean WFA at 1 year of age 
across 40 years.  Mean WFA approximately 
level to NCHS standard. 
 
Yarrabah:  No statistically significant 
change over time.  Mean WFA approx. 90% 
of NCHS 
 
Woorabinda: Non significant increase in 
mean WFA. 
 
Palm island: Significant increase in mean 
WFA   
 
Not clear if WFA corrected for prematurity. 
 
No reporting of abnormal weight.  Only mean 
WFA compared to NCHS 
 
Potential measurement bias: Use of routinely 
collected data.  However any bias is likely to be 
non-systematic. 
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Evaluation and synthesis of material 
The studies reviewed consistently report on elevated levels of underweight infants with many 
reporting deterioration in weight between six to twelve months of age.  However, there are a 
number of methodological issues that impact their validity and affect their applicability to my 
research.  A summary of these studies including their limitations is listed above in table A-1 
and this section expands on key strengths and limitations. 
The four earlier studies (Roushan 1998, Roushan 1997, Kunitz 1995 & Dugdale 1994) contained 
a number of common strengths as well as similar methodological issues.   Strengths common 
to these studies were the large number of Aboriginal and Torres Strait Islander infants in each 
study and the collection of data from the community setting, as opposed to hospitalisation 
data, thus avoiding a potential selection bias. 
The secondary use of clinical data in these studies introduces a potential measurement bias.  
This arises as there would be neither standardisation of equipment outside of normal 
protocols nor any additional training in measurement taking.  However, it is likely that any 
error would be non-systematic.  There is a potential selection bias in using clinic data as those 
included in the study are more likely to have attended the clinic frequently.  However, 
previous studies have reported no difference in rates of clinical attendance amongst 
underweight and normal weight children.12  In all four studies, as well as those by Smith and 
the NT Government, there was no description on how weights were selected when an infant’s 
record had multiple weights to choose from.  The absence of a systematic method to select 
entries introduces a potential measurement bias through the researchers ‘cherry picking’ 
entries that most suit their purpose. 
None of the four studies, nor any of the other studies reviewed, detailed whether they 
corrected age for prematurity.  It is standard practice up to two years of age to measure a 
premature infant’s age from the day they were due to be born, rather than their date of birth. 
A failure to do so results in a potential systematic measurement bias. Without correcting for 
prematurity, their weight is assessed against an older age and premature children are thus 
more likely to fall into the underweight category. 
The growth charts used within the four studies have been shown to overestimate the 
prevalence of underweight.  Whilst the NCHS charts were the recommended charts at the time, 
these charts are based on predominately bottle-fed infants from the United States of America.  
They do not accurately describe the growth of breastfed infants13 and have been replaced by 
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the WHO growth standards. This is a form of measurement bias as while valid at the time, it 
can now be demonstrated that many of these children were incorrectly classified as 
underweight.  It is akin to using laboratory equipment that results in a high number of false 
positives. This makes it difficult to interpret the prevalence data and time trends. 
All four studies did not report on abnormal growth (i.e. underweight) but instead reported on 
mean weight for age.  This makes it difficult to interpret any improvements as an increase in 
the mean weight for age may be due to increases in overweight children rather than 
improvements in underweight.   
The later three studies (Smith 2000, NT Health Service Information Branch 2011, Thurber 
2012) all addressed many of these methodological issues.  In all studies the WHO growth 
standards were used, anthropometric data were collected primarily for the study and all 
reported on abnormal growth.  However, there remain some limitations. 
The main limitation in Smiths study was the introduction of a potential measurement bias 
through the use of different methods to measure height and weight between the control and 
intervention groups.  It is also difficult to interpret the results regarding abnormal growth as 
the study did not use the standard definition of underweight but reported on medically 
diagnosed failure to thrive.   
The study by Thurber has a number of strengths but issues in the collection of anthropometric 
data significantly impact the validity of the results in regard to infant growth.  The study design 
is the strongest out of all those reviewed with trained researches collecting data primarily for 
the study, the inclusion of Aboriginal and Torres Strait Islander children from urban and 
remote settings and the reporting of abnormal growth as both under and overweight.   
The results of the first two waves are applicable to my research where the mean age of the 
young cohort was 15.73 months and 25.8 months.  In the first wave there were a high 
proportion of children whose parents did not give consent to have their child weighed (12%) or 
were weighed by an untrained relative (22%) rather than the researcher.  It is likely this 
introduced systematic measurement bias results as it is plausible that weights would more 
likely be refused by those who had concern with their weight.  Analysis of missing data also 
showed that it was most likely amongst younger children from more isolated areas.  This may 
explain why this study reported the lowest proportion of underweight children (3% in first 
wave).  While these issues improved with subsequent waves, the first wave was most relevant 
to my research and is the one most affected by potential measurement bias. 
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The NT governments report has an excellent coverage of the target population.  The 
limitations of this study are the inability to link results to birth weight, an absence of any 
statistical analysis of time trends and no reporting on overweight. 
Conclusion 
The review has found that while there are consistent reports on the elevated proportion of 
underweight Aboriginal and Torres Strait Islanders infants, the current literature has a number 
of gaps as well as several methodological issues.  
There is an absence of studies that follow infants from birth, through this crucial period of 
growth.  Evidence is accumulating on the relationship between birth weight, early growth and 
chronic disease, for example rapid growth of SGA infants has been associated with the later 
development of obesity and insulin resistance.14 It is important to determine where a child’s 
growth falters in order to determine where to best intervene.  Whilst both Smith and 
Thurber’s study attempted to look at this pattern of growth, both had significant 
methodological issues which impact the interpretation of their results. 
There are no studies that correct for prematurity in determining weight for age.  Given the 
high proportion of premature births in Aboriginal and Torres Strait Islanders15, it is important 
that this group is measured correctly. 
There is an absence of data in the urban setting, with all but one study set in a rural or remote 
location.  This is of importance given that the majority of Aboriginal and Torres Strait Islanders 
live in cities.  Likewise, there is an absence of reporting on overweight, with the one study that 
reported on this outcome showing an elevated level in this young age group.5 
This literature review has highlighted the need for studies in the growth of Aboriginal and 
Torres Strait Islanders that look longitudinally from birth through this crucial period of growth 
as well as the need to address a number of methodological issues including the correct 
measurement of premature infants and the reporting of both under and overweight.  The 
problem of underweight Aboriginal and Torres Strait Islander infants has been documented 
multiple times and the challenge now lies in conducting a study that can give further 
information on where to intervene. 
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Appendix B: Oral presentation at a scientific conference 
Presentation at the Primary Health Care Research Conference on the findings of my 
epidemiological study.  
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Appendix C: Presentation to a non-scientific audience 
Presentation to the board of Apunipima Cape York Health Council on early results from my 
epidemiological study. 
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Appendix D: Teaching exercises 
Group teaching exercise 
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Lesson from the field 
Lesson from the field 6 – Successful Communication of Research Findings 
Learning Objectives 
After completing this exercise, you should be able to: 
 Understand the importance of communication for researchers 
 Describe the components of problem tree analysis 
 Describe the components of stakeholder analysis 
 Apply problem tree and stakeholder analysis to consider ways to successfully 
communicate the implications of one piece of work that will form part of your thesis. 
 
Scenario: 
Imagine you are a Master of Philosophy in Applied Epidemiology scholar.  You have just 
completed 18 months of hard work writing a detailed thesis (or maybe 42 months if you’re a 
part time student).  You wake in a cold sweat one night thinking, ‘Will my hard work change 
anything?’ 
By coincidence, the next day someone hands you a copy of ‘Successful Communication.  A 
Toolkit for Researchers and Civil Society Organisations’ and suggests that you read the 
Introduction (pp. 1-6). 
You read through the document keeping in mind a recommendation/implication from one of 
the chapters of your thesis that would have an important impact if it were implemented. 
Question 1:  
What are some questions to consider when communicating to inform and inspire? 
Question 2:  
How can communication result in learning for the person communicating? 
Question 3: 
The paper highlights an emerging issue in communication as ‘the conditions under which 
research is communicated’.  What is your impression of the conditions for communicating 
research in Australia?  Can you provide an example of how this environment is 
assisting/hindering efforts to translate research into policy? 
 275 
One of the first steps in communication is determining your target audiences and user groups.  
However, in trying to make change you need to go a step further and determine who is in a 
position to make change and who can assist you to communicate to these change-makers 
(allies).  A tool that can help determine the importance and influence of individuals and 
groups is ‘stakeholder analysis’.   
Read pp. 8-9 of the attachment which outlines this process. 
Question 4:  
What are the steps in stakeholder analysis? 
Below is a stakeholder analysis that I did as part of my evaluation of the national Key 
Performance Indicators (nKPIs) for Aboriginal Primary Health Care services (table D-1). 
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Table D-1: Stakeholders for the national Key Performance Indicators for Aboriginal Primary 
Health Care 
Private 
organisations 
Public sector 
stakeholders 
Aboriginal 
community 
stakeholders 
Other stakeholders 
in Aboriginal 
primary health care 
Pen Computer 
Systems  
(develop data 
extraction software) 
Improvement 
Foundation  
(host web-portal for 
submitting and 
displaying data) 
Department of 
Health, Indigenous 
Health Division 
Department of Prime 
Minister and 
Cabinet, Health 
System Analysis 
Section 
Australian Institute 
of Health and 
Welfare 
National Health 
Performance 
Authority 
National Advisory 
Group on Aboriginal 
and Torres Strait 
Islander Health 
Information and 
Data 
Australian Health 
Ministers Advisory 
Council 
NACCHO board 
State and Territory 
Affiliates 
- CEO’s and Boards 
- Public Health 
Medical Officers 
Health Services 
- CEO’s and board 
- Health Practitioners 
Australian 
Indigenous Doctors 
Association 
National Aboriginal 
and Torres Strait 
Islander Health 
Workers Association 
Congress of 
Aboriginal and 
Torres Strait Islander 
Nurses and Midwives 
Royal Australian 
College of General 
Practitioners 
Australian Medical 
Association 
Research 
institutions.  In 
particular 
- Menzies 
- Lowitja 
 
Universities 
NGO’s.  In particular 
- Oxfam 
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Table D-2: Stakeholder analysis for National Key Performance Indicators for Aboriginal 
Primary Health Care 
High influence, low interest 
 
Australian Health Ministers Advisory Council 
 
Royal Australian College of General 
Practitioners 
 
Australian Medical Association 
High Influence, high interest 
 
Department of Health 
 
Department of Prime Minister and Cabinet 
 
Australian Institute of Health and Welfare 
 
Improvement Foundation 
 
Low influence, low interest 
 
Australian Indigenous Doctors Association 
 
National Aboriginal and Torres Strait Islander 
Health Workers Association 
 
Congress of Aboriginal and Torres Strait 
Islander Nurses and Midwives 
 
Universities 
 
NGO’s. 
Low influence, high interest 
 
NACCHO board 
 
State and Territory Affiliates 
 
Health Services 
 
Pen Computer Systems 
 
National Health Performance Authority 
 
Research institutions 
 
For me, performing the stakeholder analysis helped in two ways. 
1. It showed me how I have been trying to influence things.   
I first tried to work collaboratively with those with high power and high influence but 
they did not share my desire to work together. Next I worked with the ‘low power, 
high interest group’ to try and increase their power. The strategy to increase power 
focused on improving data governance to give Aboriginal and Torres Strait Islander 
people greater control of their data.  However, this too has proved quite unsuccessful, 
as there are many layers of power where the Aboriginal and Torres Strait Islander 
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people have no influence at all.  
 
2. It has showed me another strategy. 
Increase the interest of those with high power.  The RACGP and AMA have shown their 
ability to change government policy through their resistance to the Medicare co-
payment.  If they were interested in the nKPI’s they are in a better position to 
influence decision makers.  My focus in recent weeks has been to work with the 
RACGP on topics of relevance to all General Practitioners. 
Task 1: 
Produce a stakeholder analysis grid related to one component of your thesis. 
Question 5: 
Can you provide any examples within your field placement where communication has been 
ineffective by focussing on the wrong group? 
To communicate successfully to your target audience you need also to communicate what has 
lead to the issue at hand and what outcomes could be expected if things were to change.   An 
issue may often seem insurmountable at first but may be able to be broken down into more 
manageable chunks by thinking of ‘cause of causes’.  However, identifying problems may be 
insufficient to inspire change if you are unable to communicate what would happen because of 
the change, the ‘so what?’ 
A tool to help think about causes and consequences of a problem is ‘problem tree analysis’ 
outlined on pp. 12-13. 
Question 6:  
What are the trunk, root and branches of a problem tree? 
When I first came to NACCHO, one of the problems was that health services did not want to 
share their data with us.  When we first tried to sign services up, only 7 out of 134 services 
signed data sharing agreements.  That lead me to go back to the drawing board and think 
about what was holding them back and what would be the benefits for them if they did sign up.  
I produced the problem tree analysis below. 
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A year later we now have 51 of 134 services sharing all their data and 103 sharing some of  
their data.  We have addressed two of the causes but there remain concerns on the capacity of 
NACCHO to undertake this work and there are limited examples of data benefitting services. 
Task 2: 
Produce a problem tree from an issue that you found within your evaluation. 
Question 7:  
Can you think of an example where using this tool may have assisted in resolving a problem 
within your field placement?  
